| Stock | Market Cap |
Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
|
000004.SZ Shenzhen GuoHua Network Security Technology Co., Ltd.
|
115.2 million |
0.00% |
-6.37
|
- |
- |
-
|
|
000403.SZ PACIFIC SHUANGLIN
|
2.3 billion |
0.92% |
19.19
|
- |
3 |
-
|
|
000504.SZ Landfar Bio-medicine Co., Ltd
|
427.3 million |
0.00% |
-440.50
|
- |
- |
-
|
|
000518.SZ Jiangsu Sihuan Bioengineering Co., Ltd
|
425.2 million |
0.00% |
-28.10
|
- |
- |
-
|
|
000990.SZ CHENGZHI CO. LTD.
|
1.3 billion |
0.00% |
33.50
|
- |
2 |
-
|
|
002007.SZ HUALAN BIOLOGICA.E
|
4.5 billion |
1.74% |
22.03
|
- |
16 |
2%
|
|
002030.SZ DAAN GENE CO LTD
|
1.1 billion |
0.00% |
-10.17
|
- |
20 |
25%
|
|
002252.SZ S/H RAAS BLOOD PRO
|
7.3 billion |
0.00% |
26.89
|
- |
5 |
30%
|
|
002286.SZ BAOLINGBAO BIOLOGY
|
386.9 million |
1.29% |
23.73
|
2 |
13 |
28%
|
|
002287.SZ TIBET CHEEZHENG TI
|
1.7 billion |
2.26% |
18.94
|
- |
16 |
-
|
|
002566.SZ JILIN JIAN YISHENG
|
318.1 million |
0.02% |
29.73
|
1 |
5 |
-
|
|
002630.KS ORIENT BIO Inc.
|
44.9 million |
- |
-
|
- |
- |
-
|
|
002653.SZ HAISCO PHARMACEUTI
|
5.2 billion |
0.01% |
73.98
|
- |
2 |
-
|
|
002821.SZ Asymchem Laboratories (Tianjin) Co., Ltd.
|
4.5 billion |
1.19% |
32.34
|
1 |
10 |
30%
|
|
002868.SZ Lifecome Biochemistry Co.,Ltd.
|
962.1 million |
0.00% |
-17.70
|
- |
- |
-
|
|
002872.SZ Tiansheng Pharmaceutical Group Co., Ltd.
|
240.7 million |
0.00% |
-17.17
|
- |
- |
-
|
|
002873.SZ GUIYANG XINTIAN PH
|
311.7 million |
0.76% |
39.87
|
- |
7 |
26%
|
|
002880.SZ Shenzhen Weiguang Biological Products Co., Ltd.
|
966.0 million |
0.69% |
28.69
|
2 |
9 |
4%
|
|
002898.SZ Sailong Pharmaceutical Group Co., Ltd.
|
288.4 million |
0.18% |
-27.87
|
- |
- |
-
|
|
003020.SZ HEFEI LIFEON PHARM
|
493.3 million |
0.02% |
19.64
|
- |
5 |
-
|
|
005250.KS Green Cross Holdings Corporation
|
410.6 million |
2.14% |
-
|
1 |
1 |
-
|
|
005257.KS Green Cross Holdings Corporation
|
459.3 million |
1.28% |
-
|
1 |
1 |
-
|
|
005690.KS Pharmicell Co., Ltd.
|
555.7 million |
0.35% |
-
|
- |
- |
-
|
|
011000.KS GeneOne Life Science, Inc.
|
60.1 million |
- |
-1.60
|
- |
- |
-
|
|
0126Z0.KS SAMSUNG EPIS HOLDINGS
|
8.2 billion |
- |
-
|
- |
- |
-
|
|
028300.KQ HLB Co., Ltd.
|
4.3 billion |
- |
-
|
- |
- |
-
|
|
038290.KQ Macrogen, Inc.
|
120.4 million |
1.76% |
-
|
1 |
6 |
-
|
|
048410.KQ Hyundai Bioscience Co., Ltd.
|
956.2 million |
- |
-
|
- |
- |
-
|
|
048530.KQ iNtRON Biotechnology, Inc.
|
132.6 million |
1.55% |
-
|
1 |
3 |
-
|
|
053030.KQ BINEX Co., Ltd.
|
265.5 million |
- |
-
|
- |
- |
-
|
|
064550.KQ Bioneer Corporation
|
211.8 million |
0.00% |
-
|
- |
- |
-
|
|
065660.KQ Anterogen.Co.,Ltd.
|
279.8 million |
- |
-
|
- |
- |
-
|
|
068270.KS Celltrion, Inc.
|
30.2 billion |
0.35% |
50.23
|
1 |
5 |
27%
|
|
0690.HK Uni-Bio Science Group Limited
|
82.2 million |
2.56% |
10.80
|
1 |
2 |
-
|
|
0775.HK CK Life Sciences Int'l., (Holdings) Inc.
|
980.4 million |
0.00% |
-26.67
|
- |
- |
-
|
|
078160.KQ MEDIPOST Co., Ltd.
|
589.7 million |
- |
-
|
- |
- |
-
|
|
083790.KQ CG Invites Co., Ltd.
|
72.8 million |
0.00% |
-
|
- |
- |
-
|
|
084990.KQ Helixmith Co., Ltd
|
164.0 million |
0.00% |
-
|
- |
- |
-
|
|
085660.KQ Chabiotech Co.,Ltd.
|
858.4 million |
- |
-
|
- |
- |
-
|
|
086900.KQ Medy-Tox Inc.
|
427.0 million |
4.70% |
-
|
1 |
16 |
4%
|
|
087010.KQ Peptron, Inc.
|
4.0 billion |
0.00% |
-
|
- |
- |
-
|
|
095700.KQ Genexine, Inc.
|
137.8 million |
0.00% |
-
|
- |
- |
-
|
|
096530.KQ Seegene, Inc.
|
931.9 million |
3.75% |
-
|
3 |
8 |
12%
|
|
0A8E.L Xeris Biopharma Holdings, Inc.
|
922.4 million |
0.00% |
-4.06
|
- |
- |
-
|
|
0AAJ.L PolyPeptide Group AG
|
1.0 billion |
0.00% |
16.72
|
- |
- |
-
|
|
0HI3.L Arrowhead Pharmaceuticals, Inc.
|
8.1 billion |
0.00% |
-55.13
|
- |
- |
-
|
|
0I0X.L Codexis, Inc.
|
7.1 billion |
0.00% |
-
|
- |
- |
-
|
|
0K1R.L Viridian Therapeutics, Inc.
|
2.5 billion |
0.00% |
-
|
- |
- |
-
|
|
0QF.F Moderna, Inc.
|
19.0 billion |
0.00% |
-
|
- |
- |
-
|
|
0RHR.L Kuros Biosciences AG
|
1.4 billion |
0.00% |
-119.14
|
- |
- |
-
|
|
115450.KQ HLB Therapeutics Co.,Ltd.
|
154.0 million |
- |
-
|
- |
- |
-
|
|
1167.HK Jacobio Pharmaceuticals Group Co., Ltd.
|
551.7 million |
0.00% |
-78.57
|
- |
- |
-
|
|
1177.HK Sino Biopharmaceutical Limited
|
14.0 billion |
1.47% |
25.54
|
2 |
23 |
22%
|
|
1228.HK CANbridge Pharmaceuticals Inc.
|
147.3 million |
0.00% |
-7.56
|
- |
- |
-
|
|
1244.HK 3D Medicines Inc.
|
117.1 million |
0.00% |
-4.75
|
- |
- |
-
|
|
1295.TWO Synbio Tech Inc.
|
80.1 million |
4.73% |
15.58
|
1 |
3 |
-
|
|
141080.KQ LigaChem Biosciences Inc.
|
4.7 billion |
- |
-
|
- |
- |
-
|
|
145020.KQ Hugel, Inc.
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
|
1477.HK Ocumension Therapeutics
|
661.9 million |
0.00% |
-17.92
|
- |
- |
-
|
|
1521.HK Frontage Holdings Corporation
|
279.2 million |
0.00% |
54
|
- |
- |
-
|
|
1530.HK 3SBio Inc.
|
5.9 billion |
1.27% |
18.11
|
1 |
5 |
30%
|
|
1541.HK ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
|
186.0 million |
0.00% |
-3.61
|
- |
- |
-
|
|
1548.HK Genscript Biotech Corporation
|
3.2 billion |
0.00% |
-38.10
|
- |
- |
-
|
|
1672.HK Ascletis Pharma Inc.
|
2.0 billion |
0.00% |
-49.63
|
- |
- |
-
|
|
1733.TW APEX BIOTECHNOLOGY CORP
|
93.7 million |
0.03% |
28.70
|
1 |
22 |
-
|
|
1734.TW Sinphar Pharmaceutical Co.,Ltd.
|
184.5 million |
3.07% |
17.07
|
1 |
25 |
-
|
|
174900.KQ AbClon Inc.
|
653.1 million |
- |
-
|
- |
- |
-
|
|
1760.TW Panion & Bf Biotech Inc.
|
181.7 million |
2.73% |
33.25
|
1 |
12 |
-
|
|
1762.TW CHUNGHWA CHEMICAL SYNTHESIS BIO
|
81.3 million |
0.00% |
26.51
|
- |
15 |
-8%
|
|
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
|
99.8 million |
7.43% |
12.15
|
1 |
19 |
7%
|
|
1779.HK LONGBIO-B
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
177A.T Kohjin Bio Co., Ltd.
|
37.5 million |
2.03% |
8.38
|
1 |
2 |
-
|
|
1801.HK Innovent Biologics, Inc.
|
18.3 billion |
0.00% |
109.61
|
- |
- |
-
|
|
1873.HK Viva Biotech Holdings
|
562.2 million |
0.00% |
29.86
|
- |
- |
-
|
|
1875.HK BioDlink International Company Limited
|
397.1 million |
0.00% |
201.50
|
- |
- |
-
|
|
1877.HK Shanghai Junshi Biosciences Co., Ltd.
|
3.5 billion |
0.00% |
-16.11
|
- |
- |
-
|
|
1952.HK Everest Medicines Limited
|
1.5 billion |
0.00% |
-14.60
|
- |
- |
-
|
|
196170.KQ ALTEOGEN Inc.
|
12.3 billion |
0.10% |
-
|
- |
- |
-
|
|
199800.KQ ToolGen Incorporated
|
240.5 million |
- |
-
|
- |
- |
-
|
|
1AD.AX AdAlta Limited
|
405578 |
0.00% |
-0.45
|
- |
- |
-
|
|
1AI.AX Algorae Pharmaceuticals Limited
|
17.6 million |
0.00% |
-
|
- |
- |
-
|
|
206A.T PRISM BioLab Co.,LTD
|
44.1 million |
- |
-8.46
|
- |
- |
-
|
|
207940.KS SAMSUNG BIOLOGICS
|
36.8 billion |
- |
-
|
- |
- |
-
|
|
2105.HK Laekna, Inc.
|
579.8 million |
0.00% |
-
|
- |
- |
-
|
|
2126.HK JW (Cayman) Therapeutics Co. Ltd
|
101.9 million |
0.00% |
-1.14
|
- |
- |
-
|
|
2137.HK Brii Biosciences Limited
|
125.9 million |
0.00% |
-2.32
|
- |
- |
-
|
|
2142.HK HBM Holdings Limited
|
1.3 billion |
0.00% |
16.52
|
- |
- |
-
|
|
214450.KQ PharmaResearch Co., Ltd.
|
2.1 billion |
0.35% |
-
|
1 |
1 |
-
|
|
215600.KQ SillaJen, Inc.
|
310.8 million |
- |
-
|
- |
- |
-
|
|
2157.HK Lepu Biopharma Co., Ltd.
|
911.1 million |
0.00% |
-36
|
- |
- |
-
|
|
216080.KQ JETEMA, Co., Ltd.
|
213.4 million |
0.00% |
-
|
- |
- |
-
|
|
2160.T GNI Group Ltd.
|
1.2 billion |
0.00% |
-42.64
|
- |
- |
-
|
|
2162.HK Keymed Biosciences Inc.
|
1.8 billion |
0.00% |
-42.22
|
- |
- |
-
|
|
2171.HK CARsgen Therapeutics Holdings Limited
|
835.7 million |
0.00% |
-11.19
|
- |
- |
-
|
|
2179.HK Jiangsu Recbio Technology Co., Ltd.
|
261.7 million |
0.00% |
-2.79
|
- |
- |
-
|
|
2181.HK Mabpharm Limited
|
210.3 million |
0.00% |
-40
|
- |
- |
-
|
|
2183.T Linical Co., Ltd.
|
44.3 million |
5.05% |
-6.02
|
1 |
18 |
17%
|
|
2185.HK Shanghai Bio-heart Biological Technology Co., Ltd.
|
148.8 million |
0.00% |
-12.07
|
- |
- |
-
|
|
2197.HK Clover Biopharmaceuticals, Ltd.
|
309.3 million |
0.00% |
-2.34
|
- |
- |
-
|
|
2256.HK Abbisko Cayman Limited
|
938.0 million |
0.00% |
42.88
|
- |
- |
-
|
|
2257.HK Sirnaomics Ltd.
|
82.4 million |
0.00% |
-4.90
|
- |
- |
-
|
|
226950.KQ OliX Pharmaceuticals,Inc
|
2.5 billion |
0.00% |
-
|
- |
- |
-
|
|
2269.HK WuXi Biologics (Cayman) Inc.
|
19.5 billion |
0.00% |
33.33
|
- |
- |
-
|
|
228760.KQ Genomictree Inc.
|
298.2 million |
- |
-
|
- |
- |
-
|
|
22UA.F BioNTech SE
|
22.5 billion |
0.00% |
-
|
- |
- |
-
|
|
22Z.F Zealand Pharma A/S
|
3.2 billion |
0.00% |
3.38
|
- |
- |
-
|
|
2315.HK Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
|
2.6 billion |
0.00% |
133.29
|
- |
- |
-
|
|
2342.T Trans Genic Inc.
|
29.8 million |
2.08% |
-5.48
|
- |
- |
-
|
|
235980.KQ MedPacto, Inc.
|
119.7 million |
0.00% |
-
|
- |
- |
-
|
|
2370.T MEDINET Co., Ltd.
|
50.8 million |
0.00% |
-5.83
|
- |
- |
-
|
|
2385.T Soiken Holdings Inc.
|
40.5 million |
2.00% |
37.71
|
- |
10 |
-
|
|
2396.HK B&K Corp Ltd
|
76.1 million |
0.00% |
-
|
- |
- |
-
|
|
2480.HK Beijing Luzhu Biotechnology Co., Ltd.
|
337.1 million |
0.00% |
-
|
- |
- |
-
|
|
2487.HK Cutia Therapeutics
|
208.8 million |
0.00% |
-2.76
|
- |
- |
-
|
|
2493.HK MABWELL-B
|
- |
0.00% |
-
|
- |
- |
-
|
|
2496.HK YZYBIO-B
|
173.3 million |
0.00% |
-
|
- |
- |
-
|
|
2509.HK Qyuns Therapeutics Co., Ltd.
|
498.5 million |
0.00% |
-17.59
|
- |
- |
-
|
|
2511.HK HighTide Therapeutics Inc
|
174.8 million |
0.00% |
-3.29
|
- |
- |
-
|
|
2563.HK Beijing Biostar Pharms Co Ltd
|
103.6 million |
0.00% |
-9.37
|
- |
- |
-
|
|
2565.HK PegBio Co., Ltd.
|
409.9 million |
0.00% |
-
|
- |
- |
-
|
|
2566.HK Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
|
270.3 million |
1.01% |
8.63
|
1 |
1 |
-
|
|
2591.HK Guangzhou Innogen Pharmaceutl Grp Co Ltd
|
1.3 billion |
0.00% |
-40.51
|
- |
- |
-
|
|
2592.HK Cloudbreak Pharma Inc.
|
130.4 million |
0.00% |
-
|
- |
- |
-
|
|
2595.HK GenFleet Therapeutics (Shanghai) Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
2616.HK CStone Pharmaceuticals
|
1.1 billion |
0.00% |
-18.36
|
- |
- |
-
|
|
2617.HK TransThera Sciences (Nanjing), Inc.
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
|
2629.HK Mirxes Holding Company Limited
|
471.9 million |
0.00% |
-
|
- |
- |
-
|
|
2659.HK Shanghai Bao Pharmaceuticals Co., Ltd.
|
788.1 million |
0.00% |
-
|
- |
- |
-
|
|
2696.HK Shanghai Henlius Biotech, Inc.
|
4.4 billion |
0.00% |
36.47
|
- |
- |
-
|
|
298380.KQ ABL Bio Inc.
|
6.8 billion |
- |
-
|
- |
- |
-
|
|
299660.KQ Cellid, Co., Ltd.
|
48.7 million |
0.00% |
-
|
- |
- |
-
|
|
2CUREX.ST 2cureX AB (publ)
|
4.7 million |
0.00% |
-
|
- |
- |
-
|
|
2VSA.F Verastem, Inc.
|
343.8 million |
0.00% |
-1.35
|
- |
- |
-
|
|
300009.SZ ANHUI ANKE BIOTECH
|
2.0 billion |
0.03% |
17.79
|
- |
16 |
14%
|
|
300049.SZ Inner Mongolia Furui Medical Science Co., Ltd.
|
2.2 billion |
0.00% |
118.51
|
- |
- |
-
|
|
300122.SZ CHONGQING ZHIFEI B
|
9.3 billion |
0.03% |
16.08
|
- |
14 |
20%
|
|
300147.SZ Xiangxue Pharmaceutical Co.,Ltd.
|
890.7 million |
0.00% |
-6.05
|
- |
- |
-
|
|
300181.SZ ZHEJIANG JOLLY PHA
|
1.5 billion |
0.03% |
20.27
|
1 |
13 |
30%
|
|
300204.SZ Staidson (Beijing) BioPharmaceuticals Co., Ltd.
|
1.8 billion |
0.00% |
-76.03
|
- |
- |
-
|
|
300238.SZ Guanhao Biotech Co.,Ltd.
|
584.2 million |
0.00% |
149.90
|
- |
- |
-
|
|
300255.SZ Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
|
5.7 billion |
0.00% |
-126.97
|
- |
- |
-
|
|
300294.SZ CHINA RESOURCES BO
|
2.2 billion |
1.38% |
80.08
|
- |
13 |
30%
|
|
300318.SZ Beijing Bohui Innovation Biotechnology Group Co., Ltd.
|
725.2 million |
0.00% |
-100.67
|
- |
- |
-
|
|
300381.SZ GUANGDONG VTR BIO-
|
465.1 million |
0.01% |
164.75
|
- |
11 |
-
|
|
300497.SZ Jiangxi Fushine Pharmaceutical Co., Ltd.
|
1.2 billion |
0.00% |
-30.02
|
- |
- |
-
|
|
300583.SZ SHANDONG SITO BIO
|
538.1 million |
0.04% |
-113.53
|
- |
3 |
-
|
|
300653.SZ YANTAI ZHENGHAI BI
|
527.2 million |
0.04% |
21.51
|
- |
7 |
30%
|
|
300759.SZ Pharmaron Beijing Co., Ltd.
|
7.9 billion |
0.67% |
30.85
|
1 |
7 |
-1%
|
|
300841.SZ Chengdu Kanghua Biological Products Co., Ltd.
|
976.0 million |
- |
12.57
|
1 |
4 |
-
|
|
300858.SZ Beijing Scitop Bio-tech Co., Ltd.
|
646.0 million |
0.90% |
43.89
|
1 |
5 |
-26%
|
|
300871.SZ HVSEN BIOTECHNOLOG
|
229.2 million |
0.02% |
-33.75
|
- |
4 |
-
|
|
300878.SZ ZHEJIANG WECOME PH
|
301.3 million |
0.01% |
-62.74
|
- |
1 |
-
|
|
300942.SZ Shenzhen Bioeasy Biotechnology Co., Ltd.
|
536.4 million |
0.19% |
112.63
|
1 |
2 |
-
|
|
300966.SZ HUBEI GOTO BIOPHAR
|
258.6 million |
0.00% |
-127.17
|
- |
1 |
-
|
|
301207.SZ HUALAN BIOLOGICAL
|
1.5 billion |
0.03% |
20.51
|
- |
3 |
-
|
|
302440.KS SK bioscience Co.,Ltd.
|
2.4 billion |
0.00% |
-
|
- |
- |
-
|
|
310210.KQ Voronoi, Inc.
|
3.9 billion |
- |
-
|
- |
- |
-
|
|
3118.TWO Level Biotechnology Inc.
|
34.1 million |
5.37% |
13.51
|
1 |
18 |
-15%
|
|
3164.TW GENMONT BIOTECH INC
|
54.4 million |
0.00% |
32.87
|
- |
6 |
11%
|
|
3176.TWO Medigen Biotechnology Corp.
|
131.8 million |
0.00% |
-39.67
|
- |
- |
-
|
|
3205.TWO Sagittarius Life Science Corp
|
109.4 million |
0.00% |
-50.59
|
- |
- |
-
|
|
323990.KQ Vaxcell-Bio Therapeutics Co., Ltd.
|
126.4 million |
- |
-
|
- |
- |
-
|
|
326030.KS SK Biopharmaceuticals Co., Ltd.
|
5.2 billion |
0.00% |
-
|
- |
- |
-
|
|
340450.KQ GC Genome Corporation
|
114.0 million |
- |
-
|
- |
- |
-
|
|
347850.KQ D&D Pharmatech
|
2.3 billion |
- |
-
|
- |
- |
-
|
|
353810.KQ EASY BIO,Inc.
|
152.1 million |
- |
-
|
1 |
1 |
-
|
|
358570.KQ GI Innovation, Inc.
|
629.3 million |
- |
-
|
- |
- |
-
|
|
3681.HK SinoMab BioScience Limited
|
283.3 million |
0.00% |
-12.12
|
- |
- |
-
|
|
373110.KQ Xcell Therapeutics, Inc.
|
10.5 million |
- |
-
|
- |
- |
-
|
|
3750.T ADR120S, Inc.
|
48.7 million |
0.00% |
-4.28
|
- |
- |
-
|
|
3759.HK PHARMARON
|
5.6 billion |
0.02% |
11.50
|
- |
5 |
-
|
|
3880.HK Medtide Inc.
|
425.6 million |
0.00% |
26.45
|
- |
- |
-
|
|
3BBLACKBIO.BO 3B BlackBio Dx Ltd
|
113.9 million |
0.32% |
18.81
|
- |
- |
-
|
|
4130.TWO Genovate Biotechnology Co., Ltd.
|
121.6 million |
0.30% |
330
|
1 |
13 |
-30%
|
|
4131.TWO NeoCore Technology Co., Ltd.
|
47.0 million |
0.00% |
-72.88
|
- |
- |
-
|
|
4133.TW ABNOVA (TAIWAN) CORPORATION
|
57.1 million |
0.02% |
30.98
|
- |
15 |
-
|
|
4142.TW Adimmune Corporation
|
285.1 million |
0.00% |
-
|
- |
- |
-
|
|
4147.TWO TaiMed Biologics Inc.
|
434.0 million |
0.00% |
-63.25
|
- |
- |
-
|
|
4157.TWO TaiGen Biopharmaceuticals Holdings Limited
|
272.6 million |
0.00% |
-48.80
|
- |
- |
-
|
|
4162.TWO PharmaEngine, Inc.
|
320.2 million |
8.33% |
6.19
|
1 |
11 |
30%
|
|
4167.TWO Savior Lifetec Corporation
|
174.4 million |
2.28% |
11.40
|
1 |
3 |
-
|
|
4168.TWO GlycoNex Incorporation
|
85.7 million |
0.00% |
-12.32
|
- |
- |
-
|
|
4169.TWO TCM Biotech International Corp.
|
445.8 million |
0.15% |
650
|
1 |
3 |
-
|
|
4170.TWO Vectorite Biomedical Inc.
|
19.4 million |
0.00% |
-26.60
|
- |
- |
-
|
|
4171.TWO GeneReach Biotechnology Corp.
|
36.7 million |
0.00% |
-7.79
|
- |
- |
-
|
|
4174.TWO OBI Pharma, Inc.
|
163.4 million |
0.00% |
-
|
- |
- |
-
|
|
4186.TWO Taiwan Advance Bio-Pharmaceutical Inc.
|
30.1 million |
0.00% |
40.96
|
- |
- |
-
|
|
4192.TWO SynCore Biotechnology Co.,Ltd
|
22.7 million |
0.00% |
-15.61
|
- |
- |
-
|
|
4194.TWO Holy Stone Healthcare Co., Ltd.
|
32.2 million |
0.00% |
-7.73
|
- |
- |
-
|
|
4195.TWO Genomics BioSci & Tech. Co.,Ltd.
|
54.6 million |
0.00% |
-20.87
|
- |
- |
-
|
|
4197.TWO Visgeneer Inc.
|
8.9 million |
0.00% |
-233.75
|
- |
- |
-
|
|
4563.T AnGes, Inc.
|
138.5 million |
0.00% |
-4.02
|
- |
- |
-
|
|
4564.T OncoTherapy Science, Inc.
|
44.7 million |
0.00% |
-7.42
|
- |
- |
-
|
|
4565.T Nxera Pharma Co., Ltd.
|
476.5 million |
0.00% |
-6.13
|
- |
- |
-
|
|
4570.T Immuno-Biological Laboratories Co., Ltd.
|
86.7 million |
0.80% |
43.84
|
1 |
1 |
-
|
|
4571.T NANO MRNA Co.,Ltd.
|
78.8 million |
0.00% |
-16.56
|
- |
- |
-
|
|
4572.T Carna Biosciences, Inc.
|
38.9 million |
0.00% |
-2.89
|
- |
- |
-
|
|
4575.T CanBas Co., Ltd.
|
97.0 million |
0.00% |
-12.39
|
- |
- |
-
|
|
4576.T D. Western Therapeutics Institute, Inc.
|
27.1 million |
0.00% |
-3.58
|
- |
- |
-
|
|
4579.T RaQualia Pharma Inc.
|
136.0 million |
0.00% |
-37.88
|
- |
- |
-
|
|
4583.T Chiome Bioscience Inc.
|
43.8 million |
0.00% |
-6.80
|
- |
- |
-
|
|
4584.T Kidswell Bio Corporation
|
84.1 million |
0.00% |
40.23
|
- |
- |
-
|
|
4587.T PeptiDream Inc.
|
1.2 billion |
0.00% |
-51.17
|
- |
- |
-
|
|
4588.T Oncolys BioPharma Inc.
|
399.0 million |
0.00% |
-27.89
|
- |
- |
-
|
|
4591.T Ribomic Inc.
|
27.5 million |
0.00% |
-3.61
|
- |
- |
-
|
|
4592.T SanBio Company Limited
|
997.9 million |
0.00% |
-40.87
|
- |
- |
-
|
|
4593.T Healios K.K.
|
321.5 million |
0.00% |
-16.87
|
- |
- |
-
|
|
4594.T BrightPath Biotherapeutics Co., Ltd.
|
39.5 million |
0.00% |
-5.98
|
- |
- |
-
|
|
4596.T Kubota Pharmaceutical Holdings Co., Ltd.
|
47.8 million |
0.00% |
-6.94
|
- |
- |
-
|
|
4598.T Delta-Fly Pharma, Inc.
|
18.1 million |
0.00% |
-1.50
|
- |
- |
-
|
|
4599.T StemRIM
|
107.8 million |
0.00% |
-8.92
|
- |
- |
-
|
|
468530.KQ Proteina Co., Ltd.
|
438.4 million |
- |
-
|
- |
- |
-
|
|
4724.TWO Meribank Biotech Co., Ltd
|
44.0 million |
0.00% |
-19.47
|
- |
- |
-
|
|
4726.TWO Mycenax Biotech Inc.
|
216.4 million |
0.00% |
-
|
- |
- |
-
|
|
4728.TWO Sunmax Biotechnology Co., Ltd.
|
666.8 million |
2.97% |
29.70
|
2 |
9 |
30%
|
|
4732.TWO NBM
|
39.1 million |
0.00% |
93.52
|
1 |
4 |
-
|
|
4743.TWO Oneness Biotech Co., Ltd.
|
777.9 million |
0.00% |
-
|
- |
- |
-
|
|
475830.KQ Orum Therapeutics, Inc.
|
1.6 billion |
- |
-
|
- |
- |
-
|
|
4875.T MediciNova, Inc.
|
70.9 million |
0.00% |
-5.97
|
- |
- |
-
|
|
4880.T CellSource Co., Ltd.
|
44.5 million |
1.38% |
684.91
|
1 |
3 |
-
|
|
4881.T FunPep Company Limited
|
28.1 million |
0.00% |
-2.66
|
- |
- |
-
|
|
4884.T Kringle Pharma, Inc.
|
17.7 million |
0.00% |
-2.94
|
- |
- |
-
|
|
4888.T Stella Pharma Corporation
|
103.4 million |
0.00% |
-97.42
|
- |
- |
-
|
|
4891.T TMS Co., Ltd.
|
40.2 million |
0.00% |
-9.21
|
- |
- |
-
|
|
4893.T Noile-Immune Biotech Inc.
|
37.8 million |
0.00% |
-8.82
|
- |
- |
-
|
|
4894.T Cuorips Inc.
|
367.3 million |
0.00% |
-88.86
|
- |
- |
-
|
|
4896.T K Pharma,Inc.
|
57.1 million |
0.00% |
-10.68
|
- |
- |
-
|
|
4911.TWO G&E Herbal Biotechnology Co., Ltd.
|
67.5 million |
2.24% |
15.07
|
1 |
2 |
-
|
|
4974.T Takara Bio Inc.
|
853.8 million |
1.48% |
-21.63
|
- |
14 |
12%
|
|
4978.T ReproCELL Incorporated
|
112.5 million |
0.00% |
-66.44
|
- |
- |
-
|
|
4BB.L 4basebio PLC
|
1.1 million |
0.00% |
-5.45
|
- |
- |
-
|
|
5CV.DE CureVac N.V.
|
995.9 million |
0.00% |
6.80
|
- |
- |
-
|
|
5CV.F CureVac N.V.
|
1.0 billion |
0.00% |
6.85
|
- |
- |
-
|
|
600161.SS Beijing Tiantan Biological Products Co., Ltd.
|
4.1 billion |
0.00% |
29.10
|
1 |
9 |
30%
|
|
600200.SS JiangSu WuZhong Pharmaceutical Development Co., Ltd.
|
30.3 million |
0.00% |
-3.22
|
- |
- |
-
|
|
600201.SS Jinyu Bio-technology Co., Ltd.
|
2.4 billion |
0.21% |
163
|
1 |
15 |
-
|
|
600645.SS Vcanbio Cell & Gene Engineering Corp., Ltd
|
1.8 billion |
0.00% |
157.35
|
- |
- |
-
|
|
600866.SS Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
|
1.9 billion |
4.99% |
9.90
|
- |
2 |
-
|
|
603229.SS Zhejiang Ausun Pharmaceutical Co., Ltd.
|
1.1 billion |
1.08% |
42.14
|
1 |
8 |
4%
|
|
603233.SS DaShenLin Pharmaceutical Group Co., Ltd.
|
3.1 billion |
0.00% |
16.57
|
1 |
9 |
20%
|
|
603392.SS Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
7.3 billion |
0.82% |
-145.19
|
- |
- |
-
|
|
603439.SS GuiZhou SanLi Pharmaceutical Co.,Ltd
|
677.9 million |
2.96% |
28.75
|
- |
3 |
-
|
|
603566.SS Pulike Biological Engineering, Inc.
|
695.5 million |
4.34% |
32.95
|
2 |
11 |
30%
|
|
603590.SS Beijing Konruns Pharmaceutical Co.,Ltd.
|
930.9 million |
1.50% |
117.26
|
- |
7 |
-
|
|
603718.SS Shanghai Hile Bio-Technology Co., Ltd.
|
449.4 million |
1.67% |
18.04
|
1 |
3 |
-
|
|
603739.SS Qingdao Vland Biotech Inc.
|
579.4 million |
0.64% |
47.21
|
1 |
8 |
-6%
|
|
603896.SS Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
|
609.3 million |
1.29% |
30.30
|
- |
8 |
-
|
|
605116.SS Aurisco Pharmaceutical Co.,Ltd.
|
1.5 billion |
1.14% |
24.08
|
1 |
6 |
30%
|
|
605177.SS Zhejiang East Asia Pharmaceutical Co., Ltd.
|
353.7 million |
1.54% |
-11.08
|
- |
- |
-
|
|
6132.HK
|
- |
0.00% |
-
|
- |
- |
-
|
|
6160.HK BeOne Medicines AG
|
32.1 billion |
0.00% |
564.52
|
- |
- |
-
|
|
6190.T PhoenixBio Co., Ltd.
|
11.7 million |
0.00% |
-6.01
|
- |
- |
-
|
|
6236.TWO Neith Corporation
|
38.3 million |
0.00% |
2930
|
- |
- |
-
|
|
6461.TWO Intech Biopharm Corporation
|
117.3 million |
0.00% |
-9.05
|
- |
- |
-
|
|
6492.TWO Senhwa Biosciences, Inc.
|
145.3 million |
0.00% |
-17.56
|
- |
- |
-
|
|
6535.TWO Lumosa Therapeutics Co., Ltd.
|
822.8 million |
0.00% |
-78.64
|
- |
- |
-
|
|
6541.TW Tanvex BioPharma, Inc.
|
372.4 million |
0.00% |
-7.33
|
- |
- |
-
|
|
6547.TWO Medigen Vaccine Biologics Corporation
|
379.8 million |
0.00% |
-70.77
|
- |
- |
-
|
|
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
|
19.5 million |
0.00% |
-24.25
|
- |
- |
-
|
|
6550.TW Polaris Group
|
848.9 million |
0.00% |
-8
|
- |
- |
-
|
|
6564.TWO Enimmune corporation
|
39.9 million |
0.00% |
-7.96
|
- |
- |
-
|
|
6580.TWO TaiRx, Inc.
|
62.6 million |
0.00% |
-14.02
|
- |
- |
-
|
|
6586.TWO CHO Pharma, Inc.
|
167.6 million |
0.00% |
-23.32
|
- |
- |
-
|
|
6610.TWO TWi Biotechnology, Inc.
|
68.1 million |
0.00% |
-11.38
|
- |
- |
-
|
|
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
|
300.2 million |
0.00% |
-109.86
|
- |
- |
-
|
|
6622.HK Zhaoke Ophthalmology Limited
|
220.8 million |
0.00% |
-5.56
|
- |
- |
-
|
|
6628.HK Transcenta Holding Limited
|
105.6 million |
0.00% |
-2.60
|
- |
- |
-
|
|
6634.TWO Sinew Pharma Inc.
|
82.3 million |
0.00% |
-18.47
|
- |
- |
-
|
|
6652.TWO Eusol Biotech Co.,Ltd.
|
27.4 million |
0.00% |
-22.71
|
- |
- |
-
|
|
6657.TW Energenesis Biomedical CO.,LTD.
|
130.2 million |
0.00% |
-15.51
|
- |
- |
-
|
|
6660.HK AIM Vaccine Co., Ltd.
|
459.3 million |
0.00% |
-11.31
|
- |
- |
-
|
|
6662.TWO BioLASCO Taiwan Co., Ltd.
|
24.2 million |
4.99% |
17.17
|
1 |
8 |
-2%
|
|
6676.TWO Sunny Pharmtech Inc.
|
79.9 million |
0.00% |
-9.34
|
- |
- |
-
|
|
6696.TWO Lin BioScience, Inc.
|
1.0 billion |
0.00% |
-31.86
|
- |
- |
-
|
|
6704.TWO Gwo Xi Stem Cell Applied Technology Co. , Ltd
|
73.3 million |
0.00% |
-33.36
|
- |
- |
-
|
|
6709.TWO Advagene Biopharma Co., Ltd.
|
57.3 million |
0.00% |
-26.97
|
- |
- |
-
|
|
6712.TWO Ever Supreme Bio Technology Co., Ltd
|
397.3 million |
3.22% |
24.53
|
1 |
5 |
-
|
|
6733.TWO BioGend Therapeutics Co., Ltd.
|
142.5 million |
0.00% |
-52.75
|
- |
- |
-
|
|
6744.TWO Feng Chi Biotech Corp.
|
7.8 million |
5.88% |
15.99
|
1 |
7 |
-2%
|
|
6748.TWO ACRO Biomedical Co., Ltd.
|
133.9 million |
0.00% |
-47.44
|
- |
- |
-
|
|
6794.TW UnicoCell Biomed Co., Ltd.
|
170.0 million |
0.00% |
-47.54
|
- |
- |
-
|
|
6808.TWO 3D Global Biotech Inc.
|
94.1 million |
1.36% |
21.17
|
1 |
1 |
-
|
|
6810.TWO Bio Preventive Medicine Corp.
|
28.3 million |
0.00% |
-8.09
|
- |
- |
-
|
|
6814.TWO Lukas Biomedical Inc.
|
35.2 million |
0.00% |
-11.60
|
- |
- |
-
|
|
6821.HK Asymchem Laboratories (Tianjin) Co., Ltd.
|
3.9 billion |
1.45% |
25.66
|
1 |
5 |
24%
|
|
6826.HK Shanghai Haohai Biological Technology Co., Ltd.
|
1.3 billion |
4.53% |
12.45
|
2 |
11 |
29%
|
|
6827.TWO MegaPro Biomedical Co., Ltd
|
28.8 million |
0.00% |
-5.04
|
- |
- |
-
|
|
6846.TWO Greenyn Biotechnology Co., Ltd
|
61.0 million |
0.00% |
-
|
- |
4 |
-
|
|
6848.TWO RBC
|
7.8 million |
0.02% |
14.51
|
2 |
3 |
-
|
|
6850.TWO BiOptic Inc.
|
45.3 million |
0.63% |
68.13
|
1 |
4 |
-
|
|
6855.HK Ascentage Pharma Group International
|
2.1 billion |
0.00% |
-11.01
|
- |
- |
-
|
|
6864.TWO Anti-Microbial Savior BioteQ Co., Ltd
|
70.5 million |
0.00% |
-21.94
|
- |
- |
-
|
|
6872.HK TENNOR THERAP-B
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
6875.TWO Pharmosa Biopharm Inc.
|
164.1 million |
0.00% |
-22.13
|
- |
- |
-
|
|
6876.TWO LAUNXP Biomedical Co., Ltd
|
33.4 million |
0.00% |
-7.34
|
- |
- |
-
|
|
6879.TWO TCI GENE Inc.
|
31.6 million |
5.26% |
28.15
|
1 |
4 |
-
|
|
688062.SS Mabwell (Shanghai) Bioscience Co., Ltd.
|
1.9 billion |
0.00% |
-13.42
|
- |
- |
-
|
|
688068.SS Beijing Hotgen Biotech Co., Ltd.
|
1.8 billion |
0.15% |
-43.65
|
- |
- |
-
|
|
688075.SS Assure Tech (Hangzhou) Co., Ltd.
|
713.9 million |
2.09% |
40.23
|
1 |
4 |
-
|
|
688076.SS Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.
|
1.6 billion |
1.69% |
21.08
|
1 |
5 |
30%
|
|
688089.SS Cabio Biotech (Wuhan) Co., Ltd.
|
466.3 million |
1.07% |
18.66
|
1 |
6 |
-14%
|
|
688098.SS Shanghai Shen Lian Biomedical Corporation
|
533.5 million |
0.45% |
-110.50
|
- |
- |
-
|
|
688105.SS Nanjing Vazyme Biotech Co., Ltd.
|
1.1 billion |
0.76% |
-245.75
|
1 |
5 |
-
|
|
688136.SS Kexing Biopharm Co., Ltd.
|
860.7 million |
0.27% |
46.92
|
1 |
2 |
-
|
|
688180.SS Shanghai Junshi Biosciences Co., Ltd.
|
4.6 billion |
0.00% |
-29.44
|
- |
- |
-
|
|
688235.SS BeOne Medicines Ltd. Class A
|
36.7 billion |
0.00% |
853.39
|
- |
- |
-
|
|
688265.SS Shanghai Model Organisms Center, Inc.
|
509.9 million |
0.29% |
71.77
|
- |
- |
-
|
|
688266.SS Suzhou Zelgen Biopharmaceuticals Co., Ltd.
|
3.2 billion |
0.00% |
-164.30
|
- |
- |
-
|
|
688278.SS Xiamen Amoytop Biotech Co., Ltd.
|
4.2 billion |
0.88% |
30.58
|
1 |
7 |
30%
|
|
688315.SS Novogene Co., Ltd.
|
858.5 million |
0.35% |
33.53
|
1 |
5 |
-
|
|
688319.SS Chengdu Olymvax Biopharmaceuticals Inc.
|
1.8 billion |
0.00% |
608.60
|
- |
- |
-
|
|
688331.SS RemeGen Co Ltd
|
12.3 billion |
0.00% |
115.58
|
- |
- |
-
|
|
688336.SS Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
|
5.3 billion |
0.21% |
41.57
|
2 |
3 |
-
|
|
688366.SS Shanghai Haohai Biological Technology Co., Ltd.
|
1.2 billion |
2.36% |
24.88
|
2 |
7 |
30%
|
|
688399.SS Jiangsu Bioperfectus Technologies Co., Ltd.
|
703.3 million |
5.96% |
-196.72
|
1 |
1 |
-
|
|
688488.SS Jiangsu Aidea Pharmaceutical Co., Ltd.
|
1.0 billion |
0.00% |
-74.91
|
- |
- |
-
|
|
688513.SS Chengdu Easton Biopharmaceuticals Co., Ltd.
|
1.5 billion |
0.74% |
42.30
|
1 |
6 |
-
|
|
688520.SS Sinocelltech Group Limited
|
2.4 billion |
0.00% |
-52.86
|
- |
- |
-
|
|
688526.SS Wuhan Keqian Biology Co.,Ltd
|
1.1 billion |
2.72% |
16.10
|
1 |
6 |
-
|
|
688578.SS Shanghai Allist Pharmaceuticals Co., Ltd.
|
6.4 billion |
0.83% |
21.88
|
2 |
3 |
-
|
|
688639.SS Anhui Huaheng Biotechnology Co., Ltd.
|
1.2 billion |
0.79% |
42.27
|
2 |
6 |
-
|
|
688658.SS Youcare Pharmaceutical Group Co., Ltd.
|
1.2 billion |
1.05% |
-36.46
|
- |
- |
-
|
|
688670.SS Jiangsu gdk Biotechnology Co., Ltd.
|
333.2 million |
0.00% |
-17.86
|
- |
- |
-
|
|
688687.SS Beijing Kawin Technology Share-Holding Co., Ltd.
|
501.5 million |
1.47% |
24.85
|
1 |
6 |
8%
|
|
688767.SS Hangzhou Biotest Biotech Co.,Ltd.
|
737.9 million |
2.12% |
49.44
|
1 |
5 |
-22%
|
|
6891.TWO Locus Cell Co., Ltd.
|
166.4 million |
0.00% |
-
|
- |
- |
-
|
|
6892.TWO Taiwan Bio Therapeutics Co., Ltd
|
82.8 million |
0.00% |
-5.73
|
- |
- |
-
|
|
6917.TWO Andros Pharmaceuticals Co.,Ltd
|
31.9 million |
0.00% |
-10.90
|
- |
- |
-
|
|
6919.TW Caliway Biopharmaceuticals Co. L
|
7.3 billion |
0.00% |
-467.19
|
- |
- |
-
|
|
6926.TWO Shine-On BioMedical Co.,Ltd.
|
104.7 million |
0.00% |
-27.92
|
- |
- |
-
|
|
6938.HK Suzhou Ribo Life Science Co
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
6945.TWO AP Biosciences Inc
|
455.3 million |
0.00% |
-32.53
|
- |
- |
-
|
|
6949.TW Pell Bio-Med Technology Co., Ltd.
|
1.3 billion |
0.00% |
-100.95
|
- |
- |
-
|
|
6955.HK Shandong Boan Biotechnology Co., Ltd.
|
384.1 million |
0.00% |
484.00
|
- |
- |
-
|
|
6973.TWO U-Neuron Biomedical Inc
|
40.1 million |
0.00% |
-26.06
|
- |
- |
-
|
|
6976.TWO Acepodia, Inc.
|
235.4 million |
0.00% |
-11.32
|
- |
- |
-
|
|
6978.HK Immunotech Biopharm Ltd
|
153.9 million |
0.00% |
-5.22
|
- |
- |
-
|
|
6986.TWO HeXun Biosciences Co., Ltd.
|
76.8 million |
0.00% |
21.54
|
- |
- |
-
|
|
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
|
14.1 billion |
0.00% |
-
|
- |
- |
-
|
|
6996.HK Antengene Corporation Limited
|
304.6 million |
0.00% |
-9.54
|
- |
- |
-
|
|
6998.HK Genor Biopharma Holdings Limited
|
171.3 million |
0.00% |
36.57
|
- |
- |
-
|
|
7096.T StemCell Institute Inc.
|
53.3 million |
2.92% |
44.58
|
- |
- |
-
|
|
7427.TWO Great Novel Therapeutics Biotech & Medicals
|
46.0 million |
0.00% |
-16.54
|
- |
- |
-
|
|
7666.HK METIS TECHBIO-P
|
3.4 billion |
0.00% |
-
|
- |
- |
-
|
|
7725.TWO LabTurbo Biotech Corporation
|
33.0 million |
1.37% |
-6.66
|
1 |
3 |
-
|
|
7729.TWO Steminent Biotherapeutics Inc.
|
160.3 million |
0.00% |
-29.84
|
- |
- |
-
|
|
7754.TWO AnnJi
|
169.6 million |
0.00% |
-16.99
|
- |
- |
-
|
|
7774.T Japan Tissue Engineering Co., Ltd.
|
204.0 million |
0.00% |
-82.27
|
- |
- |
-
|
|
7776.T CellSeed Inc.
|
74.9 million |
0.00% |
-11.72
|
- |
- |
-
|
|
8158.HK China Regenerative Medicine International Limited
|
13.0 million |
0.00% |
16.75
|
- |
- |
-
|
|
8279.TWO Syngen Biotech Co.,Ltd.
|
98.3 million |
4.33% |
10.72
|
1 |
11 |
4%
|
|
88Q.DE 4basebio PLC
|
142.2 million |
0.00% |
-7.19
|
- |
- |
-
|
|
88Q.F 4basebio PLC
|
107.7 million |
0.00% |
-5.40
|
- |
- |
-
|
|
94E.F Zura Bio Limited
|
407.9 million |
0.00% |
-10
|
- |
- |
-
|
|
950160.KQ Kolon TissueGene, Inc.
|
5.6 billion |
- |
-
|
- |
- |
-
|
|
950210.KS Prestige BioPharma Limited
|
391.2 million |
- |
-
|
- |
- |
-
|
|
950220.KQ NeoImmuneTech, Inc.
|
7.6 million |
- |
-
|
- |
- |
-
|
|
9606.HK Duality Biotherapeutics, Inc.
|
3.3 billion |
0.00% |
-8.08
|
- |
- |
-
|
|
9688.HK Zai Lab Limited
|
2.2 billion |
0.00% |
-10.39
|
- |
- |
-
|
|
9887.HK Nanjing Leads Biolabs Co Ltd
|
1.4 billion |
0.00% |
-31.13
|
- |
- |
-
|
|
9926.HK Akeso, Inc.
|
11.2 billion |
0.00% |
-86.64
|
- |
- |
-
|
|
9939.HK Kintor Pharmaceutical Limited
|
174.0 million |
0.00% |
-6.77
|
- |
- |
-
|
|
9966.HK Alphamab Oncology
|
962.8 million |
0.00% |
28.85
|
- |
- |
-
|
|
9969.HK InnoCare Pharma Limited
|
2.1 billion |
0.00% |
-86.38
|
- |
- |
-
|
|
9995.HK RemeGen Co., Ltd.
|
6.0 billion |
0.00% |
-35.54
|
- |
- |
-
|
|
AADI Aadi Bioscience, Inc.
|
94.9 million |
0.00% |
-
|
- |
- |
-
|
|
AAGH America Great Health
|
2.1 million |
0.00% |
-
|
- |
- |
-
|
|
AARD Aardvark Therapeutics, Inc. Common Stock
|
80.3 million |
0.00% |
-
|
- |
- |
-
|
|
AAVXF Abivax S.A.
|
5.7 billion |
0.00% |
-
|
- |
- |
-
|
|
ABCL AbCellera Biologics Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
|
ABCM Abcam plc
|
5.5 billion |
0.75% |
2397
|
- |
- |
-
|
|
ABEO Abeona Therapeutics Inc.
|
331.7 million |
0.00% |
5.54
|
- |
- |
-
|
|
ABIO ARCA biopharma, Inc.
|
40.8 million |
0.00% |
-4.32
|
- |
1 |
-
|
|
ABNX.PA ABIONYX Pharma S.A.
|
132.5 million |
0.00% |
-25.35
|
- |
- |
-
|
|
ABP Abpro Corporation
|
1.1 million |
0.00% |
-0.06
|
- |
- |
-
|
|
ABPO Abpro Holdings, Inc.
|
522600 |
0.00% |
-0.02
|
- |
- |
-
|
|
ABPWW Abpro Holdings Inc
|
4.6 million |
0.00% |
-
|
- |
- |
-
|
|
ABSI Absci Corporation
|
997.8 million |
0.00% |
-
|
- |
- |
-
|
|
ABS.OL Arctic Bioscience AS
|
8.7 million |
0.00% |
-1.92
|
- |
- |
-
|
|
ABUS Arbutus Biopharma Corporation
|
859.3 million |
0.00% |
4.99
|
- |
- |
-
|
|
ABVC ABVC BioPharma, Inc.
|
18.5 million |
0.00% |
-5.18
|
- |
- |
-
|
|
ABVX Abivax S.A.
|
5.9 billion |
0.00% |
-
|
- |
- |
-
|
|
ABVX.PA Abivax S.A.
|
8.0 billion |
0.00% |
-
|
- |
- |
-
|
|
ACAD ACADIA Pharmaceuticals Inc.
|
3.7 billion |
0.00% |
9.86
|
- |
- |
-
|
|
ACER Acer Therapeutics Inc.
|
16.1 million |
3.50% |
-1.35
|
- |
- |
-
|
|
ACE.ST Ascelia Pharma AB (publ)
|
37.5 million |
0.00% |
-4.28
|
- |
- |
-
|
|
ACET Adicet Bio, Inc.
|
77.5 million |
0.00% |
-
|
- |
- |
-
|
|
ACHFF Arch Biopartners Inc.
|
23.9 million |
0.00% |
-29.15
|
- |
- |
-
|
|
ACHL Achilles Therapeutics plc
|
56.3 million |
0.00% |
-0.83
|
- |
- |
-
|
|
ACHV Achieve Life Sciences, Inc.
|
543.1 million |
0.00% |
-
|
- |
- |
-
|
|
ACIU AC Immune S.A.
|
239.7 million |
0.00% |
-
|
- |
- |
-
|
|
ACLX Arcellx, Inc.
|
6.7 billion |
0.00% |
-
|
- |
- |
-
|
|
ACOG Alpha Cognition Inc. Common Stock
|
90.4 million |
0.00% |
-
|
- |
- |
-
|
|
ACOU.ST AcouSort AB (publ)
|
4.8 million |
0.00% |
-3.47
|
- |
- |
-
|
|
ACR.AX Acrux Limited
|
3.7 million |
0.00% |
-1.30
|
- |
- |
-
|
|
ACRV Acrivon Therapeutics, Inc. Common Stock
|
45.1 million |
0.00% |
-
|
- |
- |
-
|
|
ACST Acasti Pharma, Inc.
|
33.2 million |
0.00% |
-0.41
|
- |
- |
-
|
|
ACTI.ST Active Biotech AB (publ)
|
5.9 million |
0.00% |
-1.46
|
- |
- |
-
|
|
ACUT Accustem Sciences Inc.
|
4.1 million |
0.00% |
-4
|
- |
- |
-
|
|
ACW.AX Actinogen Medical Limited
|
103.7 million |
0.00% |
-4.20
|
- |
- |
-
|
|
ACXP Acurx Pharmaceuticals, Inc.
|
2.7 million |
0.00% |
-
|
- |
- |
-
|
|
ADAG Adagene Inc.
|
133.9 million |
0.00% |
-
|
- |
- |
-
|
|
ADAP Adaptimmune Therapeutics plc
|
14.6 million |
0.00% |
-
|
- |
- |
-
|
|
ADAPY Adaptimmune Therapeutics plc
|
7.4 million |
0.00% |
-
|
- |
- |
-
|
|
ADCT ADC Therapeutics S.A.
|
131.0 million |
0.00% |
-
|
- |
- |
-
|
|
ADGI Adagio Therapeutics, Inc.
|
505.0 million |
- |
-
|
- |
- |
-
|
|
ADIL Adial Pharmaceuticals, Inc.
|
2.2 million |
0.00% |
-
|
- |
- |
-
|
|
ADMA ADMA Biologics, Inc.
|
1.9 billion |
0.00% |
11.59
|
- |
- |
-
|
|
ADO.AX AnteoTech Limited
|
22.6 million |
0.00% |
-1.10
|
- |
- |
-
|
|
ADOC.PA Adocia S.A.
|
148.2 million |
0.00% |
-7.06
|
- |
- |
-
|
|
ADOCY Adocia S.A.
|
170.4 million |
0.00% |
-3.36
|
- |
- |
-
|
|
ADPT Adaptive Biotechnologies Corporation
|
2.7 billion |
0.00% |
-
|
- |
- |
-
|
|
ADTX Aditxt, Inc.
|
50668 |
0.00% |
-
|
- |
- |
-
|
|
ADVM Adverum Biotechnologies, Inc.
|
92.1 million |
0.00% |
-0.49
|
- |
- |
-
|
|
ADXN Addex Therapeutics Ltd
|
4.2 million |
0.00% |
-
|
- |
- |
-
|
|
ADXN.SW Addex Therapeutics Ltd
|
9.1 million |
0.00% |
-
|
- |
- |
-
|
|
ADXS Ayala Pharmaceuticals, Inc.
|
25.7 million |
0.00% |
-0.08
|
- |
- |
-
|
|
ADYX Adynxx, Inc.
|
581 |
0.00% |
-
|
- |
- |
-
|
|
AELIS.PA Aelis Farma S.A.
|
19.7 million |
0.00% |
-2.12
|
- |
- |
-
|
|
AEON
|
- |
- |
-
|
- |
- |
-
|
|
AEZS Aeterna Zentaris Inc.
|
18.1 million |
0.00% |
-0.37
|
- |
- |
-
|
|
AFFY Affymax, Inc.
|
44988 |
0.00% |
0.05
|
- |
- |
-
|
|
AFMD Affimed N.V.
|
3.0 million |
0.00% |
-
|
- |
- |
-
|
|
AFMDQ Affimed N.V.
|
3278 |
0.00% |
-
|
- |
- |
-
|
|
AGE AgeX Therapeutics, Inc.
|
33.2 million |
0.00% |
-1.02
|
- |
- |
-
|
|
AGEN Agenus Inc.
|
134.1 million |
0.00% |
1.75
|
- |
- |
-
|
|
AGIO Agios Pharmaceuticals, Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
|
AGLE Spyre Therapeutics, Inc.
|
48.6 million |
- |
-4.70
|
- |
- |
-
|
|
AGMB AgomAb Therapeutics N.V. American Depositary Shares
|
488.5 million |
0.00% |
-
|
- |
- |
-
|
|
AGN.AX Argenica Therapeutics Limited
|
19.5 million |
0.00% |
-2.75
|
- |
- |
-
|
|
AGN.CN Algernon Pharmaceuticals Inc.
|
987423 |
0.00% |
-0.57
|
- |
- |
-
|
|
AGNPF Algernon Pharmaceuticals Inc.
|
1.2 million |
0.00% |
-0.60
|
- |
- |
-
|
|
AGTC Applied Genetic Technologies Corporation
|
26.6 million |
- |
-2.28
|
- |
- |
-
|
|
AGTX Agentix Corp.
|
841406 |
0.00% |
-4.85
|
- |
- |
-
|
|
AIBT Aibotics Inc.
|
440613 |
0.00% |
-0.02
|
- |
- |
-
|
|
AIKI AIkido Pharma Inc.
|
19.4 million |
- |
-0.24
|
- |
- |
-
|
|
AIM AIM ImmunoTech Inc.
|
6.5 million |
0.00% |
-
|
- |
- |
-
|
|
AIXC AIxCrypto Holdings, Inc.
|
6.7 million |
- |
0.39
|
- |
- |
-
|
|
AKBLF ALK-Abelló A/S
|
7.8 billion |
0.64% |
39.07
|
1 |
1 |
-
|
|
AKRO Akero Therapeutics, Inc.
|
4.5 billion |
0.00% |
-14.52
|
- |
- |
-
|
|
AKTX Akari Therapeutics, Plc
|
17.2 million |
0.00% |
-
|
- |
- |
-
|
|
AKUS Akouos, Inc.
|
491.0 million |
- |
-
|
- |
- |
-
|
|
ALA.AX Arovella Therapeutics Limited
|
64.2 million |
0.00% |
-7.70
|
- |
- |
-
|
|
ALBO Albireo Pharma, Inc.
|
920.7 million |
- |
-11.67
|
- |
- |
-
|
|
ALBPS.PA Biophytis S.A.
|
1.3 million |
0.00% |
-0.15
|
- |
- |
-
|
|
ALCLS.PA Cellectis S.A.
|
338.4 million |
0.00% |
-
|
- |
- |
-
|
|
ALCOX.PA Nicox S.A.
|
37.0 million |
0.00% |
-1.18
|
- |
- |
-
|
|
ALDVI.PA Advicenne S.A.
|
24.9 million |
0.00% |
-
|
- |
- |
-
|
|
ALDX Aldeyra Therapeutics, Inc.
|
98.3 million |
0.00% |
-
|
- |
- |
-
|
|
ALEC Alector, Inc.
|
197.1 million |
0.00% |
-
|
- |
- |
-
|
|
ALEMS.BR European Medical Solutions
|
25.6 million |
0.00% |
18.28
|
- |
- |
-
|
|
ALGAE.PA Fermentalg
|
47.1 million |
0.00% |
-3.91
|
- |
- |
-
|
|
ALGEN.PA genOway S.A.
|
23.8 million |
0.00% |
12.72
|
- |
- |
-
|
|
ALGS Aligos Therapeutics, Inc.
|
31.8 million |
0.00% |
-
|
- |
- |
-
|
|
ALINT.PA IntegraGen S.A.
|
1.4 million |
0.00% |
-4.49
|
- |
- |
-
|
|
ALK-B.CO ALK-Abelló A/S
|
7.5 billion |
0.00% |
41.30
|
1 |
1 |
-
|
|
ALLK Allakos Inc.
|
29.4 million |
0.00% |
-0.25
|
- |
- |
-
|
|
ALLO Allogene Therapeutics, Inc.
|
458.5 million |
0.00% |
-
|
- |
- |
-
|
|
ALLR Allarity Therapeutics, Inc.
|
25.6 million |
0.00% |
-
|
- |
- |
-
|
|
ALMS Alumis Inc. Common Stock
|
2.5 billion |
0.00% |
-
|
- |
- |
-
|
|
ALNA Allena Pharmaceuticals, Inc.
|
9.2 million |
- |
-1.19
|
- |
- |
-
|
|
ALNEV.PA Neovacs S.A.
|
815 |
0.00% |
-
|
- |
- |
-
|
|
ALNFL.PA NFL Biosciences S.A.
|
15.5 million |
0.00% |
-3.83
|
- |
- |
-
|
|
ALNY Alnylam Pharmaceuticals, Inc.
|
40.6 billion |
0.00% |
76.32
|
- |
- |
-
|
|
ALP AlphaTON Capital Corp. Common Stock
|
6.6 million |
- |
-
|
- |
- |
-
|
|
ALPAT.PA Plant Advanced Technologies S.A.
|
10.2 million |
0.00% |
9.59
|
- |
- |
-
|
|
ALPN Alpine Immune Sciences, Inc.
|
4.5 billion |
0.00% |
-22.30
|
- |
- |
-
|
|
ALRN Aileron Therapeutics, Inc.
|
41.8 million |
0.00% |
-1.64
|
- |
- |
-
|
|
ALSEN.PA Sensorion S.A.
|
365.1 million |
0.00% |
-
|
- |
- |
-
|
|
ALT Altimmune, Inc.
|
253.3 million |
0.00% |
-
|
- |
- |
-
|
|
ALTAO.PA Aton
|
5.7 million |
0.00% |
-
|
- |
- |
-
|
|
ALTHX.PA THX Pharma
|
34.7 million |
0.00% |
-9.50
|
- |
- |
-
|
|
ALTME.PA TME Pharma N.V.
|
7.7 million |
0.00% |
-1.44
|
- |
- |
-
|
|
ALVAL.PA Valbiotis S.A.
|
27.7 million |
0.00% |
-1.51
|
- |
- |
-
|
|
ALVIO.PA Valerio Therapeutics S.A.
|
56.6 million |
0.00% |
-1.58
|
- |
- |
-
|
|
ALVR AlloVir, Inc.
|
50.9 million |
0.00% |
-0.50
|
- |
- |
-
|
|
ALXN Alexion Pharmaceuticals, Inc.
|
40.3 billion |
- |
59.23
|
- |
- |
-
|
|
ALXO ALX Oncology Holdings Inc.
|
211.9 million |
0.00% |
-
|
- |
- |
-
|
|
ALZCUR.ST AlzeCure Pharma AB (publ)
|
22.6 million |
0.00% |
-4.76
|
- |
- |
-
|
|
ALZN Alzamend Neuro, Inc.
|
3.6 million |
0.00% |
-0.74
|
- |
- |
-
|
|
ALZ.ST Alzinova AB (publ)
|
5.8 million |
0.00% |
-2.08
|
- |
- |
-
|
|
AMAM Ambrx Biopharma Inc.
|
1.8 billion |
0.00% |
66.14
|
- |
- |
-
|
|
AMBS Amarantus BioScience Holdings, Inc.
|
36841 |
0.00% |
-0.01
|
- |
- |
-
|
|
AMGXF AnGes, Inc.
|
142.5 million |
0.00% |
-0.46
|
- |
- |
-
|
|
AMLX Amylyx Pharmaceuticals, Inc.
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
AMPE Ampio Pharmaceuticals, Inc.
|
207884 |
0.00% |
-0.03
|
- |
- |
-
|
|
AMTI Applied Molecular Transport Inc.
|
11.0 million |
- |
-0.14
|
- |
- |
-
|
|
ANAB AnaptysBio, Inc.
|
578.0 million |
- |
68.66
|
- |
- |
-
|
|
ANEB Anebulo Pharmaceuticals, Inc.
|
15.3 million |
0.00% |
-
|
- |
- |
-
|
|
ANGN Angion Biomedica Corp.
|
20.4 million |
- |
-
|
- |
- |
-
|
|
ANIX Anixa Biosciences, Inc.
|
84.4 million |
0.00% |
-
|
- |
- |
-
|
|
ANL Adlai Nortye Ltd.
|
574.1 million |
0.00% |
-8.11
|
- |
- |
-
|
|
ANNX Annexon, Inc.
|
644.6 million |
0.00% |
-
|
- |
- |
-
|
|
ANNX.ST Annexin Pharmaceuticals AB (publ)
|
10.4 million |
0.00% |
-2.56
|
- |
- |
-
|
|
ANPC Fresh2 Group Limited
|
27.0 million |
- |
-
|
- |
- |
-
|
|
ANR.AX Anatara Lifesciences Ltd
|
1.4 million |
0.00% |
-1
|
- |
- |
-
|
|
ANRO Alto Neuroscience, Inc.
|
640.8 million |
0.00% |
-
|
- |
- |
-
|
|
ANTH Anthera Pharmaceuticals, Inc.
|
6178 |
- |
0.00
|
- |
- |
-
|
|
ANTHEM.NS Anthem Biosciences Ltd.
|
4.0 billion |
0.00% |
77.71
|
- |
1 |
-
|
|
ANTX AN2 Therapeutics, Inc.
|
119.5 million |
0.00% |
-
|
- |
- |
-
|
|
ANVS Annovis Bio, Inc.
|
37.2 million |
0.00% |
-
|
- |
- |
-
|
|
AOBI American Oriental Bioengineering, Inc.
|
88 |
0.00% |
-
|
- |
- |
-
|
|
APGE Apogee Therapeutics, Inc.
|
5.1 billion |
0.00% |
-
|
- |
- |
-
|
|
APLIF Appili Therapeutics Inc.
|
1.5 million |
0.00% |
-1.30
|
- |
- |
-
|
|
APLI.TO Appili Therapeutics Inc.
|
1.8 million |
0.00% |
-1
|
- |
- |
-
|
|
APLM Apollomics, Inc.
|
15.2 million |
0.00% |
-0.77
|
- |
- |
-
|
|
APLMW Apollomics, Inc.
|
193.6 million |
0.00% |
-
|
- |
- |
-
|
|
APLS Apellis Pharmaceuticals, Inc.
|
5.3 billion |
0.00% |
38.34
|
- |
- |
-
|
|
APLT Applied Therapeutics, Inc.
|
14.9 million |
0.00% |
-1.03
|
- |
- |
-
|
|
APM Aptorum Group Limited
|
7.0 million |
- |
2.70
|
- |
- |
-
|
|
APOP Cellect Biotechnology Ltd.
|
51.5 million |
- |
-0.82
|
- |
- |
-
|
|
APRE Aprea Therapeutics, Inc.
|
5.0 million |
0.00% |
-
|
- |
- |
-
|
|
APS.TO Aptose Biosciences Inc.
|
3.9 million |
0.00% |
2.33
|
- |
- |
-
|
|
APTA.L Aptamer Group plc
|
294187 |
0.00% |
-0.82
|
- |
- |
-
|
|
APTA.ST Aptahem AB (publ)
|
1.6 million |
0.00% |
-2.83
|
- |
- |
-
|
|
APTO Aptose Biosciences, Inc.
|
4.4 million |
0.00% |
-0.05
|
- |
- |
-
|
|
APTX Aptinyx Inc.
|
4.4 million |
- |
-2.48
|
- |
- |
-
|
|
APVO Aptevo Therapeutics Inc.
|
10.3 million |
0.00% |
-
|
- |
- |
-
|
|
ARAV Aravive, Inc.
|
2.9 million |
- |
-0.05
|
- |
- |
-
|
|
ARBS.MI Arterra Bioscience
|
20.4 million |
4.74% |
9.45
|
1 |
5 |
30%
|
|
ARCH.V Arch Biopartners Inc.
|
37.8 million |
0.00% |
-40
|
- |
- |
-
|
|
ARCT Arcturus Therapeutics Holdings Inc.
|
217.4 million |
0.00% |
-
|
- |
- |
-
|
|
ARDS Aridis Pharmaceuticals, Inc.
|
8915 |
0.00% |
-0.01
|
- |
- |
-
|
|
ARDX Ardelyx, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
AREC.L Arecor Therapeutics plc
|
359432 |
0.00% |
-3.13
|
- |
- |
-
|
|
ARGNF argenx SE
|
51.7 billion |
0.00% |
35.71
|
- |
- |
-
|
|
ARGX argenx SE
|
52.1 billion |
0.00% |
36.08
|
- |
- |
-
|
|
ARGX.BR argenx SE
|
43.9 billion |
0.00% |
36.90
|
- |
- |
-
|
|
ARMP Armata Pharmaceuticals, Inc.
|
275.3 million |
0.00% |
-
|
- |
- |
-
|
|
ARNA Arena Pharmaceuticals, Inc.
|
6.2 billion |
- |
-6.17
|
- |
- |
-
|
|
ARNI Arno Therapeutics, Inc.
|
9870 |
0.00% |
-0.01
|
- |
- |
-
|
|
ARQT Arcutis Biotherapeutics, Inc.
|
2.7 billion |
0.00% |
-
|
- |
- |
-
|
|
ARTL Artelo Biosciences, Inc.
|
3.2 million |
0.00% |
-
|
- |
- |
-
|
|
ARTV Artiva Biotherapeutics, Inc.
|
169.3 million |
0.00% |
-
|
- |
- |
-
|
|
ARUXF Acrux Limited
|
6.8 million |
0.00% |
-0.45
|
- |
- |
-
|
|
ARVN Arvinas, Inc.
|
496.8 million |
0.00% |
-
|
- |
- |
-
|
|
ARWR Arrowhead Pharmaceuticals, Inc.
|
10.0 billion |
0.00% |
-
|
- |
- |
-
|
|
ASBP Aspire Biopharma Holdings, Inc.
|
616086 |
0.00% |
-0.05
|
- |
- |
-
|
|
ASBPW Aspire Biopharma Holdings, Inc.
|
210484 |
0.00% |
-
|
- |
- |
-
|
|
ASCLF Ascletis Pharma Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
ASEP.CN Asep Medical Holdings Inc
|
1.9 million |
0.00% |
-0.25
|
- |
- |
-
|
|
ASLN ASLAN Pharmaceuticals Limited
|
6.7 million |
0.00% |
-0.19
|
- |
- |
-
|
|
ASMB Assembly Biosciences, Inc.
|
385.4 million |
0.00% |
380.13
|
- |
- |
-
|
|
ASND Ascendis Pharma A/S
|
13.0 billion |
0.00% |
24.81
|
- |
- |
-
|
|
ASPHF Ascentage Pharma Group International
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
|
ATAI Atai Beckley Inc.
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
|
ATGGF Actinogen Medical Limited
|
2.9 million |
0.00% |
-
|
- |
- |
-
|
|
ATHA Athira Pharma, Inc.
|
26.0 million |
0.00% |
-0.68
|
- |
- |
-
|
|
ATH.AX Alterity Therapeutics Limited
|
52.6 million |
0.00% |
-0.70
|
- |
- |
-
|
|
ATHE Alterity Therapeutics Limited
|
36.7 million |
0.00% |
-5.97
|
- |
- |
-
|
|
ATHX Athersys, Inc.
|
459479 |
1.02% |
0.72
|
- |
- |
-
|
|
ATNF 180 Life Sciences Corp.
|
21.4 million |
0.00% |
-0.24
|
- |
- |
-
|
|
ATNFW CannBioRx Life Sciences Corp.
|
73074 |
0.00% |
-
|
- |
- |
-
|
|
ATNM Actinium Pharmaceuticals, Inc.
|
33.9 million |
0.00% |
-
|
- |
- |
-
|
|
ATORX.ST Alligator Bioscience AB (publ)
|
727844 |
0.00% |
-0.10
|
- |
- |
-
|
|
ATOS Atossa Therapeutics, Inc.
|
41.8 million |
0.00% |
-1.36
|
- |
- |
-
|
|
ATRA Atara Biotherapeutics, Inc.
|
89.4 million |
0.00% |
-
|
- |
- |
-
|
|
ATRX Adhera Therapeutics, Inc.
|
722 |
0.00% |
-
|
- |
- |
-
|
|
ATRY.MC Atrys Health, S.A.
|
243.3 million |
0.00% |
-8.78
|
- |
- |
-
|
|
ATX.AX Amplia Therapeutics Limited
|
39.0 million |
0.00% |
-5.50
|
- |
- |
-
|
|
ATXI Avenue Therapeutics, Inc.
|
1.2 million |
0.00% |
-
|
- |
- |
-
|
|
ATXS Astria Therapeutics, Inc.
|
731.8 million |
0.00% |
-5.99
|
- |
- |
-
|
|
ATYR aTyr Pharma, Inc.
|
50.3 million |
0.00% |
-
|
- |
- |
-
|
|
AUPH Aurinia Pharmaceuticals Inc.
|
2.0 billion |
0.00% |
7.07
|
- |
- |
-
|
|
AURA Aura Biosciences, Inc.
|
425.6 million |
0.00% |
-
|
- |
- |
-
|
|
AURX Nuo Therapeutics, Inc.
|
51.3 million |
0.00% |
-28
|
- |
- |
-
|
|
AUTL Autolus Therapeutics plc
|
407.2 million |
0.00% |
-
|
- |
- |
-
|
|
AVBP ArriVent BioPharma, Inc. Common Stock
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
AVCTF Avacta Group Plc
|
437.4 million |
0.00% |
-5.50
|
- |
- |
-
|
|
AVCT.L Avacta Group Plc
|
3.9 million |
0.00% |
-6.14
|
- |
- |
-
|
|
AVE.AX Avecho Biotechnology Limited
|
24.6 million |
0.00% |
-
|
- |
- |
-
|
|
AVEFF Avecho Biotechnology Limited
|
13.4 million |
0.00% |
-
|
- |
- |
-
|
|
AVEO AVEO Pharmaceuticals, Inc.
|
521.4 million |
- |
-3.94
|
- |
- |
-
|
|
AVIR Atea Pharmaceuticals, Inc.
|
353.7 million |
0.00% |
-
|
- |
- |
-
|
|
AVRO AVROBIO, Inc.
|
68.2 million |
0.00% |
2.20
|
- |
- |
-
|
|
AVTX Avalo Therapeutics, Inc.
|
157.7 million |
0.00% |
-
|
- |
- |
-
|
|
AVXL Anavex Life Sciences Corp.
|
228.4 million |
0.00% |
-
|
- |
- |
-
|
|
AXIM AXIM Biotechnologies, Inc.
|
1.2 million |
0.00% |
-0.27
|
- |
- |
-
|
|
AXLA Axcella Health Inc.
|
1.2 million |
- |
-0.02
|
- |
- |
-
|
|
AXSM Axsome Therapeutics, Inc.
|
11.9 billion |
0.00% |
-
|
- |
- |
-
|
|
AYLA Ayala Pharmaceuticals, Inc.
|
7.5 million |
- |
-
|
- |
- |
-
|
|
AZRX AzurRx BioPharma, Inc.
|
271.1 million |
- |
-1.26
|
- |
- |
-
|
|
AZT.OL ArcticZymes Technologies ASA
|
105.3 million |
0.00% |
78.46
|
- |
- |
-
|
|
AZTR Azitra, Inc.
|
2.3 million |
0.00% |
-
|
- |
- |
-
|
|
BALAXI.NS Balaxi Pharmaceuticals Limited
|
2.2 million |
0.00% |
10.81
|
- |
- |
-
|
|
BAVA.CO Bavarian Nordic A/S
|
2.8 billion |
0.00% |
10.39
|
- |
- |
-
|
|
BBI Brickell Biotech, Inc.
|
6.8 million |
- |
-0.60
|
- |
- |
-
|
|
BBIO BridgeBio Pharma, Inc.
|
13.2 billion |
0.00% |
-
|
- |
- |
-
|
|
BBIXF Bonus BioGroup Ltd.
|
151.8 million |
0.00% |
-13.50
|
- |
- |
-
|
|
BBOT BridgeBio Oncology Therapeutics Inc.
|
581.6 million |
0.00% |
-
|
- |
- |
-
|
|
BBZA.DE BB Biotech AG
|
3.7 billion |
3.72% |
-5.87
|
1 |
14 |
-18%
|
|
BCAB BioAtla, Inc.
|
4.2 million |
0.00% |
-
|
- |
- |
-
|
|
BCAX Bicara Therapeutics Inc. Common Stock
|
1.1 billion |
0.00% |
3.33
|
- |
- |
-
|
|
BCDA BioCardia, Inc.
|
5.1 million |
0.00% |
-
|
- |
- |
-
|
|
BCDAW BioCardia, Inc.
|
4.4 million |
0.00% |
-0.01
|
- |
- |
-
|
|
BCEL Atreca, Inc.
|
3.6 million |
0.00% |
-0.11
|
- |
- |
-
|
|
BCLI Brainstorm Cell Therapeutics Inc.
|
8.7 million |
0.00% |
-
|
- |
- |
-
|
|
BCRX BioCryst Pharmaceuticals, Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
|
BCT.TO BriaCell Therapeutics Corp.
|
7.3 million |
0.00% |
-0.12
|
- |
- |
-
|
|
BCTX BriaCell Therapeutics Corp.
|
6.2 million |
0.00% |
-0.12
|
- |
- |
-
|
|
BCTXW BriaCell Therapeutics Corp.
|
1695 |
0.00% |
-
|
- |
- |
-
|
|
BCTXZ BriaCell Therapeutics Corp. Warrant
|
149757 |
- |
-
|
- |
- |
-
|
|
BCX.WA Bioceltix S.A.
|
114.3 million |
0.00% |
-27.62
|
- |
- |
-
|
|
BCYC Bicycle Therapeutics plc
|
291.5 million |
0.00% |
-
|
- |
- |
-
|
|
BDRX Biodexa Pharmaceuticals Plc
|
602248 |
0.00% |
-0.04
|
- |
- |
-
|
|
BDTX Black Diamond Therapeutics, Inc.
|
112.9 million |
0.00% |
-
|
- |
- |
-
|
|
BEAM Beam Therapeutics Inc.
|
3.0 billion |
0.00% |
-
|
- |
- |
-
|
|
BETR.CN BetterLife Pharma Inc.
|
6.4 million |
0.00% |
-6
|
- |
- |
-
|
|
BETRF BetterLife Pharma Inc.
|
7.6 million |
0.00% |
-6.30
|
- |
- |
-
|
|
BFRA Biofrontera AG
|
80.2 million |
- |
-8.15
|
- |
- |
-
|
|
BGBIO.OL BerGenBio ASA
|
4.6 million |
0.00% |
-0.45
|
- |
- |
-
|
|
BGMS Bio Green Med Solution, Inc.
|
2.3 million |
0.00% |
-
|
- |
- |
-
|
|
BGMSP Bio Green Med Solution, Inc.
|
6.0 million |
19.35% |
-
|
4 |
2 |
-
|
|
BGNE BeiGene, Ltd.
|
20.2 billion |
0.00% |
-
|
- |
- |
-
|
|
BGT.AX Bio-Gene Technology Limited
|
7.8 million |
0.00% |
-3.70
|
- |
- |
-
|
|
BHVN Biohaven Ltd.
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
BIBCL.BO Bharat Immunologicals & Biologicals Corporation Limited
|
7.7 million |
0.00% |
-4.81
|
- |
- |
-
|
|
BICTF Biocure Technology Inc.
|
379088 |
0.00% |
-0.50
|
- |
- |
-
|
|
BINV.ST BioInvent International AB (publ)
|
154.0 million |
0.00% |
-4.60
|
- |
- |
-
|
|
BIO3.DE Biotest AG
|
1.6 billion |
0.00% |
-47.62
|
- |
2 |
-
|
|
BIOA-B.ST BioArctic AB (publ)
|
2.7 billion |
0.00% |
26.05
|
1 |
1 |
-
|
|
BIOAF Bioasis Technologies Inc.
|
7941 |
0.00% |
-
|
- |
- |
-
|
|
BIOBV.HE Biohit Oyj
|
43.6 million |
0.00% |
14
|
- |
- |
-
|
|
BIOCON.BO Biocon Limited
|
5.2 billion |
0.13% |
79.06
|
1 |
5 |
30%
|
|
BIOCON.NS Biocon Limited
|
5.2 billion |
0.13% |
79.55
|
1 |
5 |
30%
|
|
BIO.DE Biotest AG
|
1.6 billion |
0.00% |
-67.30
|
- |
2 |
-
|
|
BIOM3.SA Biomm S.A.
|
166.8 million |
0.00% |
-13.15
|
- |
- |
-
|
|
BION.SW BB Biotech AG
|
3.1 billion |
3.98% |
4.29
|
1 |
14 |
-20%
|
|
BIOR Biora Therapeutics, Inc.
|
994994 |
0.00% |
0.61
|
- |
- |
-
|
|
BIORQ Biora Therapeutics, Inc.
|
452 |
0.00% |
-
|
- |
- |
-
|
|
BIOS.BR BioSenic S.A.
|
1.9 million |
0.00% |
-0.12
|
- |
- |
-
|
|
BIOSGN.ST Biosergen AB
|
9.3 million |
0.00% |
-2.21
|
- |
- |
-
|
|
BIOV.CN BioVaxys Technology Corp.
|
2.2 million |
0.00% |
-0.44
|
- |
- |
-
|
|
BIOVIC-B.ST Biovica International AB (publ)
|
11.4 million |
0.00% |
-
|
- |
- |
-
|
|
BIO.WA Bioton S.a.
|
94.4 million |
0.00% |
-137.67
|
- |
- |
-
|
|
BIOWKS.ST Bio-Works Technologies AB (publ)
|
23.9 million |
0.00% |
-16.47
|
- |
- |
-
|
|
BIT.AX Biotron Limited
|
3.4 million |
0.00% |
-0.30
|
- |
- |
-
|
|
BITRF Biotron Limited
|
997495 |
0.00% |
-0.54
|
- |
- |
-
|
|
BIVI BioVie Inc.
|
12.6 million |
0.00% |
-
|
- |
- |
-
|
|
BIXT Bioxytran, Inc.
|
3.5 million |
0.00% |
-1.47
|
- |
- |
-
|
|
BLAB.CN Britannia Life Sciences Inc.
|
11.4 million |
0.00% |
-3.33
|
- |
- |
-
|
|
BLCM Bellicum Pharmaceuticals, Inc.
|
778326 |
0.00% |
-0.13
|
- |
- |
-
|
|
BLI Berkeley Lights, Inc.
|
86.6 million |
- |
-
|
- |
- |
-
|
|
BLPH Bellerophon Therapeutics, Inc.
|
232419 |
0.00% |
-0.07
|
- |
- |
-
|
|
BLRX BioLineRx Ltd.
|
14.2 million |
0.00% |
-
|
- |
- |
-
|
|
BLRX.TA BioLineRx Ltd.
|
113258 |
0.00% |
-
|
- |
- |
-
|
|
BLTE Belite Bio, Inc
|
5.7 billion |
0.00% |
-
|
- |
- |
-
|
|
BLT.NZ BLIS Technologies Limited
|
11.6 million |
0.00% |
-
|
- |
- |
-
|
|
BLU BELLUS Health Inc.
|
1.8 billion |
- |
-4.06
|
- |
- |
-
|
|
BLUE bluebird bio, Inc.
|
48.7 million |
0.00% |
-0.24
|
- |
- |
-
|
|
BLUEJET.BO Blue Jet Healthcare Limited
|
709.2 million |
0.31% |
22.79
|
1 |
2 |
-
|
|
BLUEJET.NS Blue Jet Healthcare Limited
|
704.1 million |
0.31% |
22.67
|
1 |
2 |
-
|
|
BM8.F BioMarin Pharmaceutical Inc.
|
11.2 billion |
0.00% |
22.35
|
- |
- |
-
|
|
BMEA Biomea Fusion, Inc.
|
75.6 million |
0.00% |
-
|
- |
- |
-
|
|
BMNDF Biomind Labs Inc.
|
9.3 million |
0.00% |
-11.40
|
- |
- |
-
|
|
BMRN BioMarin Pharmaceutical Inc.
|
10.9 billion |
0.00% |
38.89
|
- |
- |
-
|
|
BNOX Bionomics Limited - American De
|
6.3 million |
0.00% |
-0.38
|
- |
- |
-
|
|
BNTC Benitec Biopharma Inc.
|
290.0 million |
0.00% |
-
|
- |
- |
-
|
|
BNTX BioNTech SE
|
22.3 billion |
0.00% |
-
|
- |
- |
-
|
|
BOLT Bolt Biotherapeutics, Inc.
|
9.1 million |
0.00% |
-
|
- |
- |
-
|
|
BOLT.TA BioLight Life Sciences Ltd.
|
60633 |
0.00% |
-1.15
|
- |
- |
-
|
|
BONS.TA Bonus BioGroup Ltd.
|
1.6 million |
0.00% |
-10.07
|
- |
- |
-
|
|
BOT.AX Botanix Pharmaceuticals Limited
|
73.4 million |
0.00% |
-1.08
|
- |
- |
-
|
|
BOVNF BioInvent International AB (publ)
|
216.4 million |
0.00% |
-
|
- |
- |
-
|
|
BPMC Blueprint Medicines Corporation
|
8.4 billion |
0.00% |
-
|
- |
- |
-
|
|
BPMUF Basilea Pharmaceutica AG
|
805.6 million |
0.00% |
9.97
|
- |
- |
-
|
|
BPTH Bio-Path Holdings, Inc.
|
373686 |
0.00% |
-
|
- |
- |
-
|
|
BPTSY Biophytis S.A.
|
105224 |
0.00% |
-0.11
|
- |
- |
-
|
|
BRAX.CN BraxiaScience
|
998847 |
0.00% |
-0.10
|
- |
- |
-
|
|
BRAXF Braxia Scientific Corp.
|
28328 |
0.00% |
-0.03
|
- |
- |
-
|
|
BRCTF BioArctic AB (publ)
|
3.1 billion |
0.61% |
152
|
1 |
1 |
-
|
|
BRIBF Brii Biosciences Limited
|
112.1 million |
0.00% |
-2.35
|
- |
- |
-
|
|
BRNS Barinthus Biotherapeutics plc
|
26.6 million |
0.00% |
-
|
- |
- |
-
|
|
BRTX BioRestorative Therapies, Inc.
|
3.6 million |
0.00% |
-
|
- |
- |
-
|
|
BSEM BioStem Technologies, Inc.
|
63.7 million |
0.00% |
4.69
|
- |
- |
-
|
|
BSFA.L BSF Enterprise Plc
|
191 |
0.00% |
-1.12
|
- |
- |
-
|
|
BSLN.SW Basilea Pharmaceutica AG
|
816.7 million |
0.00% |
17.13
|
- |
- |
-
|
|
BSSP Baseline Productions, Inc.
|
74377 |
0.00% |
-0.01
|
- |
- |
-
|
|
BSTG Harvard Apparatus Regenerative Technology Inc.
|
81.3 million |
- |
-2.69
|
- |
- |
-
|
|
BST.MC Biotechnologies Assets S.A.
|
16.8 million |
0.00% |
-6.73
|
- |
- |
-
|
|
BTAI BioXcel Therapeutics, Inc.
|
38.0 million |
0.00% |
-
|
- |
- |
-
|
|
BTAX Biostax Corp.
|
7871 |
0.00% |
-0.01
|
- |
- |
-
|
|
BTC.AX BTC Health Limited
|
13.5 million |
0.00% |
6.30
|
- |
- |
-
|
|
BTTX Better Therapeutics, Inc.
|
5452 |
0.00% |
-
|
- |
- |
-
|
|
BTX BlackRock Technology and Private Equity Term Trust
|
1.0 billion |
7.19% |
54.42
|
12 |
6 |
1%
|
|
BVAXF BioVaxys Technology Corp.
|
5.2 million |
0.00% |
-0.59
|
- |
- |
-
|
|
BVNKF Bavarian Nordic A/S
|
2.1 billion |
0.00% |
12.89
|
- |
- |
-
|
|
BVNRY Bavarian Nordic A/S
|
2.2 billion |
0.00% |
6.03
|
- |
- |
-
|
|
BVXP.L Bioventix PLC
|
1.1 million |
9.68% |
10.84
|
2 |
13 |
21%
|
|
BVXV BiondVax Pharmaceuticals Ltd.
|
6.3 million |
- |
-0.95
|
- |
- |
-
|
|
BXPHF Botanix Pharmaceuticals Limited
|
73.5 million |
0.00% |
-
|
- |
- |
-
|
|
BXRXQ Baudax Bio, Inc.
|
4359 |
0.00% |
-
|
- |
- |
-
|
|
BYSI BeyondSpring Inc.
|
70.3 million |
0.00% |
-
|
- |
- |
-
|
|
BZYR Burzynski Research Institute, Inc.
|
1.3 million |
0.00% |
-2.50
|
- |
- |
-
|
|
CABA Cabaletta Bio, Inc.
|
529.9 million |
0.00% |
-
|
- |
- |
-
|
|
CADL Candel Therapeutics, Inc.
|
467.2 million |
0.00% |
-
|
- |
- |
-
|
|
CALA Calithera Biosciences, Inc.
|
1462 |
0.00% |
-3.31
|
- |
- |
-
|
|
CALC CalciMedica, Inc.
|
16.7 million |
0.00% |
-
|
- |
- |
-
|
|
CALT Calliditas Therapeutics AB
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
CAMP CAMP4 Therapeutics Corporation
|
87.3 million |
0.00% |
-
|
- |
- |
-
|
|
CAMRF Camurus AB (publ)
|
3.6 billion |
0.00% |
52.31
|
- |
- |
-
|
|
CAMX.ST Camurus AB (publ)
|
3.1 billion |
0.00% |
44.94
|
- |
- |
-
|
|
CANF Can-Fite BioPharma Ltd.
|
1.7 million |
0.00% |
-
|
- |
- |
-
|
|
CANF.TA Can-Fite BioPharma Ltd.
|
128.6 million |
0.00% |
-250.83
|
- |
- |
-
|
|
CANTA.ST Cantargia AB (publ)
|
110.4 million |
0.00% |
8.45
|
- |
- |
-
|
|
CAPR Capricor Therapeutics, Inc.
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
|
CARA Cara Therapeutics, Inc.
|
22.6 million |
0.00% |
-0.32
|
- |
- |
-
|
|
CARM Carisma Therapeutics, Inc.
|
4185 |
0.00% |
0.00
|
- |
- |
-
|
|
CASI CASI Pharmaceuticals, Inc.
|
3.2 million |
0.00% |
-
|
- |
- |
-
|
|
CASIF CASI Pharmaceuticals, Inc.
|
2.2 million |
0.00% |
-0.05
|
- |
- |
-
|
|
CATB Catabasis Pharmaceuticals, Inc.
|
657.1 million |
- |
-0.66
|
- |
- |
-
|
|
CBAY CymaBay Therapeutics, Inc.
|
3.7 billion |
0.00% |
-34.58
|
- |
- |
-
|
|
CBDG THC Farmaceuticals, Inc.
|
326369 |
0.00% |
-
|
- |
- |
-
|
|
CBIO Catalyst Biosciences, Inc.
|
19.4 million |
792.92% |
1.67
|
- |
- |
-
|
|
CBI.TA Clal Biotechnology Industries Ltd.
|
154399 |
0.00% |
-1.40
|
- |
- |
-
|
|
CBLI Cleveland BioLabs, Inc.
|
49.0 million |
0.00% |
-16.82
|
- |
- |
-
|
|
CCCC C4 Therapeutics, Inc.
|
345.4 million |
0.00% |
-
|
- |
- |
-
|
|
CCXI ChemoCentryx, Inc.
|
3.7 billion |
4.97% |
-91.33
|
- |
- |
-
|
|
CDAK Codiak BioSciences, Inc.
|
2.8 million |
- |
-
|
- |
- |
-
|
|
CDIO Cardio Diagnostics Holdings, Inc.
|
4.1 million |
0.00% |
-
|
- |
- |
-
|
|
CDIOW Cardio Diagnostics Holdings, Inc.
|
26090 |
0.00% |
-
|
- |
- |
-
|
|
CDMO Avid Bioservices, Inc.
|
798.9 million |
0.00% |
-
|
- |
- |
-
|
|
CDMOP Avid Bioservices, Inc.
|
205.1 million |
10.10% |
-
|
- |
- |
-
|
|
CDT CDT Equity Inc.
|
3.6 million |
0.00% |
-0.01
|
- |
- |
-
|
|
CDTTW CDT Equity Inc.
|
24446 |
0.00% |
-
|
- |
- |
-
|
|
CDTX Cidara Therapeutics, Inc.
|
5.6 billion |
0.00% |
-19.72
|
- |
- |
-
|
|
CDXI Cardax, Inc.
|
80 |
0.00% |
-
|
- |
- |
-
|
|
CDXS Codexis, Inc.
|
254.5 million |
0.00% |
-
|
- |
- |
-
|
|
CELC Celcuity Inc.
|
4.3 billion |
0.00% |
-
|
- |
- |
-
|
|
CELU Celularity Inc.
|
25.0 million |
0.00% |
-
|
- |
- |
-
|
|
CELUW Celularity Inc.
|
153616 |
0.00% |
-
|
- |
- |
-
|
|
CELZ Creative Medical Technology Holdings, Inc.
|
5.3 million |
0.00% |
-
|
- |
- |
-
|
|
CERE Cerevel Therapeutics Holdings,
|
7.5 billion |
0.00% |
-17.17
|
- |
- |
-
|
|
CERO CERo Therapeutics Holdings, Inc.
|
541348 |
0.00% |
0.00
|
- |
- |
-
|
|
CEROW CERo Therapeutics Holdings, Inc.
|
147719 |
0.00% |
-
|
- |
- |
-
|
|
CFRX ContraFect Corporation
|
267940 |
- |
-2.36
|
- |
- |
-
|
|
CFRXQ ContraFect Corporation
|
107 |
0.00% |
-
|
- |
- |
-
|
|
CGEM Cullinan Therapeutics, Inc.
|
850.3 million |
0.00% |
-
|
- |
- |
-
|
|
CGEN Compugen Ltd.
|
198.6 million |
0.00% |
7.37
|
- |
- |
-
|
|
CGEN.TA Compugen Ltd.
|
2.0 million |
0.00% |
-
|
- |
- |
-
|
|
CGON CG Oncology, Inc. Common stock
|
4.9 billion |
0.00% |
-
|
- |
- |
-
|
|
CGTX Cognition Therapeutics, Inc.
|
94.9 million |
0.00% |
-
|
- |
- |
-
|
|
CHEMOPH.BO STARSOURCE MULTITRADE LTD
|
2.2 million |
0.00% |
-
|
- |
- |
-
|
|
CHM.AX Chimeric Therapeutics Limited
|
6.1 million |
0.00% |
-0.20
|
- |
- |
-
|
|
CHMMF Chimeric Therapeutics Limited
|
4.1 million |
0.00% |
-0.10
|
- |
- |
-
|
|
CHNXF ChitogenX Inc.
|
627627 |
0.00% |
-
|
- |
- |
-
|
|
CHRS Coherus Oncology, Inc.
|
177.5 million |
0.00% |
-
|
- |
- |
-
|
|
CINC CinCor Pharma, Inc.
|
1.3 billion |
- |
-
|
- |
- |
-
|
|
CING Cingulate Inc.
|
27.4 million |
0.00% |
-
|
- |
- |
-
|
|
CINGW Cingulate Inc.
|
122239 |
0.00% |
-
|
- |
- |
-
|
|
CIZ.L Cizzle Biotechnology Holdings Plc
|
89097 |
0.00% |
-1.70
|
- |
- |
-
|
|
CKDXF Opthea Limited
|
601.9 million |
0.00% |
-1.26
|
- |
- |
-
|
|
CKPT Checkpoint Therapeutics, Inc.
|
367.7 million |
0.00% |
-3.33
|
- |
- |
-
|
|
CLABF Core One Labs Inc.
|
471 |
0.00% |
-
|
- |
- |
-
|
|
CLAZF Claritas Pharmaceuticals, Inc.
|
3659 |
0.00% |
0.00
|
- |
- |
-
|
|
CLBIO.ST Corline Biomedical AB
|
41.7 million |
0.00% |
-26.78
|
- |
- |
-
|
|
CLBS Caladrius Biosciences, Inc.
|
25.8 million |
- |
-2.40
|
- |
- |
-
|
|
CLCS Cell Source, Inc.
|
36.0 million |
0.00% |
-5.31
|
- |
- |
-
|
|
CLDI Calidi Biotherapeutics, Inc.
|
1.3 million |
0.00% |
2.11
|
- |
- |
-
|
|
CLDX Celldex Therapeutics, Inc.
|
2.0 billion |
0.00% |
-
|
- |
- |
-
|
|
CLGN CollPlant Biotechnologies Ltd.
|
4.8 million |
0.00% |
-
|
- |
- |
-
|
|
CLLS Cellectis S.A.
|
307.3 million |
0.00% |
-
|
- |
- |
-
|
|
CLRB Cellectar Biosciences, Inc.
|
8.3 million |
0.00% |
-
|
- |
- |
-
|
|
CLSD Clearside Biomedical, Inc.
|
5.2 million |
0.00% |
-0.20
|
- |
- |
-
|
|
CLSDQ Clearside Biomedical, Inc.
|
1.8 million |
0.00% |
-0.10
|
- |
- |
-
|
|
CLSN Imunon, Inc.
|
13.9 million |
- |
-2.12
|
- |
- |
-
|
|
CLTEF Calliditas Therapeutics AB (publ)
|
15.9 million |
0.00% |
-0.55
|
- |
- |
-
|
|
CLVLF Clinuvel Pharmaceuticals Limited
|
322.6 million |
0.51% |
18.13
|
2 |
8 |
30%
|
|
CLVLY Clinuvel Pharmaceuticals Limited
|
333.5 million |
0.45% |
15.58
|
1 |
8 |
10%
|
|
CLVS Clovis Oncology, Inc.
|
34.8 million |
0.92% |
-1.42
|
- |
- |
-
|
|
CLXT Calyxt, Inc.
|
31.3 million |
- |
-3.73
|
- |
- |
-
|
|
CLYM Climb Bio, Inc.
|
711.8 million |
0.00% |
-
|
- |
- |
-
|
|
CLYYF Celyad Oncology S.A.
|
11.2 million |
0.00% |
-0.26
|
- |
- |
-
|
|
CMB.AX Cambium Bio Limited
|
7.8 million |
0.00% |
-3.50
|
- |
- |
-
|
|
CMMB Chemomab Therapeutics Ltd.
|
10.7 million |
0.00% |
-
|
- |
- |
-
|
|
CMND Clearmind Medicine Inc.
|
4.1 million |
0.00% |
-0.04
|
- |
- |
-
|
|
CMOTEC-B.ST Scandinavian ChemoTech AB (publ)
|
8.5 million |
0.00% |
-10.21
|
- |
- |
-
|
|
CMPI Checkmate Pharmaceuticals, Inc.
|
227.1 million |
- |
-
|
- |
- |
-
|
|
CMRA Comera Life Sciences Holdings, Inc.
|
3074 |
0.00% |
-
|
- |
- |
-
|
|
CMRX Chimerix, Inc.
|
801.1 million |
0.00% |
-
|
- |
- |
-
|
|
CMVLF Cellectis S.A.
|
452.7 million |
0.00% |
-
|
- |
- |
-
|
|
CMXHF CSL Limited
|
33.8 billion |
4.14% |
17.20
|
4 |
33 |
30%
|
|
CNBX CNBX Pharmaceuticals Inc.
|
18502 |
0.00% |
-0.02
|
- |
- |
-
|
|
CNCE Concert Pharmaceuticals, Inc.
|
403.4 million |
- |
-4.28
|
- |
- |
-
|
|
CNSP CNS Pharmaceuticals, Inc.
|
2.9 million |
0.00% |
0.00
|
- |
- |
-
|
|
CNST Constellation Pharmaceuticals, Inc.
|
1.6 billion |
- |
-7.75
|
- |
- |
-
|
|
CNTA Centessa Pharmaceuticals plc
|
6.2 billion |
0.00% |
-
|
- |
- |
-
|
|
CNTB Connect Biopharma Holdings Limited
|
145.4 million |
0.00% |
-
|
- |
- |
-
|
|
CNTN Canton Strategic Holdings Inc
|
84.9 million |
- |
-1.22
|
- |
- |
-
|
|
CNXU Conexeu Sciences Inc.
|
359.4 million |
0.00% |
-
|
- |
- |
-
|
|
COAG Hemab Therapeutics Holdings, Inc. Common Stock
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
COCP Cocrystal Pharma, Inc.
|
10.8 million |
0.00% |
-
|
- |
- |
-
|
|
COEP Coeptis Therapeutics, Inc.
|
42.1 million |
0.00% |
-3.62
|
- |
- |
-
|
|
COEPW Coeptis Therapeutics Holdings, Inc.
|
64721 |
0.00% |
-
|
- |
- |
-
|
|
COGT Cogent Biosciences, Inc.
|
5.3 billion |
0.00% |
-
|
- |
- |
-
|
|
COMBI.ST CombiGene AB (publ)
|
5.0 million |
0.00% |
-1.09
|
- |
1 |
-
|
|
CONCORDBIO.BO Concord Biotech Limited
|
1.3 billion |
0.89% |
40.43
|
1 |
3 |
-
|
|
CONCORDBIO.NS Concord Biotech Limited
|
1.3 billion |
0.91% |
39.37
|
1 |
3 |
-
|
|
CORT Corcept Therapeutics Incorporated
|
7.8 billion |
0.00% |
149
|
- |
- |
-
|
|
COV.V Covalon Technologies Ltd.
|
43.0 million |
0.00% |
44.20
|
1 |
1 |
-
|
|
COYA Coya Therapeutics, Inc.
|
88.2 million |
0.00% |
-
|
- |
- |
-
|
|
CPMV Mosaic ImmunoEngineering Inc.
|
4.9 million |
0.00% |
-6.16
|
- |
- |
-
|
|
CPRX Catalyst Pharmaceuticals, Inc.
|
3.8 billion |
0.00% |
18.04
|
- |
- |
-
|
|
CRBP Corbus Pharmaceuticals Holdings, Inc.
|
94.8 million |
0.00% |
-
|
- |
- |
-
|
|
CRBU Caribou Biosciences, Inc.
|
190.4 million |
0.00% |
-
|
- |
- |
-
|
|
CRDF Cardiff Oncology, Inc.
|
104.6 million |
0.00% |
-
|
- |
- |
-
|
|
CRIS Curis, Inc.
|
6.6 million |
0.00% |
-
|
- |
- |
-
|
|
CRMD CorMedix Inc.
|
655.9 million |
0.00% |
3.60
|
- |
- |
-
|
|
CRNA.OL Circio Holding ASA
|
46.3 million |
0.00% |
-1.28
|
- |
- |
-
|
|
CRNX Crinetics Pharmaceuticals, Inc.
|
3.5 billion |
0.00% |
-
|
- |
- |
-
|
|
CRSP CRISPR Therapeutics AG
|
5.0 billion |
0.00% |
-
|
- |
- |
-
|
|
CRTX Cortexyme, Inc.
|
58.3 million |
- |
-20.13
|
- |
- |
-
|
|
CRTX.L CRISM Therapeutics Corporation
|
64089 |
0.00% |
-3.12
|
- |
- |
-
|
|
CRVO CervoMed Inc.
|
27.5 million |
0.00% |
-
|
- |
- |
-
|
|
CRVS Corvus Pharmaceuticals, Inc.
|
940.1 million |
0.00% |
-
|
- |
- |
-
|
|
CSBR Champions Oncology, Inc.
|
78.5 million |
0.00% |
-
|
- |
- |
-
|
|
CSCI COSCIENS Biopharma Inc.
|
8.6 million |
- |
-0.42
|
- |
- |
-
|
|
CSCIF COSCIENS Biopharma Inc.
|
6.4 million |
0.00% |
-0.32
|
- |
- |
-
|
|
CSCI.TO COSCIENS Biopharma Inc.
|
6.2 million |
0.00% |
-
|
- |
- |
-
|
|
CSL.AX CSL Limited
|
48.6 billion |
3.11% |
16.73
|
2 |
33 |
9%
|
|
CSLLY CSL Limited
|
66.8 billion |
4.20% |
8.20
|
2 |
18 |
7%
|
|
CSPHF CStone Pharmaceuticals
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
CTBO Cantabio Pharmaceuticals, Inc.
|
22769 |
0.00% |
-0.12
|
- |
- |
-
|
|
CTIC CTI BioPharma Corp.
|
646.2 million |
- |
-3.92
|
- |
- |
-
|
|
CTMX CytomX Therapeutics, Inc.
|
482.5 million |
0.00% |
-
|
- |
- |
-
|
|
CTNM Contineum Therapeutics, Inc. Class A Common Stock
|
429.6 million |
0.00% |
-
|
- |
- |
-
|
|
CTXR Citius Pharmaceuticals, Inc.
|
6.5 million |
0.00% |
-
|
- |
- |
-
|
|
CTX.WA Captor Therapeutics Spolka Akcyjna
|
124.1 million |
0.00% |
-11.02
|
- |
- |
-
|
|
CU6.AX Clarity Pharmaceuticals Ltd
|
901.4 million |
0.00% |
-
|
- |
- |
-
|
|
CUBT Curative Biotechnology, Inc.
|
10.8 million |
0.00% |
-0.87
|
- |
- |
-
|
|
CUE Cue Biopharma, Inc.
|
67.5 million |
0.00% |
-
|
- |
- |
-
|
|
CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
|
6.5 million |
- |
-3.02
|
- |
- |
-
|
|
CURX Curanex Pharmaceuticals Inc Common Stock
|
8.6 million |
0.00% |
-19.96
|
- |
- |
-
|
|
CUV.AX Clinuvel Pharmaceuticals Limited
|
352.0 million |
0.49% |
15.63
|
1 |
8 |
12%
|
|
CVAC CureVac N.V.
|
1.1 billion |
0.00% |
6.97
|
- |
- |
-
|
|
CVALF Covalon Technologies Ltd.
|
42.0 million |
6.99% |
27.60
|
- |
- |
-
|
|
CVKD Cadrenal Therapeutics, Inc. Common Stock
|
12.5 million |
0.00% |
-
|
- |
- |
-
|
|
CVM CEL-SCI Corporation
|
10.2 million |
0.00% |
-1.01
|
- |
- |
-
|
|
CWBR CohBar Inc.
|
1.2 million |
0.00% |
-0.20
|
- |
- |
-
|
|
CYAD Celyad Oncology SA
|
16.4 million |
- |
-3.91
|
- |
- |
-
|
|
CYAD.BR Celyad Oncology S.A.
|
18.4 million |
0.00% |
-0.21
|
- |
- |
-
|
|
CYBN Cybin Inc.
|
413.0 million |
0.00% |
-2.20
|
- |
- |
-
|
|
CYBN.NE Cybin Inc.
|
198.0 million |
0.00% |
-2.24
|
- |
- |
-
|
|
CYCC Cyclacel Pharmaceuticals, Inc.
|
12.4 million |
2.01% |
0.18
|
- |
1 |
-
|
|
CYCCP Cyclacel Pharmaceuticals, Inc.
|
2.1 million |
6.15% |
-9.72
|
4 |
11 |
-
|
|
CYCN Cyclerion Therapeutics, Inc.
|
12.9 million |
0.00% |
-
|
- |
- |
-
|
|
CYDY CytoDyn Inc.
|
382.5 million |
0.00% |
-7.82
|
- |
- |
-
|
|
CYP.AX Cynata Therapeutics Limited
|
58.2 million |
0.00% |
-7.10
|
- |
- |
-
|
|
CYT Cyteir Therapeutics, Inc.
|
108.7 million |
0.00% |
-3.38
|
- |
- |
-
|
|
CYTK Cytokinetics, Incorporated
|
8.8 billion |
0.00% |
-
|
- |
- |
-
|
|
CYTO Altamira Therapeutics Ltd.
|
2.0 million |
0.00% |
0.28
|
- |
- |
-
|
|
CYTR LadRx Corporation
|
4.1 million |
- |
-2.19
|
- |
- |
-
|
|
CYYNF Cynata Therapeutics Limited
|
54.2 million |
0.00% |
-7.33
|
- |
- |
-
|
|
CZO.V Ceapro Inc
|
16.0 million |
0.00% |
-5.83
|
- |
- |
-
|
|
DARE Daré Bioscience, Inc.
|
19.5 million |
0.00% |
-
|
- |
- |
-
|
|
DAWN Day One Biopharmaceuticals, Inc.
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
|
DBTX Decibel Therapeutics, Inc.
|
84.3 million |
- |
-
|
- |
- |
-
|
|
DBV.PA DBV Technologies S.A.
|
480.0 million |
0.00% |
-
|
- |
- |
-
|
|
DBVT DBV Technologies S.A.
|
415.4 million |
0.00% |
-
|
- |
- |
-
|
|
DCAL.BO Dishman Carbogen Amcis Limited
|
286.1 million |
0.00% |
22.72
|
- |
- |
-
|
|
DCAL.NS Dishman Carbogen Amcis Limited
|
272.9 million |
0.00% |
21.69
|
- |
- |
-
|
|
DCOY Decoy Therapeutics Inc.
|
4.2 million |
0.00% |
-0.03
|
- |
- |
-
|
|
DFFN Diffusion Pharmaceuticals Inc.
|
7.8 million |
- |
-2.01
|
- |
- |
-
|
|
DFTX Definium Therapeutics, Inc.
|
2.6 billion |
0.00% |
-
|
- |
- |
-
|
|
DICE DICE Therapeutics, Inc.
|
1.6 billion |
- |
11.66
|
- |
- |
-
|
|
DMAC DiaMedica Therapeutics Inc.
|
303.9 million |
0.00% |
-
|
- |
- |
-
|
|
DMRA Damora Therapeutics, Inc.
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
|
DMYD-B.ST Diamyd Medical AB (publ)
|
205.2 million |
0.00% |
-9.91
|
- |
- |
-
|
|
DNA Ginkgo Bioworks Holdings, Inc.
|
537.0 million |
0.00% |
-
|
- |
- |
-
|
|
DNA.TA Dna Group (T.R.) Ltd
|
455786 |
0.00% |
6.16
|
- |
- |
-
|
|
DNLI Denali Therapeutics Inc.
|
3.1 billion |
0.00% |
-
|
- |
- |
-
|
|
DNTH Dianthus Therapeutics, Inc.
|
3.5 billion |
0.00% |
-
|
- |
- |
-
|
|
DOMH Dominari Holdings Inc.
|
52.7 million |
29.44% |
-
|
4 |
2 |
-
|
|
DOSE.CN Rapid Dose Therapeutics Corp.
|
13.5 million |
0.00% |
-7.25
|
- |
- |
-
|
|
DOSEF Doseology Sciences Inc.
|
601719 |
0.00% |
-9.29
|
- |
- |
-
|
|
DRMA Dermata Therapeutics, Inc.
|
851946 |
0.00% |
-
|
- |
- |
-
|
|
DRMAW Dermata Therapeutics, Inc.
|
9337 |
0.00% |
-
|
- |
- |
-
|
|
DRNA Dicerna Pharmaceuticals, Inc.
|
2.9 billion |
- |
-14.22
|
- |
- |
-
|
|
DRTS Alpha Tau Medical Ltd.
|
955.6 million |
0.00% |
-
|
- |
- |
-
|
|
DRTSW Alpha Tau Medical Ltd.
|
180.4 million |
0.00% |
-
|
- |
- |
-
|
|
DRUG Bright Minds Biosciences Inc.
|
574.9 million |
0.00% |
-
|
- |
- |
-
|
|
DRUG.CN Bright Minds Biosciences Inc.
|
608.9 million |
0.00% |
-40.31
|
- |
- |
-
|
|
DSGN Design Therapeutics, Inc.
|
652.1 million |
0.00% |
-
|
- |
- |
-
|
|
DTC.CN Defence Therapeutics Inc.
|
25.1 million |
0.00% |
-7.75
|
- |
- |
-
|
|
DTCFF Defence Therapeutics Inc.
|
21.6 million |
0.00% |
-9.60
|
- |
- |
-
|
|
DTIL Precision BioSciences, Inc.
|
77.5 million |
0.00% |
-
|
- |
- |
-
|
|
DUL.DE Alnylam Pharmaceuticals, Inc.
|
41.8 billion |
0.00% |
136.88
|
- |
- |
-
|
|
DVHGF Devonian Health Group Inc.
|
29.6 million |
0.00% |
-5.27
|
- |
- |
-
|
|
DWTX Dogwood Therapeutics, Inc.
|
2.9 million |
0.00% |
1.45
|
- |
- |
-
|
|
DXB.AX Dimerix Limited
|
167.9 million |
0.00% |
-13.50
|
- |
- |
-
|
|
DYAI Dyadic International, Inc.
|
25.9 million |
0.00% |
-
|
- |
- |
-
|
|
DYN Dyne Therapeutics, Inc.
|
2.8 billion |
0.00% |
-
|
- |
- |
-
|
|
EARS Auris Medical Holding Ltd.
|
39.2 million |
3.88% |
-0.56
|
- |
- |
-
|
|
EDIT Editas Medicine, Inc.
|
276.1 million |
0.00% |
-
|
- |
- |
-
|
|
EDSA Edesa Biotech, Inc.
|
58.4 million |
0.00% |
-
|
- |
- |
-
|
|
EFTR eFFECTOR Therapeutics, Inc.
|
941 |
0.00% |
-0.65
|
- |
- |
-
|
|
EFTRW eFFECTOR Therapeutics, Inc.
|
23.4 million |
0.00% |
-0.12
|
- |
- |
-
|
|
EGTX.ST Egetis Therapeutics AB (publ)
|
228.5 million |
0.00% |
-
|
- |
- |
-
|
|
EIGR Eiger BioPharmaceuticals, Inc.
|
2.6 million |
0.00% |
-0.10
|
- |
- |
-
|
|
EIKN Eikon Therapeutics, Inc. Common Stock
|
26.4 million |
0.00% |
-
|
- |
- |
-
|
|
ELAB PMGC Holdings Inc.
|
3.5 million |
0.00% |
0.01
|
- |
- |
-
|
|
ELDN Eledon Pharmaceuticals, Inc.
|
215.8 million |
0.00% |
-
|
- |
- |
-
|
|
ELEV Elevation Oncology, Inc.
|
21.6 million |
0.00% |
-0.45
|
- |
- |
-
|
|
ELIC.ST Elicera Therapeutics AB (publ)
|
32.5 million |
0.00% |
-17.11
|
- |
- |
-
|
|
ELOX Eloxx Pharmaceuticals, Inc.
|
47.0 million |
0.00% |
-0.10
|
- |
- |
-
|
|
ELTX Elicio Therapeutics, Inc.
|
253.1 million |
0.00% |
-
|
- |
- |
-
|
|
ELVAF EvoNext Holdings S.A.
|
8.1 million |
0.00% |
-7.80
|
- |
- |
-
|
|
ELVN Enliven Therapeutics, Inc.
|
2.1 billion |
0.00% |
-
|
- |
- |
-
|
|
ELYM Eliem Therapeutics, Inc
|
342.7 million |
0.00% |
-1.85
|
- |
- |
-
|
|
EMBT Ember Therapeutics, Inc.
|
398 |
0.00% |
-
|
- |
- |
-
|
|
EMMA Emmaus Life Sciences, Inc.
|
708901 |
0.00% |
-0.12
|
- |
- |
-
|
|
ENBI.CN Entheon Biomedical Corp.
|
977333 |
0.00% |
-3.33
|
- |
- |
-
|
|
ENDV Endonovo Therapeutics, Inc.
|
31875 |
0.00% |
-0.01
|
- |
- |
-
|
|
ENGN enGene Holdings Inc.
|
118.9 million |
0.00% |
-
|
- |
- |
-
|
|
ENGNW enGene Holdings Inc. Warrants
|
12.8 million |
0.00% |
-
|
- |
- |
-
|
|
ENLV Enlivex Therapeutics Ltd.
|
137.4 million |
0.00% |
0.02
|
- |
- |
-
|
|
ENLV.TA Enlivex Therapeutics Ltd.
|
284330 |
0.00% |
-2.07
|
- |
- |
-
|
|
ENOB Enochian Biosciences Inc.
|
72.4 million |
- |
-14.56
|
- |
- |
-
|
|
ENP.AX Entropy Neurodynamics Limited
|
36.8 million |
0.00% |
-
|
- |
- |
-
|
|
ENSC Ensysce Biosciences, Inc.
|
2.4 million |
0.00% |
-
|
- |
- |
-
|
|
ENSCW Leisure Acquisition Corp.
|
- |
0.00% |
-
|
- |
- |
-
|
|
ENTA Enanta Pharmaceuticals, Inc.
|
272.3 million |
0.00% |
-
|
- |
- |
-
|
|
ENTO Entero Therapeutics, Inc.
|
16.9 million |
0.00% |
-0.30
|
- |
- |
-
|
|
ENTX Entera Bio Ltd.
|
60.1 million |
0.00% |
-
|
- |
- |
-
|
|
ENVB Enveric Biosciences, Inc.
|
1.2 million |
0.00% |
-0.05
|
- |
- |
-
|
|
ENZC Enzolytics Inc.
|
3.2 million |
0.00% |
-
|
- |
- |
-
|
|
ENZN Enzon Pharmaceuticals, Inc.
|
4.3 million |
0.00% |
-1.21
|
- |
- |
-
|
|
EPIX ESSA Pharma Inc.
|
10.0 million |
798.41% |
-0.37
|
- |
1 |
-
|
|
EPRX Eupraxia Pharmaceuticals Inc.
|
199.2 million |
0.00% |
-
|
- |
- |
-
|
|
EPRX.TO Eupraxia Pharmaceuticals Inc.
|
276.5 million |
0.00% |
-9.09
|
- |
- |
-
|
|
EPZM Epizyme, Inc.
|
247.5 million |
1.66% |
-5.27
|
- |
- |
-
|
|
EQ Equillium, Inc.
|
104.4 million |
0.00% |
-
|
- |
- |
-
|
|
EQRX EQRx, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
|
EQRXW EQRx, Inc.
|
- |
- |
-
|
- |
- |
-
|
|
ERAS Erasca, Inc.
|
4.2 billion |
0.00% |
-
|
- |
- |
-
|
|
ERGO Entia Biosciences, Inc.
|
20197 |
0.00% |
-
|
- |
- |
-
|
|
ERNA Ernexa Therapeutics Inc.
|
2.5 million |
0.00% |
0.01
|
- |
- |
-
|
|
ERYP PHAXIAM Therapeutics S.A.
|
23.9 million |
- |
-1.86
|
- |
- |
-
|
|
ESLA Estrella Immunopharma, Inc.
|
49.1 million |
0.00% |
-
|
- |
- |
-
|
|
ESLAW Estrella Immunopharma, Inc.
|
4.6 million |
0.00% |
-
|
- |
- |
-
|
|
ETBI Eastgate Biotech Corp.
|
6.2 million |
0.00% |
-0.10
|
- |
- |
-
|
|
ETHZ Ethzilla Corp.
|
56.4 million |
0.00% |
-0.02
|
- |
- |
-
|
|
ETHZW Ethzilla Corp.
|
1.4 million |
0.00% |
-
|
- |
- |
-
|
|
ETNB 89bio, Inc.
|
2.2 billion |
0.00% |
-4.02
|
- |
- |
-
|
|
ETTX Entasis Therapeutics Holdings Inc.
|
104.3 million |
- |
-0.51
|
- |
- |
-
|
|
EVAX Evaxion Biotech A/S
|
22.4 million |
0.00% |
-
|
- |
- |
-
|
|
EVE.SW EvoNext Holdings S.A.
|
8.6 million |
0.00% |
-8.07
|
- |
- |
-
|
|
EVFM Evofem Biosciences, Inc.
|
1.1 million |
0.00% |
-0.18
|
- |
- |
-
|
|
EVFMD Evofem Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
|
EVGN Evogene Ltd.
|
5.3 million |
0.00% |
-
|
- |
- |
-
|
|
EVGN.TA Evogene Ltd.
|
68454 |
0.00% |
-
|
- |
- |
-
|
|
EVLO Evelo Biosciences, Inc.
|
1898 |
0.00% |
-1.81
|
- |
- |
-
|
|
EVMN Evommune, Inc.
|
738.0 million |
0.00% |
-
|
- |
- |
-
|
|
EWTX Edgewise Therapeutics, Inc.
|
4.0 billion |
0.00% |
-
|
- |
- |
-
|
|
EXAI Exscientia Plc
|
733.9 million |
0.00% |
-
|
- |
- |
-
|
|
EXEL Exelixis, Inc.
|
13.2 billion |
0.00% |
16.46
|
- |
- |
-
|
|
EXOZ eXoZymes, Inc.
|
78.7 million |
0.00% |
-7.39
|
- |
- |
-
|
|
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
|
1.8 million |
0.00% |
-0.49
|
- |
- |
-
|
|
EYEG EyeGate Pharmaceuticals, Inc.
|
13.8 million |
- |
-1.72
|
- |
- |
-
|
|
EYEN Eyenovia, Inc.
|
80.8 million |
0.00% |
-0.37
|
- |
- |
-
|
|
EYPT EyePoint Pharmaceuticals, Inc.
|
987.7 million |
0.00% |
-
|
- |
- |
-
|
|
EZZ.AX EZZ Life Science Holdings Limited
|
35.4 million |
3.67% |
18.17
|
1 |
5 |
30%
|
|
FAB.L Fusion Antibodies plc
|
202870 |
0.00% |
-13.50
|
- |
- |
-
|
|
FAMDF Futura Medical plc
|
9.1 million |
0.00% |
-0.40
|
- |
- |
-
|
|
FARN.L Faron Pharmaceuticals Oy
|
829735 |
0.00% |
-2.36
|
- |
- |
-
|
|
FATE Fate Therapeutics, Inc.
|
230.8 million |
0.00% |
-
|
- |
- |
-
|
|
FBIO Fortress Biotech, Inc.
|
86.7 million |
0.00% |
0.77
|
- |
- |
-
|
|
FBIOP Fortress Biotech, Inc.
|
162.7 million |
11.32% |
-
|
12 |
- |
-
|
|
FBIOX Fidelity Select Biotechnology Portfolio
|
5.2 billion |
6.60% |
-
|
2 |
4 |
-
|
|
FBLG FibroBiologics, Inc. Common Stock
|
2.2 million |
0.00% |
-
|
- |
- |
-
|
|
FBRX Forte Biosciences, Inc.
|
231.8 million |
0.00% |
-
|
- |
- |
-
|
|
FDMT 4D Molecular Therapeutics, Inc.
|
489.3 million |
0.00% |
-
|
- |
- |
-
|
|
FENC Fennec Pharmaceuticals Inc.
|
248.6 million |
0.00% |
-
|
- |
- |
-
|
|
FERMENTA.BO Fermenta Biotech Ltd.
|
98.4 million |
0.79% |
10.65
|
1 |
5 |
-
|
|
FGEN FibroGen, Inc.
|
37.1 million |
0.00% |
-0.71
|
- |
- |
-
|
|
FGHQF Frontage Holdings Corporation
|
223.1 million |
0.00% |
-
|
- |
- |
-
|
|
FHTX Foghorn Therapeutics Inc.
|
219.0 million |
0.00% |
-
|
- |
- |
-
|
|
FIXX Homology Medicines, Inc.
|
51.9 million |
0.00% |
-0.31
|
- |
- |
-
|
|
FLERIE.ST Flerie AB (publ)
|
294.2 million |
0.00% |
-3.80
|
- |
- |
-
|
|
FLNA Filana Therapeutics, Inc.
|
69.6 million |
0.00% |
-
|
- |
- |
-
|
|
FLUI.ST Fluicell AB (publ)
|
1.5 million |
0.00% |
-1.80
|
- |
- |
-
|
|
FLUO.ST FluoGuide A/S
|
47.1 million |
0.00% |
-8.26
|
- |
- |
-
|
|
FMTX Forma Therapeutics Holdings, Inc.
|
998.7 million |
- |
-
|
- |
- |
-
|
|
FNAM Evolutionary Genomics, Inc.
|
1331 |
0.00% |
-
|
- |
- |
-
|
|
FNCH Finch Therapeutics Group, Inc.
|
12.0 million |
0.00% |
-
|
- |
- |
-
|
|
FOLD Amicus Therapeutics, Inc.
|
4.5 billion |
0.00% |
-
|
- |
- |
-
|
|
FORU ForU Holdings, Inc.
|
2171 |
0.00% |
-
|
- |
- |
-
|
|
FPMI FluoroPharma Medical, Inc.
|
6852 |
0.00% |
-
|
- |
- |
-
|
|
FREQ Frequency Therapeutics, Inc.
|
10.9 million |
- |
-42.89
|
- |
- |
-
|
|
FRLN Freeline Therapeutics Holdings plc
|
28.2 million |
0.00% |
-0.56
|
- |
- |
-
|
|
FRX.TO Fennec Pharmaceuticals Inc.
|
202.5 million |
0.00% |
-
|
- |
- |
-
|
|
FSTX F-star Therapeutics, Inc.
|
156.5 million |
- |
-
|
- |
- |
-
|
|
FTH Faeth Therapeutics, Inc.
|
19.5 million |
- |
-
|
- |
- |
-
|
|
FTRE Fortrea Holdings Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
|
FULC Fulcrum Therapeutics, Inc.
|
199.7 million |
0.00% |
-
|
- |
- |
-
|
|
FUM.L Futura Medical plc
|
49782 |
0.00% |
-0.62
|
- |
- |
-
|
|
FUSN Fusion Pharmaceuticals Inc.
|
1.8 billion |
0.00% |
-6.94
|
- |
- |
-
|
|
FWBI First Wave BioPharma, Inc.
|
5.8 million |
0.00% |
0.00
|
- |
- |
-
|
|
FWP Forward Pharma A/S
|
20.5 million |
1393.21% |
-7.66
|
- |
- |
-
|
|
FYB.DE Formycon AG
|
363.2 million |
0.00% |
-
|
- |
- |
-
|
|
GALT Galectin Therapeutics Inc.
|
154.8 million |
0.00% |
-
|
- |
- |
-
|
|
GANX Gain Therapeutics, Inc.
|
76.4 million |
0.00% |
-
|
- |
- |
-
|
|
GBIM GlobeImmune, Inc.
|
2.0 million |
- |
-0.27
|
- |
- |
-
|
|
GBIO Generation Bio Co.
|
38.0 million |
0.00% |
-0.60
|
- |
- |
-
|
|
GBLX GB Sciences, Inc.
|
122121 |
0.00% |
-0.03
|
- |
- |
-
|
|
GBM.F Inovio Pharmaceuticals, Inc.
|
111.3 million |
0.00% |
-0.62
|
- |
- |
-
|
|
GBT Global Blood Therapeutics, Inc.
|
4.6 billion |
- |
-9.31
|
- |
- |
-
|
|
GDTC CytoMed Therapeutics Limited
|
15.3 million |
0.00% |
-
|
- |
- |
-
|
|
GENESIS.BO Genesis IBRC India Ltd.
|
11.4 million |
0.00% |
-461.11
|
- |
- |
-
|
|
GENF.L Genflow Biosciences plc
|
117461 |
0.00% |
-1.80
|
- |
- |
-
|
|
GENO.ST Genovis AB (publ.)
|
113.6 million |
0.00% |
46.33
|
- |
- |
-
|
|
GENSF Genus plc
|
1.9 billion |
1.39% |
44.29
|
2 |
13 |
4%
|
|
GENSY GENUS UNSPON ADR EA REPR 1 ORD
|
1.5 billion |
- |
-
|
- |
1 |
-
|
|
GERN Geron Corporation
|
744.2 million |
0.00% |
-
|
- |
- |
-
|
|
GFC-M.TA G.F.C Green Fields Capital Ltd.
|
500791 |
0.00% |
5.73
|
- |
- |
-
|
|
GHRS GH Research PLC
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
|
GLAB.CN Gemina Laboratories Ltd.
|
3.2 million |
0.00% |
-1.50
|
- |
- |
-
|
|
GLABF Gemina Laboratories Ltd.
|
3.8 million |
0.00% |
-1.67
|
- |
- |
-
|
|
GLMD Galmed Pharmaceuticals Ltd.
|
3.8 million |
0.00% |
-
|
- |
- |
-
|
|
GLOW.CN Glow Lifetech Corp.
|
6.4 million |
0.00% |
-2.50
|
- |
- |
-
|
|
GLPG Galapagos N.V.
|
1.9 billion |
0.00% |
-4.28
|
- |
- |
-
|
|
GLPG.AS Galapagos N.V.
|
2.1 billion |
0.00% |
-4.24
|
- |
- |
-
|
|
GLPGF Galapagos N.V.
|
1.9 billion |
0.00% |
5.58
|
- |
- |
-
|
|
GLSHQ Gelesis Holdings, Inc.
|
7333 |
0.00% |
-
|
- |
- |
-
|
|
GLSI Greenwich LifeSciences, Inc.
|
326.6 million |
0.00% |
-
|
- |
- |
-
|
|
GLTO Galecto, Inc.
|
44.9 million |
0.00% |
-2.32
|
- |
- |
-
|
|
GLUE Monte Rosa Therapeutics, Inc.
|
216.9 million |
- |
-1.61
|
- |
- |
-
|
|
GLWLF Glow Lifetech Corp.
|
6.7 million |
0.00% |
-3.80
|
- |
- |
-
|
|
GLYC GlycoMimetics, Inc.
|
1.0 billion |
0.00% |
-0.34
|
- |
- |
-
|
|
GMAB Genmab A/S
|
15.4 billion |
0.00% |
20.27
|
- |
- |
-
|
|
GMAB.CO Genmab A/S
|
15.8 billion |
0.00% |
20.24
|
- |
- |
-
|
|
GMDA Gamida Cell Ltd.
|
4.3 million |
0.00% |
-0.47
|
- |
- |
-
|
|
GMTX Gemini Therapeutics, Inc.
|
71.1 million |
- |
-
|
- |
- |
-
|
|
GNCA Genocea Biosciences, Inc.
|
396373 |
- |
-1.64
|
- |
- |
-
|
|
GNFT Genfit S.A.
|
449.2 million |
0.00% |
-10.02
|
- |
- |
-
|
|
GNFTF Genfit S.A.
|
475.8 million |
0.00% |
-10.87
|
- |
- |
-
|
|
GNFT.PA Genfit S.A.
|
484.3 million |
0.00% |
-10.92
|
- |
- |
-
|
|
GNFTY Genfit S.A.
|
450.3 million |
0.00% |
-9.78
|
- |
- |
-
|
|
GNLX Genelux Corporation
|
110.2 million |
0.00% |
-
|
- |
- |
-
|
|
GNMSF Genmab A/S
|
15.3 billion |
0.00% |
20.12
|
- |
- |
-
|
|
GNNSF Genscript Biotech Corporation
|
3.5 billion |
0.00% |
-
|
- |
- |
-
|
|
GNPX Genprex, Inc.
|
1.1 million |
0.00% |
0.14
|
- |
- |
-
|
|
GNRO.PA GeNeuro S.A.
|
1.0 million |
0.00% |
-0.05
|
- |
- |
-
|
|
GNS.L Genus plc
|
24.2 million |
1.16% |
95
|
2 |
26 |
3%
|
|
GNTA Genenta Science S.p.A.
|
40.4 million |
0.00% |
-1.67
|
- |
- |
-
|
|
GOSS Gossamer Bio, Inc.
|
44.5 million |
0.00% |
-
|
- |
- |
-
|
|
GOVX GeoVax Labs, Inc.
|
1.9 million |
0.00% |
-
|
- |
- |
-
|
|
GOVXW GeoVax Labs, Inc.
|
3.0 million |
0.00% |
-
|
- |
- |
-
|
|
GPCR Structure Therapeutics Inc.
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
|
GPLL GPL Holdings, Inc.
|
4.2 million |
0.00% |
-
|
- |
- |
-
|
|
GRAY Graybug Vision, Inc.
|
121.0 million |
- |
-
|
- |
- |
-
|
|
GRCE Grace Therapeutics, Inc.
|
38.7 million |
0.00% |
-
|
- |
- |
-
|
|
GRCL Gracell Biotechnologies Inc.
|
989.9 million |
0.00% |
-10.59
|
- |
- |
-
|
|
GRDX GridAI Technologies Corp.
|
21.3 million |
- |
-0.19
|
- |
- |
-
|
|
GRI GRI Bio, Inc.
|
180562 |
0.00% |
0.05
|
- |
- |
-
|
|
GRPH Graphite Bio, Inc.
|
189.8 million |
0.00% |
-1.37
|
- |
1 |
-
|
|
GRTS Gritstone bio, Inc.
|
3.8 million |
0.00% |
-
|
- |
- |
-
|
|
GRTX Galera Therapeutics, Inc.
|
7.6 million |
0.00% |
0.16
|
- |
- |
-
|
|
GSGTF GenSight Biologics S.A.
|
31.0 million |
0.00% |
-1.27
|
- |
- |
-
|
|
GSTC GlobeStar Therapeutics Corporation
|
124111 |
0.00% |
-
|
- |
- |
-
|
|
GTBP GT Biopharma, Inc.
|
4.6 million |
0.00% |
-
|
- |
- |
-
|
|
GTHX G1 Therapeutics, Inc.
|
377.2 million |
0.00% |
-
|
- |
- |
-
|
|
GUARD.ST Guard Therapeutics International AB (publ)
|
3.3 million |
0.00% |
-0.23
|
- |
- |
-
|
|
GUBRA.CO Gubra A/S
|
934.5 million |
0.00% |
3.65
|
- |
1 |
-
|
|
GUJINJEC.BO Gujarat Inject (Kerala) Ltd.
|
9.9 million |
0.00% |
106.25
|
- |
- |
-
|
|
GUTS Fractyl Health, Inc. Common Stock
|
54.9 million |
0.00% |
-
|
- |
- |
-
|
|
GVBL.BO Genomic Valley Biotech Ltd.
|
912773 |
0.00% |
-256.36
|
- |
- |
-
|
|
GWIN Glorywin Entertainment Group, Inc.
|
343.0 million |
0.00% |
-0.93
|
- |
- |
-
|
|
GYRE Gyre Therapeutics, Inc.
|
610.1 million |
0.00% |
-
|
- |
- |
-
|
|
HALB Halberd Corporation
|
515875 |
0.00% |
-
|
- |
- |
-
|
|
HALEOSLABS.BO Haleos Labs Limited
|
40.8 million |
0.12% |
19.42
|
1 |
5 |
-
|
|
HALEOSLABS.NS Haleos Labs Limited
|
41.6 million |
0.12% |
19.81
|
1 |
5 |
-
|
|
HALO Halozyme Therapeutics, Inc.
|
8.5 billion |
0.00% |
23.55
|
- |
- |
-
|
|
HARP Harpoon Therapeutics, Inc.
|
492.3 million |
0.00% |
-14.67
|
- |
- |
-
|
|
HAVLF HAVN Life Sciences Inc.
|
2565 |
0.00% |
-
|
- |
- |
-
|
|
HBMHF HBM Holdings Limited
|
1.3 billion |
0.00% |
17.33
|
- |
- |
-
|
|
HBPCF Helix BioPharma Corp.
|
130.6 million |
0.00% |
-
|
- |
- |
-
|
|
HBP.TO Helix BioPharma Corp.
|
110.4 million |
0.00% |
-29.29
|
- |
- |
-
|
|
HCWB HCW Biologics Inc.
|
3.4 million |
0.00% |
-
|
- |
- |
-
|
|
HEAL.CN Restart Life Sciences Corp.
|
3.1 million |
0.00% |
-2.40
|
- |
- |
-
|
|
HELP Cybin Inc. Common Stock
|
221.0 million |
- |
-1.84
|
- |
- |
-
|
|
HEMO.L Hemogenyx Pharmaceuticals Plc
|
791424 |
0.00% |
-4.06
|
- |
- |
-
|
|
HEM.V Hemostemix Inc.
|
10.6 million |
0.00% |
-2.67
|
- |
- |
-
|
|
HEPA Hepion Pharmaceuticals, Inc.
|
664856 |
0.00% |
-
|
- |
- |
-
|
|
HESG Health Sciences Group, Inc.
|
1.9 million |
0.00% |
-
|
- |
- |
-
|
|
HGEN Humanigen, Inc.
|
23816 |
- |
-5.60
|
- |
- |
-
|
|
HILS Hillstream BioPharma, Inc.
|
4.9 million |
- |
-
|
- |
- |
-
|
|
HIND Vyome Holdings, Inc.
|
12.2 million |
0.00% |
-14.90
|
- |
- |
-
|
|
HLOSF Healios K.K.
|
193.8 million |
0.00% |
-
|
- |
- |
-
|
|
HLUN HEALTHeUNIVERSE, Inc.
|
1178 |
0.00% |
0.01
|
- |
- |
-
|
|
HLX.MI Helyx Industries S.p.A.
|
21.9 million |
0.00% |
-36.90
|
- |
- |
-
|
|
HMGN Hemagen Diagnostics, Inc.
|
4650 |
0.00% |
-
|
- |
- |
-
|
|
HMTXF Hemostemix Inc.
|
7.5 million |
0.00% |
-2.99
|
- |
- |
-
|
|
HNSA.ST Hansa Biopharma AB (publ)
|
278.4 million |
0.00% |
-
|
- |
- |
-
|
|
HNSBF Hansa Biopharma AB (publ)
|
245.8 million |
0.00% |
-
|
- |
- |
-
|
|
HOOK HOOKIPA Pharma Inc.
|
14.4 million |
0.00% |
-
|
- |
- |
-
|
|
HOPHF Hemogenyx Pharmaceuticals Plc
|
15.8 million |
0.00% |
-0.75
|
- |
- |
-
|
|
HOTH Hoth Therapeutics, Inc.
|
9.6 million |
0.00% |
-1.01
|
- |
- |
-
|
|
HPHA.DE Heidelberg Pharma AG
|
164.3 million |
0.00% |
-5.50
|
- |
- |
-
|
|
HRGN Harvard Apparatus Regenerative Technology Inc.
|
19.0 million |
0.00% |
-4.42
|
- |
- |
-
|
|
HRMY Harmony Biosciences Holdings, Inc.
|
1.9 billion |
0.00% |
12.16
|
- |
- |
-
|
|
HRTIS.HE Herantis Pharma Oyj
|
57.4 million |
0.00% |
-
|
- |
- |
-
|
|
HRTX Heron Therapeutics, Inc.
|
70.4 million |
0.00% |
-
|
- |
- |
-
|
|
HSITF Hadasit Bio-Holdings Ltd
|
1.3 million |
0.00% |
-0.63
|
- |
- |
-
|
|
HSTC HST Global, Inc.
|
29.9 million |
0.00% |
-50
|
- |
- |
-
|
|
HSTO Histogen Inc.
|
897069 |
0.00% |
-0.12
|
- |
- |
-
|
|
HTBX Heat Biologics, Inc.
|
81.8 million |
4.65% |
-3.29
|
- |
- |
-
|
|
HUMA Humacyte, Inc.
|
226.8 million |
0.00% |
-
|
- |
- |
-
|
|
HUMAW Humacyte, Inc.
|
66.2 million |
0.00% |
-
|
- |
- |
-
|
|
HURA TuHURA Biosciences, Inc.
|
139.5 million |
0.00% |
-
|
- |
- |
-
|
|
HVO.L hVIVO plc
|
851030 |
0.00% |
-
|
- |
3 |
-
|
|
HXBM Helix BioMedix, Inc.
|
402227 |
0.00% |
-2
|
- |
- |
-
|
|
HYFT MindWalk Holdings Corp.
|
84.1 million |
0.00% |
-
|
- |
- |
-
|
|
HYL.BR Hyloris Pharmaceuticals S.A.
|
214.0 million |
0.00% |
-27.92
|
- |
- |
-
|
|
HYPD Hyperion DeFi, Inc.
|
14.9 million |
0.00% |
-
|
- |
- |
-
|
|
IBIO iBio, Inc.
|
30.6 million |
0.00% |
-
|
- |
- |
-
|
|
IBOGF Universal Ibogaine Inc.
|
10.1 million |
0.00% |
-0.85
|
- |
- |
-
|
|
IBO.V Universal Ibogaine Inc.
|
1.1 million |
0.00% |
-0.25
|
- |
- |
-
|
|
IBRX ImmunityBio, Inc.
|
7.7 billion |
0.00% |
-
|
- |
- |
-
|
|
IBT-B.ST Infant Bacterial Therapeutics AB (publ)
|
66.6 million |
0.00% |
-10.26
|
- |
- |
-
|
|
IBT.L International Biotechnology Trust plc
|
3.8 million |
3.50% |
-302.67
|
2 |
9 |
0%
|
|
ICCC ImmuCell Corporation
|
86.9 million |
0.00% |
-
|
- |
- |
-
|
|
ICPT Intercept Pharmaceuticals, Inc.
|
794.7 million |
- |
-5.82
|
- |
- |
-
|
|
ICU SeaStar Medical Holding Corporation
|
8.2 million |
0.00% |
-
|
- |
- |
-
|
|
ICUCW SeaStar Medical Holding Corporation
|
677685 |
0.00% |
-
|
- |
- |
-
|
|
IDIA.SW Idorsia Ltd
|
871.5 million |
0.00% |
-6.79
|
- |
- |
-
|
|
IDRA Idera Pharmaceuticals, Inc.
|
18.7 million |
- |
-0.31
|
- |
- |
-
|
|
IDRSF Idorsia Ltd
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
|
IDYA IDEAYA Biosciences, Inc.
|
2.4 billion |
0.00% |
-
|
- |
- |
-
|
|
IFRX InflaRx N.V.
|
144.5 million |
0.00% |
-
|
- |
- |
-
|
|
IGC IGC Pharma, Inc.
|
26.3 million |
0.00% |
-
|
- |
- |
-
|
|
IGMS IGM Biosciences, Inc.
|
76.6 million |
0.00% |
-
|
- |
- |
-
|
|
IKNA Ikena Oncology, Inc.
|
718.8 million |
0.00% |
-2.23
|
- |
- |
-
|
|
IKT Inhibikase Therapeutics, Inc.
|
224.5 million |
0.00% |
-
|
- |
- |
-
|
|
ILA.AX Island Pharmaceuticals Limited
|
73.4 million |
0.00% |
-14.17
|
- |
- |
-
|
|
IMA ImageneBio Inc
|
64.2 million |
0.00% |
-
|
- |
- |
-
|
|
IMAB I-Mab
|
378.9 million |
0.00% |
-9.08
|
- |
- |
-
|
|
IMC.AX Immuron Limited
|
5.0 million |
0.00% |
-1.40
|
- |
- |
-
|
|
IMCR Immunocore Holdings plc
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
IMGN ImmunoGen, Inc.
|
8.7 billion |
0.00% |
-111.54
|
- |
- |
-
|
|
IMGO Imago BioSciences, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
|
IMM.AX Immutep Limited
|
386.1 million |
0.00% |
-6.33
|
- |
- |
-
|
|
IMMB Immunotech Laboratories, Inc.
|
114993 |
0.00% |
-
|
- |
- |
-
|
|
IMMG Immage Biotherapeutics Corp.
|
15174 |
0.00% |
-0.01
|
- |
- |
-
|
|
IMM.L ImmuPharma plc
|
474591 |
0.00% |
-7.14
|
- |
- |
-
|
|
IMMP Immutep Limited
|
55.5 million |
0.00% |
-6.82
|
- |
- |
-
|
|
IMMU.ST Mendus AB (publ)
|
21.7 million |
0.00% |
-1.91
|
- |
- |
-
|
|
IMMX Immix Biopharma, Inc.
|
562.4 million |
0.00% |
-
|
- |
- |
-
|
|
IMNM Immunome, Inc.
|
1.9 billion |
0.00% |
-
|
- |
- |
-
|
|
IMNN Imunon, Inc.
|
5.2 million |
0.00% |
-
|
- |
- |
-
|
|
IMPL Impel Pharmaceuticals Inc.
|
8.8 million |
- |
-
|
- |
- |
-
|
|
IMRA IMARA Inc.
|
165.8 million |
- |
105.33
|
- |
- |
-
|
|
IMRN Immuron Limited
|
8.1 million |
0.00% |
-1.18
|
- |
- |
-
|
|
IMTX Immatics N.V.
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
IMTXW Immatics N.V.
|
484.4 million |
0.00% |
-
|
- |
- |
-
|
|
IMU.AX Imugene Limited
|
53.3 million |
0.00% |
-1.04
|
- |
- |
-
|
|
IMUC EOM Pharmaceuticals Holdings, Inc.
|
24.0 million |
0.00% |
0.02
|
- |
- |
-
|
|
IMUX Immunic, Inc.
|
127.4 million |
0.00% |
-
|
- |
- |
-
|
|
IMV IMV Inc.
|
9.7 million |
- |
-7.90
|
- |
- |
-
|
|
IMVIF IMV Inc.
|
23423 |
0.00% |
-
|
- |
- |
-
|
|
IMVT Immunovant, Inc.
|
6.5 billion |
0.00% |
-
|
- |
- |
-
|
|
INBX Inhibrx Biosciences, Inc.
|
1.4 billion |
0.89% |
-
|
- |
- |
-
|
|
INCPF InnoCare Pharma Limited
|
2.3 billion |
0.00% |
25.83
|
- |
- |
-
|
|
INCY Incyte Corporation
|
20.5 billion |
0.00% |
13.68
|
- |
- |
-
|
|
INDP Indaptus Therapeutics, Inc.
|
6.4 million |
0.00% |
-
|
- |
- |
-
|
|
INFI I:SPX Oct 2023 Weekly 3100.000
|
17.9 million |
- |
-4.52
|
- |
- |
-
|
|
INFIQ Infinity Pharmaceuticals, Inc.
|
9076 |
0.00% |
-
|
- |
- |
-
|
|
INIT.ST Initiator Pharma A/S
|
20.5 million |
0.00% |
-10.03
|
- |
- |
-
|
|
INKT MiNK Therapeutics, Inc.
|
59.1 million |
0.00% |
-
|
- |
- |
-
|
|
INM InMed Pharmaceuticals Inc.
|
2.8 million |
0.00% |
-0.14
|
- |
- |
-
|
|
INMB INmune Bio, Inc.
|
36.2 million |
0.00% |
-
|
- |
- |
-
|
|
INNMF Amplia Therapeutics Limited
|
48.7 million |
0.00% |
-8.50
|
- |
- |
-
|
|
INO Inovio Pharmaceuticals, Inc.
|
57.3 million |
0.00% |
-
|
- |
- |
-
|
|
INRLF Valneva SE
|
519.6 million |
0.00% |
-
|
- |
- |
-
|
|
INSM Insmed Incorporated
|
20.4 billion |
0.00% |
-
|
- |
- |
-
|
|
INTI Inhibitor Therapeutics, Inc.
|
14.5 million |
0.00% |
-5.55
|
- |
- |
-
|
|
INVA Innoviva, Inc.
|
1.6 billion |
0.00% |
3.60
|
- |
- |
-
|
|
INZY Inozyme Pharma, Inc.
|
258.2 million |
0.00% |
-2.38
|
- |
- |
-
|
|
IOBT IO Biotech, Inc.
|
3.5 million |
0.00% |
-
|
- |
- |
-
|
|
IONS Ionis Pharmaceuticals, Inc.
|
12.5 billion |
0.00% |
-
|
- |
- |
-
|
|
IOVA Iovance Biotherapeutics, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
|
IPA ImmunoPrecise Antibodies Ltd.
|
95.5 million |
0.00% |
-3.14
|
- |
- |
-
|
|
IP.BK Inter Pharma Public Company Limited
|
70.0 million |
0.78% |
21.44
|
1 |
1 |
-
|
|
IPHA Innate Pharma S.A.
|
168.1 million |
0.00% |
-
|
- |
- |
-
|
|
IPH.PA Innate Pharma S.A.
|
120.2 million |
0.00% |
-
|
- |
- |
-
|
|
IPHYF Innate Pharma S.A.
|
154.9 million |
0.00% |
-
|
- |
- |
-
|
|
IPIX Innovation Pharmaceuticals Inc.
|
155504 |
0.00% |
-0.07
|
- |
- |
-
|
|
IPSC Century Therapeutics, Inc.
|
179.2 million |
0.00% |
-
|
- |
- |
-
|
|
IRD Opus Genetics, Inc.
|
341.9 million |
0.00% |
-
|
- |
- |
-
|
|
IRLAB-A.ST IRLAB Therapeutics AB (publ)
|
14.0 million |
0.00% |
-0.98
|
- |
- |
-
|
|
IRON Disc Medicine, Inc.
|
2.7 billion |
0.00% |
-
|
- |
- |
-
|
|
IRX.AX InhaleRx Limited
|
4.1 million |
0.00% |
-2.40
|
- |
- |
-
|
|
ISCO International Stem Cell Corporation
|
1.4 million |
0.00% |
-14.17
|
- |
- |
-
|
|
ISEE IVERIC bio, Inc.
|
5.5 billion |
- |
-4.87
|
- |
- |
-
|
|
ISOFOL.ST Isofol Medical AB (publ)
|
19.3 million |
0.00% |
-2.67
|
- |
- |
-
|
|
ITECH.ST I-Tech AB
|
56.8 million |
2.18% |
16.39
|
1 |
3 |
-
|
|
ITMC Itoco Inc.
|
17051 |
0.00% |
-0.01
|
- |
- |
-
|
|
ITOS iTeos Therapeutics, Inc.
|
448.7 million |
0.00% |
-2.15
|
- |
- |
-
|
|
ITRM Iterum Therapeutics plc
|
1.6 million |
0.00% |
-
|
- |
- |
-
|
|
ITRMF Iterum Therapeutics plc
|
3.0 million |
0.00% |
-
|
- |
- |
-
|
|
ITRX inTerra Resources Corp
|
23.7 million |
0.00% |
-7.78
|
- |
- |
-
|
|
IUGNF Imugene Limited
|
36.2 million |
0.00% |
-0.94
|
- |
- |
-
|
|
IVA Inventiva S.A.
|
209.5 million |
0.00% |
-
|
- |
- |
-
|
|
IVACC.ST Intervacc AB (publ)
|
23.1 million |
0.00% |
-2.44
|
- |
- |
-
|
|
IVA.PA Inventiva S.A.
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
IVBXF Innovent Biologics, Inc.
|
17.5 billion |
0.00% |
167.14
|
- |
- |
-
|
|
IVEVF Inventiva S.A.
|
741.2 million |
0.00% |
-
|
- |
- |
-
|
|
IVVD Invivyd, Inc.
|
146.0 million |
0.00% |
-
|
- |
- |
-
|
|
IXC.AX INVEX THER FPO [IXC]
|
3.4 million |
0.00% |
-3.25
|
1 |
- |
-
|
|
IXI.L IXICO plc
|
93217 |
0.00% |
-3.80
|
- |
- |
-
|
|
IXSBF InNexus Biotechnology, Inc.
|
12627 |
0.00% |
-0.01
|
- |
- |
-
|
|
JAGX Jaguar Health, Inc.
|
194589 |
0.00% |
-
|
- |
- |
-
|
|
JANX Janux Therapeutics, Inc.
|
829.3 million |
0.00% |
-
|
- |
- |
-
|
|
JAZZ Jazz Pharmaceuticals plc
|
14.5 billion |
0.00% |
2032.82
|
- |
- |
-
|
|
JBIO Jade Biosciences, Inc.
|
552.7 million |
14.17% |
-
|
- |
- |
-
|
|
JNCE Jounce Therapeutics, Inc.
|
101.6 million |
- |
-2.45
|
- |
- |
-
|
|
JUNS Jupiter Neurosciences, Inc.
|
9.4 million |
0.00% |
-
|
- |
- |
-
|
|
JWCTF JW (Cayman) Therapeutics Co. Ltd
|
98.9 million |
0.00% |
-1.40
|
- |
- |
-
|
|
KALA KALA BIO, Inc.
|
45.2 million |
0.00% |
-
|
- |
- |
-
|
|
KALV KalVista Pharmaceuticals, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
KAPA Kairos Pharma, Ltd.
|
10.2 million |
0.00% |
-
|
- |
- |
-
|
|
KARD Kardigan, Inc.
|
1.8 billion |
- |
-
|
- |
- |
-
|
|
KDEV.ST Karolinska Development AB (publ)
|
6.8 million |
0.00% |
-0.60
|
- |
- |
-
|
|
KDMN Kadmon Holdings, Inc.
|
1.6 billion |
- |
-13.43
|
- |
- |
-
|
|
KDNY Chinook Therapeutics, Inc.
|
1.5 billion |
- |
-2.01
|
- |
- |
-
|
|
KLDO Kaleido Biosciences, Inc.
|
4262 |
- |
-
|
- |
- |
-
|
|
KLRA Kailera Therapeutics, Inc.
|
3.1 billion |
0.00% |
-
|
- |
- |
-
|
|
KLRS Kalaris Therapeutics Inc
|
87.0 million |
0.00% |
-
|
- |
- |
-
|
|
KLTO Klotho Neurosciences, Inc.
|
21.7 million |
0.00% |
-1.38
|
- |
- |
-
|
|
KLTOW Klotho Neurosciences, Inc.
|
6.9 million |
0.00% |
-
|
- |
- |
-
|
|
KMPH KemPharm, Inc.
|
200.5 million |
- |
17.60
|
- |
- |
-
|
|
KNBIF Kane Biotech Inc.
|
4.0 million |
0.00% |
-2.70
|
- |
- |
-
|
|
KNE.V Kane Biotech Inc.
|
4.1 million |
0.00% |
-3.50
|
- |
- |
-
|
|
KNTE Kinnate Biopharma Inc.
|
125.0 million |
0.00% |
-0.84
|
- |
- |
-
|
|
KNTPF Kintor Pharmaceutical Limited
|
125.9 million |
0.00% |
-6.54
|
- |
- |
-
|
|
KOD Kodiak Sciences Inc.
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
|
KPRX Kiora Pharmaceuticals, Inc.
|
11.7 million |
0.00% |
-
|
- |
- |
-
|
|
KPTI Karyopharm Therapeutics Inc.
|
205.6 million |
0.00% |
-
|
- |
- |
-
|
|
KRBP Kiromic BioPharma, Inc.
|
318418 |
0.00% |
-0.04
|
- |
- |
-
|
|
KRON Kronos Bio, Inc.
|
41.5 million |
0.00% |
-0.64
|
- |
- |
-
|
|
KROS Keros Therapeutics, Inc.
|
336.0 million |
0.00% |
-
|
- |
- |
-
|
|
KRRO Korro Bio, Inc.
|
111.3 million |
0.00% |
-
|
- |
- |
-
|
|
KRTX Karuna Therapeutics, Inc.
|
12.6 billion |
0.00% |
-29.07
|
- |
- |
-
|
|
KRYS Krystal Biotech, Inc.
|
8.9 billion |
0.00% |
40.98
|
- |
- |
-
|
|
KTRA Kintara Therapeutics, Inc.
|
10.5 million |
0.00% |
-0.01
|
- |
- |
-
|
|
KTTA Pasithea Therapeutics Corp.
|
19.5 million |
0.00% |
-
|
- |
- |
-
|
|
KTTAW Pasithea Therapeutics Corp. Warrant
|
25329 |
0.00% |
-
|
- |
- |
-
|
|
KURA Kura Oncology, Inc.
|
768.3 million |
0.00% |
-
|
- |
- |
-
|
|
KYMR Kymera Therapeutics, Inc.
|
6.0 billion |
0.00% |
-
|
- |
- |
-
|
|
KYTX Kyverna Therapeutics, Inc.
|
342.5 million |
0.00% |
-
|
- |
- |
-
|
|
KZIA Kazia Therapeutics Limited
|
17.8 million |
0.00% |
-0.65
|
- |
- |
-
|
|
KZR Kezar Life Sciences, Inc.
|
53.9 million |
0.00% |
-
|
- |
- |
-
|
|
LABP Landos Biopharma, Inc.
|
69.4 million |
0.00% |
-1.37
|
- |
- |
-
|
|
LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock
|
3.4 million |
- |
-
|
- |
- |
-
|
|
LADX LadRx Corporation
|
52975 |
0.00% |
-0.02
|
- |
- |
-
|
|
LBPH Longboard Pharmaceuticals, Inc.
|
2.3 billion |
0.00% |
-8.09
|
- |
- |
-
|
|
LBPS 4D pharma plc
|
37.2 million |
- |
-
|
- |
- |
-
|
|
LBRX LB Pharmaceuticals Inc Common Stock
|
828.8 million |
0.00% |
-
|
- |
- |
-
|
|
LCTX Lineage Cell Therapeutics, Inc.
|
299.2 million |
0.00% |
-
|
- |
- |
-
|
|
LCTX.TA Lineage Cell Therapeutics, Inc.
|
4.4 million |
0.00% |
-6.32
|
- |
- |
-
|
|
LEGN Legend Biotech Corporation
|
6.7 billion |
0.00% |
-
|
- |
- |
-
|
|
LENZ LENZ Therapeutics, Inc.
|
219.8 million |
102.85% |
-
|
- |
- |
-
|
|
LEXX Lexaria Bioscience Corp.
|
12.5 million |
0.00% |
-
|
- |
- |
-
|
|
LGND Ligand Pharmaceuticals Incorporated
|
4.7 billion |
0.00% |
27.09
|
- |
- |
-
|
|
LIAN LianBio
|
34.5 million |
0.00% |
-4.99
|
1 |
1 |
-
|
|
LIANY LianBio
|
17.5 million |
268.75% |
-
|
- |
- |
-
|
|
LIDDS.ST LIDDS AB (publ)
|
298179 |
0.00% |
-0.71
|
- |
- |
-
|
|
LIFE aTyr Pharma, Inc.
|
131.1 million |
0.00% |
-1.77
|
- |
- |
-
|
|
LIFE.ME PHARMSYNTHEZ PJSC
|
17.5 million |
0.00% |
-
|
- |
- |
-
|
|
LIMNW Liminatus Pharma, Inc. Warrants
|
1.6 million |
- |
-
|
- |
- |
-
|
|
LIPO Lipella Pharmaceuticals Inc.
|
485188 |
0.00% |
-0.07
|
- |
- |
-
|
|
LIPUM.ST Lipum AB (publ)
|
31.4 million |
0.00% |
-4.26
|
- |
- |
-
|
|
LITS Lite Strategy, Inc.
|
29.4 million |
0.00% |
-
|
- |
- |
-
|
|
LIXT Lixte Biotechnology Holdings, Inc.
|
88.0 million |
0.00% |
-2.21
|
- |
- |
-
|
|
LIXTW Lixte Biotechnology Holdings, I
|
71534 |
0.00% |
-
|
- |
- |
-
|
|
LJPC La Jolla Pharmaceutical Company
|
171.2 million |
0.00% |
38.78
|
- |
- |
-
|
|
LKFT Lakefront Biotherapeutics N.V.
|
1.9 billion |
- |
-
|
- |
- |
-
|
|
LMNL Liminal BioSciences Inc.
|
21.0 million |
- |
0.71
|
- |
- |
-
|
|
LNAI Lunai Bioworks Inc.
|
11.1 million |
0.00% |
-0.03
|
- |
- |
-
|
|
LOBE.CN Lobe Sciences Ltd.
|
7.5 million |
0.00% |
-1.37
|
- |
- |
-
|
|
LOBEF Lobe Sciences Ltd.
|
1.7 million |
0.00% |
-0.16
|
- |
- |
-
|
|
LOGC LogicBio Therapeutics, Inc.
|
68.2 million |
- |
-3.94
|
- |
- |
-
|
|
LONA LeonaBio, Inc.
|
34.5 million |
- |
-0.22
|
- |
- |
-
|
|
LPCN Lipocine Inc.
|
12.8 million |
0.00% |
-
|
- |
- |
-
|
|
LPGO.ST Lipigon Pharmaceuticals AB (publ)
|
399697 |
0.00% |
-0.05
|
- |
- |
-
|
|
LPTX Leap Therapeutics, Inc.
|
21.9 million |
0.00% |
-0.33
|
- |
- |
-
|
|
LQDA Liquidia Corporation
|
5.5 billion |
0.00% |
334.88
|
- |
- |
-
|
|
LRMR Larimar Therapeutics, Inc.
|
271.3 million |
0.00% |
-
|
- |
- |
-
|
|
LSBCF LakeShore Biopharma Co., Ltd
|
2.9 million |
0.00% |
-0.08
|
- |
- |
-
|
|
LSTA Lisata Therapeutics, Inc.
|
30.1 million |
0.00% |
-
|
- |
- |
-
|
|
LTRN Lantern Pharma Inc.
|
45.8 million |
0.00% |
-
|
- |
- |
-
|
|
LUMO Lumos Pharma, Inc.
|
37.5 million |
0.00% |
-
|
- |
- |
-
|
|
LVCLF Algorae Pharmaceuticals Limited
|
14.4 million |
0.00% |
-0.39
|
- |
- |
-
|
|
LVTX LAVA Therapeutics N.V.
|
45.8 million |
0.00% |
-2
|
- |
- |
-
|
|
LXEO Lexeo Therapeutics, Inc. Common Stock
|
343.1 million |
0.00% |
-
|
- |
- |
-
|
|
LXRX Lexicon Pharmaceuticals, Inc.
|
806.1 million |
0.00% |
-
|
- |
- |
-
|
|
LYEL Lyell Immunopharma, Inc.
|
279.3 million |
0.00% |
-
|
- |
- |
-
|
|
LYKALABS.BO Lyka Labs Limited
|
22.9 million |
0.00% |
102.83
|
- |
- |
-
|
|
LYKALABS.NS Lyka Labs Limited
|
22.8 million |
0.00% |
-354
|
- |
- |
-
|
|
LYRA Lyra Therapeutics, Inc.
|
878566 |
0.00% |
-
|
- |
- |
-
|
|
LYTIX.OL Lytix Biopharma AS
|
60.3 million |
0.00% |
-10.80
|
- |
- |
-
|
|
MAAT.PA MaaT Pharma S.A.
|
126.7 million |
0.00% |
-
|
- |
- |
-
|
|
MAB.WA Mabion S.A.
|
34.7 million |
0.00% |
-2.20
|
- |
- |
-
|
|
MACK Merrimack Pharmaceuticals, Inc.
|
218.4 million |
0.00% |
-138
|
- |
- |
-
|
|
MAGLE.ST Magle Chemoswed Holding AB (publ)
|
8.9 million |
0.00% |
-
|
- |
- |
-
|
|
MAIA MAIA Biotechnology, Inc.
|
82.7 million |
0.00% |
-
|
- |
- |
-
|
|
MANE Veradermics, Incorporated
|
3.8 billion |
0.00% |
-
|
- |
- |
-
|
|
MARI.VI Marinomed Biotech AG
|
35.7 million |
0.00% |
3.11
|
- |
- |
-
|
|
MAZE Maze Therapeutics, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
MBIO Mustang Bio, Inc.
|
5.6 million |
0.00% |
-0.14
|
- |
- |
-
|
|
MBRX Moleculin Biotech, Inc.
|
3.1 million |
0.00% |
-
|
- |
- |
-
|
|
MBX MBX Biosciences, Inc. Common Stock
|
1.0 billion |
0.00% |
4.08
|
- |
- |
-
|
|
MBXBF Microbix Biosystems Inc.
|
25.9 million |
0.00% |
-17.20
|
- |
- |
-
|
|
MBX.TO Microbix Biosystems Inc.
|
22.5 million |
0.00% |
-
|
- |
- |
-
|
|
MCRB Seres Therapeutics, Inc.
|
69.7 million |
0.00% |
-
|
- |
- |
-
|
|
MCRT Microart Inc.
|
26149 |
0.00% |
-
|
- |
- |
-
|
|
MDCLF MedinCell S.A.
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
|
MDG1.F Medigene AG
|
558026 |
0.00% |
-0.03
|
- |
- |
-
|
|
MDGEF Medigene AG
|
38.2 million |
0.00% |
-2.02
|
- |
- |
-
|
|
MDGL Madrigal Pharmaceuticals, Inc.
|
11.2 billion |
0.00% |
-
|
- |
- |
-
|
|
MDMA.CN Pharmala Biotech Holdings Inc.
|
8.1 million |
0.00% |
-5.25
|
- |
- |
-
|
|
MDNA Medicenna Therapeutics Corp.
|
11.2 million |
- |
-18.44
|
- |
- |
-
|
|
MDNA.TO Medicenna Therapeutics Corp.
|
39.7 million |
0.00% |
-5.47
|
- |
- |
-
|
|
MDWD MediWound Ltd.
|
157.0 million |
0.00% |
-
|
- |
- |
-
|
|
MDXG MiMedx Group, Inc.
|
557.1 million |
0.00% |
18.20
|
- |
- |
-
|
|
MEDCL.PA MedinCell S.A.
|
900.2 million |
0.00% |
-38.59
|
- |
- |
-
|
|
MEIP MEI Pharma, Inc.
|
30.2 million |
0.00% |
-0.95
|
1 |
- |
-
|
|
MEM.AX Memphasys Limited
|
11.8 million |
0.00% |
-
|
- |
- |
-
|
|
MENS Jyong Biotech Ltd. Ordinary Shares
|
153.6 million |
- |
-53.50
|
- |
- |
-
|
|
MEOBF Mesoblast Limited
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
|
MESO Mesoblast Limited
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
|
MGNX MacroGenics, Inc.
|
248.5 million |
0.00% |
-
|
- |
- |
-
|
|
MGTA Magenta Therapeutics, Inc. Common Stock
|
44.2 million |
- |
-3.45
|
- |
- |
-
|
|
MGTX MeiraGTx Holdings plc
|
886.3 million |
0.00% |
-
|
- |
- |
-
|
|
MGX Metagenomi, Inc. Common Stock
|
50.1 million |
0.00% |
-
|
- |
- |
-
|
|
MIRM Mirum Pharmaceuticals, Inc.
|
4.6 billion |
0.00% |
-
|
- |
- |
-
|
|
MIRO Miromatrix Medical Inc.
|
93.0 million |
- |
-
|
- |
- |
-
|
|
MIR.V MedMira Inc.
|
32.2 million |
0.00% |
-6.50
|
- |
- |
-
|
|
MIST Milestone Pharmaceuticals Inc.
|
110.8 million |
0.00% |
-
|
- |
- |
-
|
|
MITO Stealth BioTherapeutics Corp
|
18.4 million |
- |
-2.07
|
- |
- |
-
|
|
MLEC Moolec Science S.A.
|
5.4 million |
0.00% |
-
|
- |
- |
-
|
|
MLECW Moolec Science S.A.
|
211301 |
0.00% |
-
|
- |
- |
-
|
|
MLLCF Molecular Partners AG
|
181.9 million |
0.00% |
-
|
- |
- |
-
|
|
MLND Millendo Therapeutics, Inc.
|
20.2 million |
- |
-0.64
|
- |
- |
-
|
|
MLTX MoonLake Immunotherapeutics
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
MLYS Mineralys Therapeutics, Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
|
MMIRF MedMira Inc.
|
8.5 million |
0.00% |
-1.33
|
- |
- |
-
|
|
MMTX.SW MindMaze Therapeutics Holding S.A.
|
132.0 million |
0.00% |
-
|
- |
- |
-
|
|
MNKD MannKind Corporation
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
MNMD Mind Medicine (MindMed) Inc.
|
1.3 billion |
0.00% |
-8.97
|
- |
- |
-
|
|
MNOV MediciNova, Inc.
|
64.5 million |
0.00% |
-
|
- |
- |
-
|
|
MNPR Monopar Therapeutics Inc.
|
398.5 million |
0.00% |
-
|
- |
- |
-
|
|
MOC.WA Molecure S.A.
|
40.7 million |
0.00% |
-7.49
|
- |
- |
-
|
|
MODTX.ST Modus Therapeutics Holding AB (publ)
|
2.8 million |
0.00% |
-1.63
|
- |
- |
-
|
|
MOLN Molecular Partners AG
|
153.8 million |
0.00% |
-
|
- |
- |
-
|
|
MOLN.SW Molecular Partners AG
|
178.6 million |
0.00% |
-2.38
|
- |
- |
-
|
|
MOOD.CN Doseology Sciences Inc.
|
2.4 million |
0.00% |
-7.50
|
- |
- |
-
|
|
MOR MorphoSys AG
|
2.9 billion |
0.00% |
-
|
- |
- |
-
|
|
MORF Morphic Holding, Inc.
|
2.9 billion |
0.00% |
-10.56
|
- |
- |
-
|
|
MPLT MapLight Therapeutics, Inc.
|
24.1 million |
0.00% |
-7.46
|
- |
- |
-
|
|
MREO Mereo BioPharma Group plc
|
48.2 million |
0.00% |
-
|
- |
- |
-
|
|
MRES Institute of Biomedical Research Corp.
|
4.3 million |
0.00% |
-
|
- |
- |
-
|
|
MRKR Marker Therapeutics, Inc.
|
15.3 million |
0.00% |
-
|
- |
- |
-
|
|
MRNA Moderna, Inc.
|
19.5 billion |
0.00% |
-
|
- |
- |
-
|
|
MRNS Marinus Pharmaceuticals, Inc.
|
30.4 million |
0.00% |
-
|
- |
- |
-
|
|
MRPI Mera Pharmaceuticals, Inc.
|
55730 |
0.00% |
-
|
- |
- |
-
|
|
MRSN Mersana Therapeutics, Inc.
|
147.0 million |
0.00% |
-2.11
|
- |
- |
-
|
|
MRTX Mirati Therapeutics, Inc.
|
4.2 billion |
- |
-4.71
|
- |
- |
-
|
|
MRUS Merus N.V.
|
6.8 billion |
0.00% |
-17.05
|
- |
- |
-
|
|
MRVI Maravai LifeSciences Holdings, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
MRVL.V Marvel Biosciences Corp.
|
5.7 million |
0.00% |
-2.80
|
- |
- |
-
|
|
MRZM Marizyme, Inc.
|
39538 |
0.00% |
-0.01
|
- |
- |
-
|
|
MSB.AX Mesoblast Limited
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
|
MSCLF Satellos Bioscience Inc.
|
96.6 million |
0.00% |
4.38
|
- |
- |
-
|
|
MSCL.TO Satellos Bioscience Inc.
|
194.6 million |
0.00% |
5.09
|
- |
- |
-
|
|
MTCR Metacrine, Inc.
|
25.5 million |
- |
-
|
1 |
1 |
-
|
|
MTEM Molecular Templates, Inc.
|
658 |
0.00% |
0.00
|
- |
- |
-
|
|
MTLF.TA Matricelf Ltd
|
281059 |
0.00% |
-
|
- |
- |
-
|
|
MTNB Matinas BioPharma Holdings, Inc.
|
4.4 million |
0.00% |
-0.18
|
- |
- |
-
|
|
MTP Midatech Pharma PLC
|
2.0 million |
0.00% |
-0.34
|
- |
- |
-
|
|
MTSR Metsera, Inc.
|
7.4 billion |
0.00% |
-
|
- |
- |
-
|
|
MTST MetaStat, Inc.
|
5877 |
0.00% |
-0.01
|
- |
- |
-
|
|
MTVA MetaVia Inc.
|
5.5 million |
0.00% |
-
|
- |
- |
-
|
|
MURA Mural Oncology plc
|
35.4 million |
0.00% |
-0.29
|
- |
- |
-
|
|
MYMD MyMD Pharmaceuticals, Inc.
|
4.5 million |
0.00% |
-0.82
|
- |
- |
-
|
|
MYMX Mymetics Corporation
|
334134 |
0.34% |
-0.02
|
- |
- |
-
|
|
MYNDF MYND Life Sciences Inc.
|
657843 |
0.00% |
-0.81
|
- |
- |
-
|
|
MYOV Myovant Sciences Ltd.
|
2.6 billion |
- |
-7.04
|
- |
- |
-
|
|
NAGE Niagen Bioscience Inc
|
274.8 million |
0.00% |
18.95
|
- |
- |
-
|
|
NAMS NewAmsterdam Pharma Company N.V.
|
3.7 billion |
0.00% |
-
|
- |
- |
-
|
|
NAMSW NewAmsterdam Pharma Company N.V.
|
2.3 billion |
0.00% |
-
|
- |
- |
-
|
|
NANOFH.HE Nanoform Finland Oyj
|
67.2 million |
0.00% |
-
|
- |
- |
-
|
|
NANO.PA Nanobiotix S.A.
|
1.6 billion |
0.00% |
-26.28
|
- |
- |
-
|
|
NAUT Nautilus Biotechnology, Inc.
|
322.1 million |
0.00% |
-
|
- |
- |
-
|
|
NAVB Navidea Biopharmaceuticals, Inc
|
3.5 million |
0.00% |
-0.17
|
- |
- |
-
|
|
NAVBQ Navidea Biopharmaceuticals, Inc.
|
10008 |
0.00% |
-
|
- |
- |
-
|
|
NBCO Neon Bloom, Inc.
|
1.4 million |
0.00% |
-0.01
|
- |
- |
-
|
|
NBIO Nascent Biotech, Inc.
|
68887 |
0.00% |
-0.03
|
- |
- |
-
|
|
NBP NovaBridge Biosciences
|
201.7 million |
0.00% |
-10
|
- |
- |
-
|
|
NBRV Nabriva Therapeutics plc
|
6.0 million |
- |
-0.62
|
- |
- |
-
|
|
NBRVF Nabriva Therapeutics plc
|
646 |
0.00% |
-
|
- |
- |
-
|
|
NBSE NeuBase Therapeutics, Inc.
|
1.4 million |
0.00% |
-0.04
|
- |
- |
-
|
|
NBTX Nanobiotix S.A.
|
1.9 billion |
0.00% |
-
|
- |
- |
-
|
|
NBY NovaBay Pharmaceuticals, Inc.
|
51.9 million |
0.00% |
-
|
- |
- |
-
|
|
NCEL NewcelX Ltd.
|
1.3 million |
0.00% |
-0.42
|
- |
- |
-
|
|
NCNA NuCana plc
|
11.8 million |
0.00% |
-
|
- |
- |
-
|
|
NDTP NDT Pharmaceuticals Inc.
|
98.7 million |
0.00% |
-2.50
|
- |
- |
-
|
|
NERV Minerva Neurosciences, Inc.
|
34.7 million |
0.00% |
-3.25
|
- |
- |
-
|
|
NEU.AX Neuren Pharmaceuticals Limited
|
1.1 billion |
0.00% |
53.70
|
- |
- |
-
|
|
NEUP Neuphoria Therapeutics Inc.
|
25.0 million |
0.00% |
-
|
- |
- |
-
|
|
NEXI NexImmune, Inc.
|
139 |
0.00% |
-0.01
|
- |
- |
-
|
|
NFX.L Nuformix plc
|
76711 |
0.00% |
-
|
- |
- |
-
|
|
NGEN NervGen Pharma Corp. Common stock
|
154.6 million |
0.00% |
-
|
- |
- |
-
|
|
NGENF NervGen Pharma Corp.
|
329.5 million |
0.00% |
-16
|
- |
- |
-
|
|
NGEN.V NervGen Pharma Corp.
|
302.2 million |
0.00% |
-15.03
|
- |
- |
-
|
|
NGM NGM Biopharmaceuticals, Inc.
|
128.5 million |
0.00% |
-0.83
|
- |
- |
-
|
|
NGNE Neurogene Inc.
|
418.6 million |
0.00% |
-
|
- |
- |
-
|
|
NICA.ST Nanologica AB (publ)
|
11.1 million |
0.00% |
-
|
- |
- |
-
|
|
NICXF Nicox S.A.
|
30.9 million |
0.00% |
-0.79
|
- |
- |
-
|
|
NIRV.CN Nirvana Life Sciences Inc.
|
238098 |
0.00% |
7
|
- |
- |
-
|
|
NK NantKwest, Inc.
|
3.6 billion |
- |
-10.73
|
- |
- |
-
|
|
NKGN NKGen Biotech, Inc. Common Stock
|
7.8 million |
0.00% |
-0.05
|
- |
- |
-
|
|
NKGNW NKGen Biotech, Inc. Warrants
|
- |
0.00% |
-
|
- |
- |
-
|
|
NKTR Nektar Therapeutics
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
NKTX Nkarta, Inc.
|
194.6 million |
0.00% |
-
|
- |
- |
-
|
|
NLTX Neoleukin Therapeutics, Inc.
|
31.5 million |
- |
-19.78
|
- |
- |
-
|
|
NMLSF Restart Life Sciences Corp.
|
771213 |
0.00% |
-1.97
|
- |
- |
-
|
|
NMRA Neumora Therapeutics, Inc. Common Stock
|
302.0 million |
0.00% |
-
|
- |
- |
-
|
|
NMTR 9 Meters Biopharma, Inc.
|
11.1 million |
- |
-0.88
|
- |
- |
-
|
|
NMTRQ 9 Meters Biopharma, Inc.
|
145 |
0.00% |
-
|
- |
- |
-
|
|
NNBP Nanobac Pharmaceuticals, Incorporated
|
24951 |
0.00% |
-
|
- |
- |
-
|
|
NNG.WA NanoGroup S.A.
|
21.8 million |
0.00% |
-13.39
|
- |
- |
-
|
|
NNLX NanoLogix, Inc.
|
11961 |
0.00% |
-0.01
|
- |
- |
-
|
|
NNVC NanoViricides, Inc.
|
27.0 million |
0.00% |
-
|
- |
- |
-
|
|
NOVC.DE Novo Nordisk A/S
|
399.6 billion |
1.06% |
22.93
|
2 |
22 |
12%
|
|
NOVKAN.ST Novakand Pharma AB (publ)
|
1.6 million |
0.00% |
-0.32
|
- |
- |
-
|
|
NOVN Novan, Inc.
|
33.9 million |
- |
-2.25
|
- |
- |
-
|
|
NOVNQ NVN Liquidation, Inc.
|
2802 |
- |
-
|
- |
- |
-
|
|
NOX.AX Noxopharm Limited
|
13.8 million |
0.00% |
-3.25
|
- |
- |
-
|
|
NP5.DE Newron Pharmaceuticals S.p.A.
|
365.7 million |
0.00% |
-
|
- |
- |
-
|
|
NRBO NeuroBo Pharmaceuticals, Inc.
|
21.6 million |
0.00% |
13.28
|
- |
- |
-
|
|
NRIX Nurix Therapeutics, Inc.
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
NRSN NeuroSense Therapeutics Ltd.
|
27.4 million |
0.00% |
-
|
- |
- |
-
|
|
NRSNW NeuroSense Therapeutics Ltd.
|
5.0 million |
0.00% |
-
|
- |
- |
-
|
|
NRXBF NurExone Biologic Inc.
|
29.4 million |
0.00% |
-
|
- |
- |
-
|
|
NRXP NRx Pharmaceuticals, Inc.
|
71.6 million |
0.00% |
-
|
- |
- |
-
|
|
NRXPW NRx Pharmaceuticals, Inc.
|
361784 |
0.00% |
-
|
- |
- |
-
|
|
NRXS NeurAxis, Inc.
|
86.3 million |
0.00% |
-
|
- |
- |
-
|
|
NRX.V NurExone Biologic Inc.
|
36.4 million |
0.00% |
-
|
- |
- |
-
|
|
NSB.AX NeuroScientific Biopharmaceuticals Limited
|
22.3 million |
0.00% |
-4.85
|
- |
- |
-
|
|
NSHS.CN NanoSphere Health Sciences Inc.
|
217383 |
0.00% |
0.75
|
- |
- |
-
|
|
NSHSF NanoSphere Health Sciences Inc.
|
98642 |
0.00% |
0.33
|
- |
- |
-
|
|
NTEC Intec Pharma Ltd
|
46.4 million |
- |
-0.47
|
- |
- |
-
|
|
NTI.AX Neurotech International Limited
|
9.1 million |
0.00% |
-1.30
|
- |
- |
-
|
|
NTII Neurobiological Technologies, Inc.
|
10862 |
1.06% |
-
|
- |
- |
-
|
|
NTLA Intellia Therapeutics, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
|
NTRB Nutriband Inc.
|
43.2 million |
0.00% |
-
|
- |
- |
-
|
|
NTRBW Nutriband Inc.
|
10.6 million |
0.00% |
-
|
- |
- |
-
|
|
NURPF Neuren Pharmaceuticals Limited
|
1.1 billion |
0.00% |
53.28
|
- |
- |
-
|
|
NUVB-WT Nuvation Bio Inc.
|
23.0 million |
- |
-
|
- |
- |
-
|
|
NUZ.AX Neurizon Therapeutics Limited
|
39.5 million |
0.00% |
-2.73
|
- |
- |
-
|
|
NVAX Novavax, Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
|
NVCT Nuvectis Pharma, Inc.
|
251.2 million |
0.00% |
-
|
- |
- |
-
|
|
NVIV InVivo Therapeutics Holdings Corp.
|
995917 |
0.00% |
-0.16
|
- |
- |
-
|
|
NVV1.F Novavax, Inc.
|
1.5 billion |
0.00% |
4.60
|
- |
- |
-
|
|
NWBO Northwest Biotherapeutics, Inc.
|
328.7 million |
0.00% |
-3.73
|
- |
- |
-
|
|
NWPHF Newron Pharmaceuticals S.p.A.
|
416.1 million |
0.00% |
-
|
- |
- |
-
|
|
NWRN.SW Newron Pharmaceuticals S.p.A.
|
350.6 million |
0.00% |
11.36
|
- |
- |
-
|
|
NXTC NextCure, Inc.
|
8.4 million |
0.00% |
-
|
- |
- |
-
|
|
NXTCL.ST NextCell Pharma AB
|
15.1 million |
0.00% |
-2.87
|
- |
- |
-
|
|
NYKD.OL Nykode Therapeutics AS
|
100.6 million |
0.00% |
-
|
- |
1 |
-
|
|
NYMX Nymox Pharmaceutical Corporation
|
43.0 million |
- |
-10.83
|
- |
- |
-
|
|
NYMXF Nymox Pharmaceutical Corporation
|
5.8 million |
0.00% |
-1.32
|
- |
- |
-
|
|
NYR.AX Nyrada Inc.
|
87.2 million |
0.00% |
-31.62
|
- |
- |
-
|
|
OABI OmniAb, Inc.
|
295.3 million |
0.00% |
-
|
- |
- |
-
|
|
OABIW OmniAb, Inc.
|
14.5 million |
0.00% |
-
|
- |
- |
-
|
|
OBI.L Ondine Biomedical Inc.
|
577627 |
0.00% |
-2.55
|
- |
- |
-
|
|
OBIO Orchestra BioMed Holdings, Inc.
|
233.5 million |
0.00% |
-
|
- |
- |
-
|
|
OBSV ObsEva SA
|
11.0 million |
- |
-1.14
|
- |
- |
-
|
|
OCC.AX Orthocell Limited
|
136.4 million |
0.00% |
-17.80
|
- |
- |
-
|
|
OCEA Ocean Biomedical, Inc.
|
46473 |
0.00% |
-
|
- |
- |
-
|
|
OCEAW Ocean Biomedical, Inc.
|
7.9 million |
0.00% |
-
|
- |
- |
-
|
|
OCGN Ocugen, Inc.
|
433.3 million |
0.00% |
-
|
- |
- |
-
|
|
OCS Oculis Holding AG
|
735.8 million |
0.00% |
-
|
- |
- |
-
|
|
OCUL Ocular Therapeutix, Inc.
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
|
OCUP Ocuphire Pharma, Inc.
|
31.7 million |
0.00% |
-
|
- |
- |
-
|
|
ODT Odonate Therapeutics, Inc.
|
51.0 million |
- |
-3.67
|
- |
- |
-
|
|
ODTX Odyssey Therapeutics, Inc.
|
474.7 million |
0.00% |
-
|
- |
- |
-
|
|
OGEN Oragenics, Inc.
|
2.8 million |
0.00% |
-
|
- |
- |
-
|
|
OKUR OnKure Therapeutics, Inc.
|
57.3 million |
0.00% |
-
|
- |
- |
-
|
|
OKYO OKYO Pharma Limited
|
83.4 million |
0.00% |
-
|
- |
- |
-
|
|
OLMA Olema Pharmaceuticals, Inc.
|
932.9 million |
0.00% |
-
|
- |
- |
-
|
|
OMER Omeros Corporation
|
708.6 million |
0.00% |
10.26
|
- |
- |
-
|
|
OMGA Omega Therapeutics, Inc.
|
10.4 million |
0.00% |
-0.14
|
- |
- |
-
|
|
OMMH Omnimmune Holdings, Inc.
|
981 |
0.00% |
-0.01
|
- |
- |
-
|
|
ONBI ONE Bio Corp.
|
4236 |
0.00% |
0.05
|
- |
- |
-
|
|
ONC BeOne Medicines Ltd.
|
29.8 billion |
0.00% |
71.44
|
- |
- |
-
|
|
ONCIN.OL Oncoinvent ASA
|
18.3 million |
0.00% |
-0.24
|
- |
- |
-
|
|
ONCO Onconetix, Inc.
|
319031 |
0.00% |
0.00
|
- |
- |
-
|
|
ONCO.ST Oncopeptides AB (publ)
|
35.9 million |
0.00% |
-1.56
|
- |
- |
-
|
|
ONCOZ.ST OncoZenge AB (publ)
|
8.3 million |
0.00% |
-8.82
|
- |
- |
-
|
|
ONCR Oncorus, Inc.
|
547992 |
- |
-
|
- |
- |
-
|
|
ONCS OncoSec Medical Incorporated
|
3.8 million |
- |
-1.88
|
- |
- |
-
|
|
ONCSQ OncoSec Medical Incorporated
|
596 |
0.00% |
-
|
- |
- |
-
|
|
ONCT Oncternal Therapeutics, Inc.
|
1.6 million |
0.00% |
-
|
- |
- |
-
|
|
ONCY Oncolytics Biotech Inc.
|
87.0 million |
0.00% |
-
|
- |
- |
-
|
|
ONESOURCE.NS Onesource Specialty Pharma Ltd.
|
1.6 billion |
0.00% |
748.29
|
- |
- |
-
|
|
ONPH Oncology Pharma Inc.
|
1.9 million |
0.00% |
-1.03
|
- |
- |
-
|
|
ONT.L Oxford Nanopore Technologies plc
|
15.6 million |
0.00% |
-7.61
|
- |
- |
-
|
|
ONTTF Oxford Nanopore Technologies plc
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
|
ONTX Onconova Therapeutics, Inc.
|
17.6 million |
0.00% |
-0.68
|
- |
- |
-
|
|
ONVO Organovo Holdings, Inc.
|
3.7 million |
0.00% |
-0.22
|
- |
- |
-
|
|
ONWD.BR Onward Medical N.V.
|
201.3 million |
0.00% |
-5.34
|
- |
- |
-
|
|
OPNT Opiant Pharmaceuticals, Inc.
|
108.8 million |
- |
34.80
|
- |
- |
-
|
|
OPORF HVIVO PLC
|
251.6 million |
0.01% |
-
|
- |
- |
-
|
|
OPT Opthea Limited
|
65.6 million |
0.00% |
-1.52
|
- |
- |
-
|
|
OPTI.L OptiBiotix Health Plc
|
78535 |
0.00% |
-2.87
|
- |
- |
-
|
|
ORGS Orgenesis Inc.
|
2.6 million |
0.00% |
-0.02
|
- |
- |
-
|
|
ORIC ORIC Pharmaceuticals, Inc.
|
830.2 million |
0.00% |
-
|
- |
- |
-
|
|
ORKA Oruka Therapeutics, Inc.
|
2.3 billion |
32.18% |
-
|
- |
- |
-
|
|
ORMP Oramed Pharmaceuticals Inc.
|
149.4 million |
6.85% |
2.26
|
- |
1 |
-
|
|
ORMP.TA Oramed Pharmaceuticals Inc.
|
1.5 million |
7.32% |
3.45
|
1 |
1 |
-
|
|
ORPH Orphazyme A/S
|
86.0 million |
- |
-3.59
|
- |
- |
-
|
|
ORTX Orchard Therapeutics plc
|
753.2 million |
- |
-4.05
|
- |
- |
-
|
|
ORY.MC Oryzon Genomics S.A.
|
249.1 million |
0.00% |
-92.33
|
- |
- |
-
|
|
ORYZF Oryzon Genomics S.A.
|
286.8 million |
0.00% |
-
|
- |
- |
-
|
|
OSE.PA OSE Immunotherapeutics S.A.
|
106.9 million |
0.00% |
-17.40
|
- |
- |
-
|
|
OSMT Osmotica Pharmaceuticals plc
|
65.9 million |
- |
-6.37
|
- |
- |
-
|
|
OSRH OSR Holdings, Inc.
|
10.2 million |
0.00% |
16.73
|
- |
- |
-
|
|
OSRHW OSR Holdings, Inc.
|
1.4 million |
0.00% |
-
|
- |
- |
-
|
|
OTIC Otonomy, Inc.
|
582482 |
- |
-3.12
|
- |
- |
-
|
|
OTLC Oncotelic Therapeutics, Inc.
|
22.2 million |
0.00% |
-4
|
- |
- |
-
|
|
OTLK Outlook Therapeutics, Inc.
|
30.6 million |
0.00% |
-
|
- |
- |
-
|
|
OVB.L Ovoca Bio plc
|
79695 |
0.00% |
-1.85
|
- |
- |
-
|
|
OVID Ovid Therapeutics Inc.
|
316.5 million |
0.00% |
-
|
- |
- |
-
|
|
OVIT OncoVista Innovative Therapies, Inc.
|
2356 |
0.00% |
-
|
- |
- |
-
|
|
OXB.L Oxford Biomedica plc
|
9.1 million |
0.00% |
-
|
- |
- |
-
|
|
OXUR.BR Oxurion N.V.
|
436311 |
0.00% |
0.01
|
- |
- |
-
|
|
OYST Oyster Point Pharma, Inc.
|
298.5 million |
- |
-8.09
|
- |
- |
-
|
|
OZYMF Strategic Partners A/S
|
3.7 million |
0.00% |
-0.04
|
- |
- |
-
|
|
PAB.AX Patrys Limited
|
8.2 million |
0.00% |
-1.75
|
- |
- |
-
|
|
PALI Palisade Bio, Inc.
|
335.0 million |
0.00% |
15.25
|
- |
- |
-
|
|
PANACEABIO.BO Panacea Biotec Limited
|
207.9 million |
0.00% |
-250.27
|
- |
- |
-
|
|
PANACEABIO.NS Panacea Biotec Limited
|
211.9 million |
0.00% |
-253.02
|
- |
- |
-
|
|
PANC Panacos Pharmaceuticals, Inc.
|
5367 |
0.00% |
-0.01
|
- |
- |
-
|
|
PAR.AX Paradigm Biopharmaceuticals Limited
|
75.8 million |
0.00% |
-2.50
|
- |
- |
-
|
|
PARD Poniard Pharmaceuticals, Inc.
|
150 |
0.00% |
-0.01
|
- |
- |
-
|
|
PASG Passage Bio, Inc.
|
19.0 million |
0.00% |
-
|
- |
- |
-
|
|
PBIGF Paradigm Biopharmaceuticals Limited
|
61.5 million |
0.00% |
-2.64
|
- |
- |
-
|
|
PBLA Panbela Therapeutics, Inc.
|
53889 |
0.00% |
-0.01
|
- |
- |
-
|
|
PBLS Parabilis Medicines, Inc.
|
103.5 million |
0.00% |
-
|
- |
- |
-
|
|
PBM Psyence Biomedical Ltd.
|
75125 |
0.00% |
-0.01
|
- |
- |
-
|
|
PBMWW Psyence Biomedical Ltd. Warrant
|
1853 |
0.00% |
-
|
- |
- |
-
|
|
PBYI Puma Biotechnology, Inc.
|
357.8 million |
0.00% |
14.94
|
- |
- |
-
|
|
PCIB.OL PCI Biotech Holding ASA
|
1.2 million |
0.00% |
-0.57
|
- |
- |
-
|
|
PCSA Processa Pharmaceuticals, Inc.
|
6.3 million |
0.00% |
-
|
- |
- |
-
|
|
PCVX Vaxcyte, Inc.
|
6.8 billion |
0.00% |
-
|
- |
- |
-
|
|
PDSB PDS Biotechnology Corporation
|
56.9 million |
0.00% |
-
|
- |
- |
-
|
|
PEG.CO Pharma Equity Group A/S
|
17.4 million |
0.00% |
-4.65
|
- |
- |
-
|
|
PEPG PepGen Inc.
|
100.3 million |
0.00% |
-
|
- |
- |
-
|
|
PFND Pathfinder Cell Therapy, Inc.
|
66716 |
0.00% |
-
|
- |
- |
-
|
|
PGEN Precigen, Inc.
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
PHAR Pharming Group N.V.
|
864.5 million |
0.00% |
68.85
|
- |
- |
-
|
|
PHARM.AS Pharming Group N.V.
|
890.8 million |
0.00% |
55.30
|
- |
- |
-
|
|
PHAS PhaseBio Pharmaceuticals, Inc.
|
3.4 million |
- |
-1.33
|
- |
- |
-
|
|
PHAT Phathom Pharmaceuticals, Inc.
|
786.4 million |
0.00% |
-
|
- |
- |
-
|
|
PHGE BiomX Inc.
|
1.2 million |
0.00% |
-0.18
|
- |
- |
-
|
|
PHGUF Pharming Group N.V.
|
769.8 million |
- |
-38.33
|
- |
- |
-
|
|
PHIL.MI Philogen S.p.A.
|
678.9 million |
0.00% |
18.07
|
1 |
1 |
-
|
|
PHIO Phio Pharmaceuticals Corp.
|
12.3 million |
0.00% |
-
|
- |
- |
-
|
|
PHIOW Phio Pharmaceuticals Corp.
|
421414 |
- |
-
|
- |
- |
-
|
|
PHM.MC Pharma Mar, S.A.
|
1.9 billion |
0.00% |
22.33
|
- |
6 |
30%
|
|
PHMMF PHARMA MAR SA
|
628.5 million |
0.02% |
-
|
- |
- |
-
|
|
PHRM.CN PharmaTher Holdings Ltd.
|
6.1 million |
0.00% |
-4.75
|
- |
- |
-
|
|
PHRRF PharmaTher Holdings Ltd.
|
4.0 million |
0.00% |
-6.80
|
- |
- |
-
|
|
PHR.WA Pharmena S.A.
|
10.4 million |
24.15% |
-17.60
|
- |
- |
-
|
|
PHVS Pharvaris N.V.
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
|
PHYOF IXICO plc
|
6.5 million |
0.00% |
-
|
- |
- |
-
|
|
PI3.F Gubra A/S
|
832.1 million |
0.00% |
3.20
|
- |
1 |
-
|
|
PILA.ST Pila Pharma AB (publ)
|
5.9 million |
0.00% |
-2.01
|
- |
- |
-
|
|
PIQ.AX Proteomics International Laboratories Limited
|
35.9 million |
0.00% |
-4.50
|
- |
- |
-
|
|
PIRS Pieris Pharmaceuticals, Inc.
|
21.9 million |
0.00% |
-
|
- |
- |
-
|
|
PKTX ProtoKinetix, Incorporated
|
2.1 million |
0.00% |
-0.59
|
- |
- |
-
|
|
PLNT.TA PlantArc Bio Ltd.
|
24440 |
0.00% |
-1.13
|
- |
- |
-
|
|
PLRX Pliant Therapeutics, Inc.
|
71.2 million |
0.00% |
-
|
- |
- |
-
|
|
PLRZ Polyrizon Ltd.
|
15.1 million |
0.00% |
-10.75
|
- |
- |
-
|
|
PLUR Pluri Inc.
|
21.6 million |
0.00% |
-
|
- |
- |
-
|
|
PLUR.TA Pluri Inc.
|
296970 |
0.00% |
-1.07
|
- |
- |
-
|
|
PLX Protalix BioTherapeutics, Inc.
|
160.7 million |
0.00% |
10.05
|
- |
- |
-
|
|
PLYX Polaryx Therapeutics, Inc. Common Stock
|
116.1 million |
0.00% |
-
|
- |
- |
-
|
|
PMCB PharmaCyte Biotech, Inc.
|
5.0 million |
0.00% |
-0.64
|
- |
- |
-
|
|
PMN ProMIS Neurosciences, Inc.
|
13.3 million |
0.00% |
-
|
- |
- |
-
|
|
PMVP PMV Pharmaceuticals, Inc.
|
61.9 million |
0.00% |
-
|
- |
- |
-
|
|
PNT POINT Biopharma Global Inc.
|
1.5 billion |
- |
12.51
|
- |
- |
-
|
|
POLBF Poolbeg Pharma PLC
|
74.0 million |
0.00% |
-3.30
|
- |
- |
-
|
|
POLB.L Poolbeg Pharma PLC
|
391556 |
0.00% |
-4.20
|
- |
- |
-
|
|
POXEL.PA Poxel S.A.
|
14.8 million |
0.00% |
-0.93
|
- |
- |
-
|
|
PPBT Purple Biotech Ltd.
|
407348 |
0.00% |
0.00
|
- |
- |
-
|
|
PPBT.TA Purple Biotech Ltd.
|
17956 |
0.00% |
-0.01
|
- |
- |
-
|
|
PPCB Propanc Biopharma, Inc.
|
1.5 million |
0.00% |
-0.05
|
- |
- |
-
|
|
PPTDF PeptiDream Inc.
|
848.0 million |
0.00% |
-
|
- |
- |
-
|
|
PRAX Praxis Precision Medicines, Inc.
|
5.4 billion |
0.00% |
-
|
- |
- |
-
|
|
PRDS Pardes Biosciences, Inc.
|
116.3 million |
- |
-
|
- |
- |
-
|
|
PREV.CN PreveCeutical Medical Inc.
|
8.3 million |
0.00% |
-2
|
- |
- |
-
|
|
PRLD Prelude Therapeutics Incorporated
|
216.9 million |
0.00% |
-
|
- |
- |
-
|
|
PRME Prime Medicine, Inc.
|
542.8 million |
0.00% |
-
|
- |
- |
-
|
|
PRNAF Alterity Therapeutics Limited
|
12.0 million |
0.00% |
-1.01
|
- |
- |
-
|
|
PROG Progenity, Inc.
|
340.6 million |
- |
-0.48
|
- |
- |
-
|
|
PROK ProKidney Corp.
|
602.3 million |
0.00% |
-
|
- |
- |
-
|
|
PROT Proteonomix, Inc.
|
791 |
0.00% |
-
|
- |
- |
-
|
|
PRQR ProQR Therapeutics N.V.
|
161.2 million |
0.00% |
-
|
- |
- |
-
|
|
PRRUF Immutep Limited
|
73.7 million |
0.00% |
-8.33
|
- |
- |
-
|
|
PRTA Prothena Corporation plc
|
484.3 million |
0.00% |
-
|
- |
- |
-
|
|
PRTC PureTech Health plc
|
411.2 million |
0.00% |
-
|
- |
- |
-
|
|
PRTC.L PureTech Health plc
|
4.0 million |
0.00% |
9.58
|
- |
- |
-
|
|
PRTG Portage Biotech Inc.
|
15.5 million |
0.00% |
-1.19
|
- |
- |
-
|
|
PRTK Paratek Pharmaceuticals, Inc.
|
106.0 million |
0.00% |
-4.84
|
- |
- |
-
|
|
PRVB Provention Bio, Inc.
|
2.3 billion |
- |
-9.92
|
- |
- |
-
|
|
PRVCF PreveCeutical Medical Inc.
|
6.6 million |
0.00% |
-
|
- |
- |
-
|
|
PSTI Pluristem Therapeutics Inc.
|
32.1 million |
- |
-6.23
|
- |
- |
-
|
|
PSTV Plus Therapeutics, Inc.
|
13.1 million |
0.00% |
0.30
|
- |
- |
-
|
|
PSTX Poseida Therapeutics, Inc.
|
927.9 million |
0.00% |
-
|
- |
- |
-
|
|
PSYBF PsyBio Therapeutics Corp.
|
1275 |
0.00% |
-
|
- |
- |
-
|
|
PTCHF PureTech Health plc
|
453.2 million |
0.00% |
-
|
- |
- |
-
|
|
PTCT PTC Therapeutics, Inc.
|
5.7 billion |
0.00% |
-
|
- |
- |
-
|
|
PTE PolarityTE, Inc.
|
3.3 million |
- |
-0.56
|
- |
- |
-
|
|
PTG.WA Poltreg S.A.
|
30.7 million |
0.00% |
-4.69
|
- |
- |
-
|
|
PTGX Protagonist Therapeutics, Inc.
|
6.3 billion |
0.00% |
-
|
- |
- |
-
|
|
PTHS Pelthos Therapeutics Inc.
|
16.8 million |
0.00% |
-
|
- |
- |
-
|
|
PTIX Protagenic Therapeutics, Inc.
|
905104 |
0.00% |
-
|
- |
- |
-
|
|
PTIXW Protagenic Therapeutics, Inc. Warrant
|
3.7 million |
0.00% |
-
|
- |
- |
-
|
|
PTN Palatin Technologies, Inc.
|
6.1 million |
0.00% |
-0.14
|
- |
- |
-
|
|
PTX.AX Prescient Therapeutics Limited
|
43.6 million |
0.00% |
-6
|
- |
- |
-
|
|
PULM Pulmatrix, Inc.
|
4.7 million |
0.00% |
-1.27
|
- |
- |
-
|
|
PUR.WA Pure Biologics Spólka Akcyjna
|
5.2 million |
0.00% |
-1.33
|
- |
- |
-
|
|
PVCT Provectus Biopharmaceuticals, Inc.
|
26.5 million |
0.00% |
-5.09
|
- |
- |
-
|
|
PVLA Palvella Therapeutics, Inc.
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
|
PXXLF Poxel S.A.
|
15.9 million |
0.00% |
-
|
- |
- |
-
|
|
PYC.AX PYC Therapeutics Limited
|
603.7 million |
0.00% |
-18.75
|
- |
- |
-
|
|
PYC.L Physiomics Plc
|
18040 |
0.00% |
-0.45
|
- |
- |
-
|
|
PYPD PolyPid Ltd.
|
48.1 million |
0.00% |
-
|
- |
- |
-
|
|
PYXS Pyxis Oncology, Inc.
|
108.3 million |
0.00% |
-
|
- |
- |
-
|
|
PZRXQ PhaseRx, Inc.
|
1169 |
0.00% |
-
|
- |
- |
-
|
|
QBIO Q BioMed Inc.
|
14509 |
0.00% |
-
|
- |
- |
-
|
|
QLGN Qualigen Therapeutics, Inc.
|
4.8 million |
0.00% |
0.45
|
- |
- |
-
|
|
QNCX Quince Therapeutics, Inc.
|
5.6 million |
0.00% |
-
|
- |
- |
-
|
|
QNRX Quoin Pharmaceuticals, Ltd.
|
2.6 million |
0.00% |
-
|
- |
- |
-
|
|
QPTFF Quest PharmaTech Inc.
|
5.2 million |
0.00% |
-1.33
|
- |
- |
-
|
|
QRON Qrons Inc.
|
199800 |
0.00% |
-0.37
|
- |
- |
-
|
|
QTTB Q32 Bio Inc.
|
155.7 million |
0.00% |
2.09
|
- |
- |
-
|
|
QUIA.ST Quia Pharma AB (publ)
|
243070 |
0.00% |
-0.04
|
- |
- |
-
|
|
QURE uniQure N.V.
|
1.9 billion |
0.00% |
-
|
- |
- |
-
|
|
RAC.AX Race Oncology Limited
|
293.5 million |
0.00% |
-78
|
- |
- |
-
|
|
RAD.AX Radiopharm Theranostics Limited
|
34.3 million |
0.00% |
-1.05
|
- |
- |
-
|
|
RADX Radiopharm Theranostics Limited
|
5.6 million |
0.00% |
-1.25
|
- |
- |
-
|
|
RAIN Rain Oncology Inc.
|
43.7 million |
- |
-
|
- |
- |
-
|
|
RANI Rani Therapeutics Holdings, Inc.
|
57.2 million |
0.00% |
-
|
- |
- |
-
|
|
RAPP Rapport Therapeutics, Inc. Common Stock
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
RAPT RAPT Therapeutics, Inc.
|
959.5 million |
0.00% |
-4.98
|
- |
- |
-
|
|
RARE Ultragenyx Pharmaceutical Inc.
|
2.3 billion |
0.00% |
-
|
- |
- |
-
|
|
RASP Actavia Life Sciences, Inc.
|
385906 |
0.00% |
-0.05
|
- |
- |
-
|
|
RBSH Rebus Holdings, Inc.
|
3213 |
0.00% |
0.01
|
- |
- |
-
|
|
RCAR RenovaCare, Inc.
|
8735 |
0.00% |
-
|
- |
- |
-
|
|
RCE.AX Recce Pharmaceuticals Ltd
|
92.8 million |
0.00% |
-4.23
|
- |
- |
-
|
|
RCKT Rocket Pharmaceuticals, Inc.
|
300.3 million |
0.00% |
-
|
- |
- |
-
|
|
RCOR Renovacor, Inc.
|
51.2 million |
- |
-
|
- |
- |
-
|
|
RCUS Arcus Biosciences, Inc.
|
2.3 billion |
0.00% |
-
|
- |
- |
-
|
|
RDTCF Rapid Dose Therapeutics Corp.
|
10.5 million |
0.00% |
-11
|
- |
- |
-
|
|
RECEF Recce Pharmaceuticals Ltd
|
80.4 million |
0.00% |
-
|
- |
- |
-
|
|
REGMF RemeGen Co., Ltd.
|
6.8 billion |
0.00% |
57.63
|
- |
- |
-
|
|
REGN Regeneron Pharmaceuticals, Inc.
|
65.5 billion |
0.59% |
17.13
|
4 |
2 |
-
|
|
REPCF RepliCel Life Sciences Inc.
|
7000 |
0.00% |
-0.01
|
- |
- |
-
|
|
REPL Replimune Group, Inc.
|
960.3 million |
0.00% |
-
|
- |
- |
-
|
|
RETA Reata Pharmaceuticals, Inc.
|
3.9 billion |
- |
-13.24
|
- |
- |
-
|
|
REVB Revelation Biosciences, Inc.
|
3.9 million |
0.00% |
-
|
- |
- |
-
|
|
REVBU Revelation Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
|
REVBW Revelation Biosciences, Inc.
|
59834 |
0.00% |
-
|
- |
- |
-
|
|
RGBP Regen BioPharma, Inc.
|
9466 |
0.00% |
0.01
|
- |
- |
-
|
|
RGBPP Regen BioPharma, Inc.
|
177421 |
0.00% |
-0.12
|
- |
- |
-
|
|
RGIN Regenicin, Inc.
|
15348 |
0.00% |
-0.01
|
- |
- |
-
|
|
RGLS Regulus Therapeutics Inc.
|
565.0 million |
0.00% |
-12
|
- |
- |
-
|
|
RGNX REGENXBIO Inc.
|
314.3 million |
0.00% |
-
|
- |
- |
-
|
|
RGRX RegeneRx Biopharmaceuticals, Inc.
|
898 |
0.00% |
-
|
- |
- |
-
|
|
RIGL Rigel Pharmaceuticals, Inc.
|
559.7 million |
0.00% |
1.36
|
- |
- |
-
|
|
RLAY Relay Therapeutics, Inc.
|
2.9 billion |
0.00% |
-
|
- |
- |
-
|
|
RLF.SW Relief Therapeutics Holding AG
|
44.9 million |
0.00% |
-2.12
|
- |
- |
-
|
|
RLFTF MindMaze Therapeutics Holding S.A.
|
5.7 million |
0.00% |
-0.43
|
- |
- |
-
|
|
RLFTY MindMaze Therapeutics Holding S.A. Sponsored ADR
|
5.3 million |
0.00% |
-0.56
|
- |
- |
-
|
|
RLMD Relmada Therapeutics, Inc.
|
462.7 million |
0.00% |
-
|
- |
- |
-
|
|
RMTG Regenerative Medical Technology Group Inc.
|
446725 |
0.00% |
-0.05
|
- |
- |
-
|
|
RNA Avidity Biosciences, Inc.
|
229.9 million |
0.00% |
-
|
- |
- |
-
|
|
RNAC Cartesian Therapeutics, Inc.
|
184.1 million |
0.00% |
-
|
- |
- |
-
|
|
RNAM Avidity Biosciences Inc
|
11.2 billion |
0.00% |
-
|
- |
- |
-
|
|
RNTX Rein Therapeutics Inc.
|
26.6 million |
0.00% |
-
|
- |
- |
-
|
|
RNUGF ReNeuron Group plc
|
62891 |
0.00% |
-0.01
|
- |
- |
-
|
|
RNXT RenovoRx, Inc.
|
32.5 million |
0.00% |
-
|
- |
- |
-
|
|
ROIV Roivant Sciences Ltd.
|
20.6 billion |
0.00% |
-
|
- |
- |
-
|
|
ROIVW Roivant Sciences Ltd. Warrant
|
- |
- |
-
|
- |
- |
-
|
|
ROQ.L Roquefort Therapeutics plc
|
21106 |
0.00% |
-0.97
|
- |
- |
-
|
|
ROTH PharmaRoth Labs, Inc.
|
3512 |
0.00% |
-0.02
|
- |
- |
-
|
|
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
|
4.7 billion |
1.16% |
34.19
|
1 |
19 |
5%
|
|
RPHM Reneo Pharmaceuticals, Inc.
|
43.8 million |
0.00% |
-0.74
|
- |
- |
-
|
|
RPRX Royalty Pharma plc
Challengers
|
23.6 billion |
1.66% |
27.18
|
4 |
7 |
6%
|
|
RPTX Repare Therapeutics Inc.
|
110.5 million |
0.00% |
-1.51
|
- |
- |
-
|
|
RSPI RespireRx Pharmaceuticals Inc.
|
657754 |
0.00% |
-0.09
|
- |
- |
-
|
|
RUBY Rubius Therapeutics, Inc.
|
1.7 million |
- |
-2.31
|
- |
- |
-
|
|
RVMD Revolution Medicines, Inc.
|
32.2 billion |
0.00% |
-
|
- |
- |
-
|
|
RVMDW Revolution Medicines, Inc. Warrant
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
RVNC Revance Therapeutics, Inc.
|
381.0 million |
0.00% |
-
|
- |
- |
-
|
|
RVPH Reviva Pharmaceuticals Holdings, Inc.
|
2.1 million |
0.00% |
-
|
- |
- |
-
|
|
RVPHW Reviva Pharmaceuticals Holdings, Inc.
|
343911 |
0.00% |
-
|
- |
- |
-
|
|
RVU.WA Ryvu Therapeutics S.A.
|
155.8 million |
0.00% |
-4.96
|
- |
- |
-
|
|
RVXCF Resverlogix Corp.
|
22.2 million |
0.00% |
-
|
- |
- |
-
|
|
RVX.TO Resverlogix Corp.
|
26.3 million |
0.00% |
-3.25
|
- |
- |
-
|
|
RXDX Prometheus Biosciences, Inc.
|
9.3 billion |
- |
-9.98
|
- |
- |
-
|
|
RXRX Recursion Pharmaceuticals, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
|
RYTM Rhythm Pharmaceuticals, Inc.
|
5.9 billion |
0.00% |
-
|
- |
- |
-
|
|
RZLT Rezolute, Inc.
|
441.0 million |
0.00% |
-
|
- |
- |
-
|
|
SABS SAB Biotherapeutics, Inc.
|
33.2 million |
0.00% |
-
|
- |
- |
-
|
|
SABSW SAB Biotherapeutics, Inc.
|
160577 |
0.00% |
0.06
|
- |
- |
-
|
|
SAGE Sage Therapeutics, Inc.
|
544.9 million |
0.00% |
-
|
- |
- |
-
|
|
SANA Sana Biotechnology, Inc.
|
868.3 million |
0.00% |
-
|
- |
- |
-
|
|
SANION.ST Saniona AB (publ)
|
207.4 million |
0.00% |
7.08
|
- |
- |
-
|
|
SANN.SW Santhera Pharmaceuticals Holding AG
|
263.9 million |
0.00% |
-2.84
|
- |
- |
-
|
|
SAR.L Sareum Holdings plc
|
282948 |
0.00% |
-3.87
|
- |
- |
-
|
|
SAVA Cassava Sciences, Inc.
|
98.1 million |
0.00% |
-0.91
|
- |
- |
-
|
|
SBBP Strongbridge Biopharma plc
|
135.5 million |
- |
-3.29
|
- |
- |
-
|
|
SBPH Spring Bank Pharmaceuticals, In
|
5.2 million |
- |
-0.81
|
- |
- |
-
|
|
SBTX Silverback Therapeutics, Inc.
|
206.2 million |
- |
-
|
- |
- |
-
|
|
SBTX.L SkinBioTherapeutics Plc
|
326395 |
0.00% |
-9.53
|
- |
- |
-
|
|
SCLP.L Scancell Holdings plc
|
1.8 million |
0.00% |
-12.76
|
- |
- |
-
|
|
SCNI Scinai Immunotherapeutics Ltd.
|
542325 |
0.00% |
0.20
|
- |
- |
-
|
|
SCNLF Scancell Holdings plc
|
347.5 million |
0.00% |
-15.56
|
- |
- |
-
|
|
SCPH scPharmaceuticals Inc.
|
302.2 million |
0.00% |
-3.13
|
- |
- |
-
|
|
SCPS Scopus BioPharma Inc.
|
294590 |
- |
-0.02
|
- |
- |
-
|
|
SCPX Scorpius Holdings, Inc.
|
17343 |
0.00% |
-
|
- |
- |
-
|
|
SEEL Seelos Therapeutics, Inc.
|
429940 |
0.00% |
0.00
|
- |
- |
-
|
|
SEER Seer, Inc.
|
98.4 million |
0.00% |
-
|
- |
- |
-
|
|
SELB Selecta Biosciences, Inc.
|
153.4 million |
- |
10.41
|
- |
- |
-
|
|
SEOVF Sernova Corp.
|
44.2 million |
0.00% |
-
|
- |
- |
-
|
|
SEPN Septerna, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
SEPSF Asep Medical Holdings Inc
|
121249 |
0.00% |
-
|
- |
- |
-
|
|
SER Serina Therapeutics, Inc.
|
20.4 million |
0.00% |
-
|
- |
- |
-
|
|
SESN Sesen Bio, Inc.
|
119.3 million |
- |
1.91
|
1 |
1 |
-
|
|
SGEN Seagen Inc.
|
41.2 billion |
6.15% |
-54.52
|
- |
- |
-
|
|
SGMO Sangamo Therapeutics, Inc.
|
91.1 million |
0.00% |
-
|
- |
- |
-
|
|
SGMT Sagimet Biosciences Inc.
|
223.5 million |
0.00% |
-
|
- |
- |
-
|
|
SGP SpyGlass Pharma, Inc. Common Stock
|
616.5 million |
0.00% |
-
|
- |
- |
-
|
|
SGTX Sigilon Therapeutics, Inc.
|
18.2 million |
- |
-
|
- |
- |
-
|
|
SHJBF Shanghai Junshi Biosciences Co., Ltd.
|
4.8 billion |
0.00% |
-20
|
- |
- |
-
|
|
SIGHT.PA GenSight Biologics S.A.
|
19.0 million |
0.00% |
-0.67
|
- |
- |
-
|
|
SIGY Sigyn Therapeutics, Inc.
|
64215 |
0.00% |
-0.03
|
- |
- |
-
|
|
SILO Silo Pharma, Inc.
|
5.3 million |
0.00% |
-
|
- |
- |
-
|
|
SIMRIS-B.ST Simris Alg AB (publ)
|
6.4 million |
0.00% |
-1.67
|
- |
- |
-
|
|
SION Sionna Therapeutics, Inc.
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
|
SIOX Sio Gene Therapies Inc.
|
28.8 million |
- |
-1
|
- |
1 |
-
|
|
SKYE Skye Bioscience, Inc.
|
27.1 million |
0.00% |
-
|
- |
- |
-
|
|
SLBT SL Science Holding Limited Ordinary Shares
|
- |
- |
-
|
- |
- |
-
|
|
SLDB Solid Biosciences Inc.
|
564.1 million |
0.00% |
-
|
- |
- |
-
|
|
SLGL Sol-Gel Technologies Ltd.
|
219.1 million |
0.00% |
-
|
- |
- |
-
|
|
SLN Silence Therapeutics plc
|
302.8 million |
0.00% |
-
|
- |
- |
-
|
|
SLNCF Silence Therapeutics plc
|
150.2 million |
0.00% |
-3.89
|
- |
- |
-
|
|
SLNO Soleno Therapeutics, Inc.
|
2.8 billion |
0.00% |
27.47
|
- |
- |
-
|
|
SLRN Acelyrin, Inc.
|
229.2 million |
0.00% |
-0.84
|
- |
- |
-
|
|
SLRX Salarius Pharmaceuticals, Inc.
|
3.8 million |
0.00% |
-0.03
|
- |
- |
-
|
|
SLS SELLAS Life Sciences Group, Inc.
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
|
SLXN Silexion Therapeutics Ltd.
|
2.0 million |
0.00% |
-
|
- |
- |
-
|
|
SLXNW Silexion Therapeutics Ltd.
|
20083 |
0.00% |
-
|
- |
- |
-
|
|
SMMT Summit Therapeutics Inc.
|
11.7 billion |
0.00% |
-
|
- |
- |
-
|
|
SMSLIFE.BO Haleos Labs Ltd.
|
40.8 million |
0.12% |
20.61
|
1 |
5 |
-
|
|
SMSLIFE.NS SMS Lifesciences India Limited
|
39.7 million |
0.12% |
20.06
|
1 |
5 |
-
|
|
SNBIF SanBio Company Limited
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
SNDX Syndax Pharmaceuticals, Inc.
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
|
SNGX Soligenix, Inc.
|
4.6 million |
0.00% |
-
|
- |
- |
-
|
|
SNNAQ Sienna Biopharmaceuticals, Inc.
|
3091 |
0.00% |
-
|
- |
- |
-
|
|
SNPX Synaptogenix, Inc.
|
10.9 million |
0.00% |
-0.75
|
- |
- |
-
|
|
SNSE Sensei Biotherapeutics, Inc.
|
19.7 million |
0.00% |
-
|
- |
- |
-
|
|
SNTI Senti Biosciences, Inc.
|
26.3 million |
0.00% |
-
|
- |
- |
-
|
|
SOLTF Nxera Pharma Co., Ltd.
|
642.1 million |
0.00% |
-6.11
|
- |
- |
-
|
|
SONN Sonnet BioTherapeutics Holdings, Inc.
|
8.4 million |
0.00% |
-0.18
|
- |
- |
-
|
|
SPAGO.ST Spago Nanomedical AB (publ)
|
4.6 million |
0.00% |
-1.71
|
- |
- |
-
|
|
SPHDF Santhera Pharmaceuticals Holding AG
|
337.7 million |
0.00% |
-
|
- |
- |
-
|
|
SPHRF Starpharma Holdings Limited
|
210.5 million |
0.00% |
-32
|
- |
- |
-
|
|
SPHRY Starpharma Holdings Limited
|
220.6 million |
0.00% |
-52.50
|
- |
- |
-
|
|
SPHS Sophiris Bio, Inc.
|
34 |
- |
0.00
|
- |
- |
-
|
|
SPL.AX Starpharma Holdings Limited
|
117.4 million |
0.00% |
-40.50
|
- |
- |
-
|
|
SPPH Spencer Pharmaceutical Inc.
|
29436 |
0.00% |
-0.03
|
- |
- |
-
|
|
SPPI Spectrum Pharmaceuticals, Inc.
|
266.9 million |
0.00% |
-2.93
|
- |
- |
-
|
|
SPRB Spruce Biosciences, Inc.
|
5.1 million |
0.00% |
-
|
- |
- |
-
|
|
SPRC SciSparc Ltd.
|
667462 |
0.00% |
-0.14
|
- |
- |
-
|
|
SPRINT.ST Sprint Bioscience AB (publ)
|
20.5 million |
0.00% |
-6.28
|
- |
- |
-
|
|
SPRO Spero Therapeutics, Inc.
|
163.3 million |
0.00% |
9.63
|
- |
- |
-
|
|
SPRY ARS Pharmaceuticals, Inc.
|
850.0 million |
0.00% |
-
|
- |
- |
-
|
|
SPTX Seaport Therapeutics, Inc. Common Stock
|
1.0 billion |
0.00% |
-
|
- |
- |
-
|
|
SQZ SQZ Biotechnologies Company
|
19.0 million |
- |
-
|
- |
- |
-
|
|
SQZB SQZ Biotechnologies Company
|
707787 |
0.00% |
-
|
- |
- |
-
|
|
SRBCF Sirona Biochem Corp.
|
1.6 million |
0.00% |
-0.51
|
- |
- |
-
|
|
SRNE Sorrento Therapeutics, Inc.
|
168.4 million |
- |
-4.43
|
- |
- |
-
|
|
SRPT Sarepta Therapeutics, Inc.
|
1.7 billion |
0.00% |
55.43
|
- |
- |
-
|
|
SRRA Sierra Oncology, Inc.
|
827.9 million |
- |
-1.06
|
- |
- |
-
|
|
SRRK Scholar Rock Holding Corporation
|
5.4 billion |
0.00% |
-
|
- |
- |
-
|
|
SRZN Surrozen, Inc.
|
160.9 million |
0.00% |
-
|
- |
- |
-
|
|
SRZNW Surrozen, Inc.
|
331.7 million |
- |
-
|
- |
- |
-
|
|
STAB Statera Biopharma, Inc.
|
42850 |
0.00% |
-
|
- |
- |
-
|
|
STABL.ST Stayble Therapeutics AB (publ)
|
1.2 million |
0.00% |
-1.62
|
- |
- |
-
|
|
STARSOURCE.BO Starsource Multitrade Limited
|
1.4 million |
0.00% |
-1.10
|
- |
- |
-
|
|
STMM Stemcell Holdings, Inc.
|
1.6 million |
0.00% |
0.55
|
- |
- |
-
|
|
STOK Stoke Therapeutics, Inc.
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
|
STRAP.CO Strategic Partners A/S
|
3.7 million |
0.00% |
-6.59
|
- |
- |
-
|
|
STRO Sutro Biopharma, Inc.
|
249.6 million |
0.00% |
-
|
- |
- |
-
|
|
STSA Satsuma Pharmaceuticals, Inc.
|
34.8 million |
0.72% |
-1.58
|
- |
- |
-
|
|
STTK Shattuck Labs, Inc.
|
219.4 million |
0.00% |
-
|
- |
- |
-
|
|
SUPRIYA.BO Supriya Lifescience Limited
|
534.5 million |
0.16% |
27.20
|
1 |
4 |
-
|
|
SUPRIYA.NS Supriya Lifescience Limited
|
529.0 million |
0.16% |
26.96
|
1 |
4 |
-
|
|
SURF Surface Oncology, Inc.
|
37.6 million |
- |
0.98
|
- |
- |
-
|
|
SUVZ Suvanza Pharma, LLC
|
1.0 million |
0.00% |
-
|
- |
- |
-
|
|
SVA Sinovac Biotech Ltd.
|
642.4 million |
2.82% |
6.66
|
- |
- |
-
|
|
SVA.TO Sernova Corp.
|
35.6 million |
0.00% |
-3
|
- |
- |
-
|
|
SVE.WA Synthaverse S.A.
|
74.0 million |
0.00% |
-45.87
|
- |
- |
-
|
|
SVRA Savara Inc.
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
|
SWTX SpringWorks Therapeutics, Inc.
|
3.5 billion |
0.00% |
-13.78
|
- |
- |
-
|
|
SXTP 60 Degrees Pharmaceuticals, Inc.
|
1.2 million |
0.00% |
-
|
- |
- |
-
|
|
SYBE SYBLEU Inc
|
583742 |
0.00% |
-1.83
|
- |
- |
-
|
|
SYBX Synlogic, Inc.
|
8.1 million |
0.00% |
-2.31
|
- |
- |
-
|
|
SYGGF Synairgen plc
|
110266 |
0.00% |
-
|
- |
- |
-
|
|
SYN Synthetic Biologics, Inc.
|
134.7 million |
- |
-0.48
|
- |
- |
-
|
|
SYNACT.ST SynAct Pharma AB
|
98.1 million |
0.00% |
-8.26
|
- |
- |
-
|
|
SYNGENE.BO Syngene International Limited
|
1.7 billion |
0.31% |
46.67
|
1 |
5 |
30%
|
|
SYNGENE.NS Syngene International Limited
|
1.7 billion |
0.31% |
45.84
|
1 |
5 |
8%
|
|
SYRE Spyre Therapeutics, Inc.
|
4.7 billion |
0.00% |
-
|
- |
- |
-
|
|
SYRS Syros Pharmaceuticals, Inc.
|
5366 |
0.00% |
-0.01
|
- |
- |
-
|
|
SYVC Synovics Pharmaceuticals, Inc.
|
2983 |
0.00% |
-
|
- |
- |
-
|
|
TAKE.BO TAKE Solutions Limited
|
54.1 million |
0.00% |
-344.80
|
- |
- |
-
|
|
TAKE.NS TAKE Solutions Limited
|
59.7 million |
0.00% |
-381.10
|
- |
- |
-
|
|
TALS Talaris Therapeutics, Inc.
|
125.7 million |
- |
-
|
- |
- |
-
|
|
TARA Protara Therapeutics, Inc.
|
160.5 million |
0.00% |
-
|
- |
- |
-
|
|
TARS Tarsus Pharmaceuticals, Inc.
|
2.5 billion |
0.00% |
-
|
- |
- |
-
|
|
TBPH Theravance Biopharma, Inc.
|
803.2 million |
0.00% |
7.41
|
- |
- |
-
|
|
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF
|
3.1 million |
1.67% |
23.57
|
2 |
1 |
-
|
|
TCDA Tricida, Inc.
|
2.4 million |
- |
-1.20
|
- |
- |
-
|
|
TCF.L Theracryf Plc
|
58247 |
0.00% |
-0.20
|
- |
- |
-
|
|
TCON TRACON Pharmaceuticals, Inc.
|
109725 |
0.00% |
0.01
|
- |
- |
-
|
|
TCRR TCR2 Therapeutics Inc.
|
77.7 million |
- |
-11.16
|
- |
- |
-
|
|
TCRT Alaunos Therapeutics, Inc.
|
5.7 million |
0.00% |
-1.57
|
- |
- |
-
|
|
TCRX TScan Therapeutics, Inc.
|
60.0 million |
0.00% |
-
|
- |
- |
-
|
|
TECH Bio-Techne Corporation
|
8.1 billion |
0.62% |
67.74
|
4 |
19 |
13%
|
|
TECX Tectonic Therapeutic, Inc.
|
547.2 million |
0.00% |
-
|
- |
- |
-
|
|
TELI.CN Telescope Innovations Corp.
|
13.9 million |
0.00% |
-9
|
- |
- |
-
|
|
TELIF Telescope Innovations Corp.
|
33.1 million |
0.00% |
-8.92
|
- |
- |
-
|
|
TELO Telomir Pharmaceuticals, Inc. Common Stock
|
41.6 million |
0.00% |
-
|
- |
- |
-
|
|
TENX Tenax Therapeutics, Inc.
|
188.8 million |
0.00% |
-
|
- |
- |
-
|
|
TERN Terns Pharmaceuticals, Inc.
|
6.1 billion |
0.00% |
-
|
- |
- |
-
|
|
TFFP TFF Pharmaceuticals, Inc.
|
722882 |
0.00% |
-
|
- |
- |
-
|
|
TGRP TRON Group Inc.
|
7.9 million |
0.00% |
-
|
- |
- |
-
|
|
TGTX TG Therapeutics, Inc.
|
6.1 billion |
0.00% |
15.08
|
- |
- |
-
|
|
THAR Tharimmune, Inc.
|
203.2 million |
0.00% |
-1.40
|
- |
- |
-
|
|
THAT.L Thalia Therapeutics Plc
|
52270 |
0.00% |
-
|
- |
- |
-
|
|
THER Theralink Technologies, Inc.
|
615149 |
0.00% |
-0.01
|
- |
- |
-
|
|
THRD Third Harmonic Bio, Inc.
|
242.8 million |
0.00% |
-4.34
|
- |
- |
-
|
|
THRX Theseus Pharmaceuticals, Inc.
|
181.3 million |
0.00% |
-3.03
|
- |
- |
-
|
|
THTX Theratechnologies Inc.
|
155.9 million |
0.00% |
-17.84
|
- |
- |
-
|
|
TIL Instil Bio, Inc.
|
55.2 million |
0.00% |
-
|
- |
- |
-
|
|
TITANBIO.BO Titan Biotech Limited
|
118.9 million |
0.74% |
41.26
|
1 |
6 |
10%
|
|
TLC Taiwan Liposome Company, Ltd.
|
294.5 million |
- |
-5.13
|
- |
- |
-
|
|
TLOG TetraLogic Pharmaceuticals Corporation
|
458720 |
4.85% |
-0.02
|
- |
- |
-
|
|
TLPPF Telix Pharmaceuticals Limited
|
3.2 billion |
0.00% |
-350
|
- |
- |
-
|
|
TLSA Tiziana Life Sciences Ltd
|
75.5 million |
0.00% |
-11.58
|
- |
- |
-
|
|
TLX.AX Telix Pharmaceuticals Limited
|
2.4 billion |
0.00% |
-336.33
|
- |
- |
-
|
|
TMBR Timber Pharmaceuticals, Inc.
|
1.3 million |
- |
-0.05
|
- |
- |
-
|
|
TNGNQ Tengion, Inc.
|
4025 |
0.00% |
-
|
- |
- |
-
|
|
TNG.PA Transgene S.A.
|
123.5 million |
0.00% |
-2.93
|
- |
- |
-
|
|
TNGX Tango Therapeutics, Inc.
|
2.6 billion |
0.00% |
-
|
- |
- |
-
|
|
TNXP Tonix Pharmaceuticals Holding Corp.
|
178.0 million |
0.00% |
-
|
- |
- |
-
|
|
TOVX Theriva Biologics, Inc.
|
10.1 million |
0.00% |
-
|
- |
- |
-
|
|
TPST Tempest Therapeutics, Inc.
|
5.6 million |
0.00% |
-
|
- |
- |
-
|
|
TPTX Turning Point Therapeutics, Inc.
|
3.8 billion |
- |
-31.45
|
- |
- |
-
|
|
TRABI.BO Transgene Biotek Limited
|
2.1 million |
0.00% |
-11.64
|
- |
- |
-
|
|
TRAW Traws Pharma, Inc.
|
12.5 million |
0.00% |
-
|
- |
- |
-
|
|
TRAX First Tracks Biotherapeutics Inc
|
579.2 million |
- |
-
|
- |
- |
-
|
|
TRAXV First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
|
- |
0.00% |
-
|
- |
- |
-
|
|
TRDA Entrada Therapeutics, Inc.
|
247.3 million |
0.00% |
-
|
- |
- |
-
|
|
TRGNF Transgene S.A.
|
132.1 million |
0.00% |
-3.03
|
- |
- |
-
|
|
TRIL Trillium Therapeutics Inc.
|
1.9 billion |
5.56% |
-10.91
|
- |
- |
-
|
|
TRMED.OL Thor Medical ASA
|
152.1 million |
0.00% |
-19.32
|
- |
- |
-
|
|
TRML Tourmaline Bio, Inc.
|
1.2 billion |
- |
-13.95
|
1 |
- |
-
|
|
TRP.AX Tissue Repair Ltd
|
6.5 million |
0.00% |
-2.21
|
- |
- |
-
|
|
TRRI Trinity Resources Inc.
|
753 |
0.00% |
-
|
- |
- |
-
|
|
TRVI Trevi Therapeutics, Inc.
|
1.9 billion |
0.00% |
-
|
- |
- |
-
|
|
TRVN Trevena, Inc.
|
864 |
0.00% |
-
|
- |
- |
-
|
|
TSHA Taysha Gene Therapies, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
TSOI Therapeutic Solutions International, Inc.
|
512271 |
0.00% |
-
|
- |
- |
-
|
|
TSVT 2seventy bio, Inc.
|
266.1 million |
0.00% |
-
|
- |
- |
-
|
|
TTNP Titan Pharmaceuticals, Inc.
|
3.1 million |
0.00% |
-0.80
|
- |
- |
-
|
|
TTRX Turn Therapeutics Inc.
|
171.1 million |
0.00% |
-
|
- |
- |
-
|
|
TTX.AX Tetratherix Ltd.
|
136.7 million |
0.00% |
-9.75
|
- |
- |
-
|
|
TUB.BR Financière de Tubize S.A.
|
11.1 billion |
0.41% |
104.55
|
1 |
27 |
10%
|
|
TVGN Tevogen Bio Holdings Inc.
|
37.9 million |
0.00% |
-
|
- |
- |
-
|
|
TVGNW Tevogen Bio Holdings Inc.
|
8.7 million |
0.00% |
-
|
- |
- |
-
|
|
TVRD Tvardi Therapeutics, Inc.
|
27.1 million |
0.00% |
-
|
- |
- |
-
|
|
TVTX Travere Therapeutics, Inc.
|
4.3 billion |
0.00% |
-
|
- |
- |
-
|
|
TXTM ProText Mobility, Inc.
|
12.3 million |
0.00% |
0.00
|
- |
- |
-
|
|
TYME Tyme Technologies, Inc.
|
53.5 million |
- |
-4.02
|
- |
- |
-
|
|
TYRA Tyra Biosciences, Inc.
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
|
UBM.MI Ulisse Biomed S.p.A.
|
22.4 million |
0.00% |
-40.30
|
- |
- |
-
|
|
UBX Unity Biotechnology, Inc.
|
5.0 million |
0.00% |
-0.18
|
- |
- |
-
|
|
UCB.BR UCB S.A.
|
54.2 billion |
0.58% |
36.38
|
1 |
27 |
-1%
|
|
UCBJF UCB S.A.
|
23.2 billion |
0.01% |
64.21
|
- |
- |
-
|
|
UCBJY UCB S.A.
|
57.4 billion |
0.56% |
36.57
|
1 |
17 |
7%
|
|
UNBX Unity Biotechnology, Inc.
|
965603 |
- |
-0.03
|
- |
- |
-
|
|
UNCY Unicycive Therapeutics, Inc.
|
148.7 million |
0.00% |
-
|
- |
- |
-
|
|
UPB Upstream Bio, Inc.
|
383.7 million |
0.00% |
-1.22
|
- |
- |
-
|
|
URGN UroGen Pharma Ltd.
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
URT.WA Urteste S.A.
|
20.7 million |
0.00% |
-13.14
|
- |
- |
-
|
|
USRM U.S. Stem Cell, Inc.
|
64151 |
0.00% |
-0.01
|
- |
- |
-
|
|
UTHR United Therapeutics Corporation
|
23.2 billion |
0.00% |
21.51
|
- |
- |
-
|
|
VACC Barinthus Biotherapeutics plc
|
192.7 million |
- |
15.64
|
- |
- |
-
|
|
VAL.L ValiRx plc
|
16581 |
0.00% |
-0.33
|
- |
- |
-
|
|
VALN Valneva SE
|
488.0 million |
0.00% |
-
|
- |
- |
-
|
|
VANI Vivani Medical, Inc.
|
69.7 million |
0.00% |
-
|
- |
- |
-
|
|
VAXX Vaxxinity, Inc.
|
25357 |
0.00% |
-0.05
|
- |
- |
-
|
|
VBIV VBI Vaccines, Inc.
|
1.9 million |
0.00% |
-
|
- |
- |
-
|
|
VBIZF Viva Biotech Holdings
|
337.8 million |
0.00% |
34.34
|
- |
- |
-
|
|
VBLT Vascular Biogenics Ltd.
|
15.0 million |
8.81% |
-2.03
|
- |
- |
-
|
|
VBS.AX Vectus Biosystems Limited
|
4.6 million |
0.00% |
-4.17
|
- |
- |
-
|
|
VCEL Vericel Corporation
|
1.8 billion |
0.00% |
76.56
|
- |
- |
-
|
|
VCNX Vaccinex, Inc.
|
2.7 million |
0.00% |
-
|
- |
- |
-
|
|
VECT VectivBio Holding AG
|
799.9 million |
- |
-
|
- |
- |
-
|
|
VERA Vera Therapeutics, Inc.
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
|
VERU Veru Inc.
|
54.6 million |
0.00% |
-
|
- |
- |
-
|
|
VERV Verve Therapeutics, Inc.
|
994.0 million |
0.00% |
-
|
- |
- |
-
|
|
VIAP VIA Pharmaceuticals, Inc.
|
10279 |
0.00% |
-0.05
|
- |
- |
-
|
|
VICO.ST Vicore Pharma Holding AB (publ)
|
311.6 million |
0.00% |
-
|
- |
- |
-
|
|
VICP Vicapsys Life Sciences, Inc.
|
47.3 million |
0.00% |
-50
|
- |
- |
-
|
|
VIGL Vigil Neuroscience, Inc.
|
383.9 million |
0.00% |
-3.91
|
- |
- |
-
|
|
VINC Vincerx Pharma, Inc.
|
66475 |
0.00% |
-0.01
|
- |
- |
-
|
|
VIR Vir Biotechnology, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
|
VIRI Virios Therapeutics, Inc.
|
4.7 million |
0.00% |
-2.54
|
- |
- |
-
|
|
VIRX Viracta Therapeutics, Inc.
|
388698 |
0.00% |
-0.01
|
- |
- |
-
|
|
VIVOBIOT.BO Vivo Bio Tech Limited
|
4.8 million |
0.00% |
11.27
|
- |
- |
-
|
|
VIVS VivoSim Labs, Inc.
|
3.3 million |
0.00% |
0.64
|
- |
- |
-
|
|
VKTX Viking Therapeutics, Inc.
|
3.5 billion |
0.00% |
-
|
- |
- |
-
|
|
VLA.PA Valneva SE
|
559.1 million |
0.00% |
-
|
- |
- |
-
|
|
VNDA Vanda Pharmaceuticals Inc.
|
366.2 million |
0.00% |
-
|
- |
- |
-
|
|
VOQP VioQuest Pharmaceuticals, Inc.
|
14719 |
0.00% |
-0.01
|
- |
- |
-
|
|
VOR Vor Biopharma Inc.
|
91.1 million |
0.00% |
-
|
- |
- |
-
|
|
VRAX Virax Biolabs Group Limited
|
1.4 million |
0.00% |
-
|
- |
- |
-
|
|
VRCA Verrica Pharmaceuticals Inc.
|
64.3 million |
0.00% |
-
|
- |
- |
-
|
|
VRNA Verona Pharma plc
|
9.1 billion |
0.00% |
-102.70
|
- |
- |
-
|
|
VRPX Virpax Pharmaceuticals, Inc.
|
497 |
0.00% |
-0.01
|
- |
- |
-
|
|
VRTX Vertex Pharmaceuticals Incorporated
|
108.7 billion |
0.00% |
25.51
|
- |
- |
-
|
|
VRXA Veraxa Biotech Holding AG
|
- |
- |
-
|
- |
- |
-
|
|
VRXAW Voyager Acquisition Corp
|
- |
- |
-
|
- |
- |
-
|
|
VSBC VitaSpring Biomedical Co. Ltd.
|
2.3 million |
0.00% |
-0.56
|
- |
- |
-
|
|
VSTM Verastem, Inc.
|
257.2 million |
0.00% |
-
|
- |
- |
-
|
|
VTGN VistaGen Therapeutics, Inc.
|
27.5 million |
0.00% |
-
|
- |
- |
-
|
|
VTVT vTv Therapeutics Inc.
|
90.6 million |
0.00% |
-
|
- |
- |
-
|
|
VTYX Ventyx Biosciences, Inc.
|
1.0 billion |
0.00% |
-9.40
|
- |
- |
-
|
|
VVY.AS Vivoryon Therapeutics N.V.
|
46.9 million |
0.00% |
-2.90
|
- |
- |
-
|
|
VX1.DE Vertex Pharmaceuticals Incorporated
|
117.7 billion |
0.00% |
31.29
|
- |
- |
-
|
|
VXL.V Vaxil Bio Ltd.
|
309113 |
0.00% |
-8
|
- |
- |
-
|
|
VXRT Vaxart, Inc.
|
150.1 million |
0.00% |
4.31
|
- |
- |
-
|
|
VYGR Voyager Therapeutics, Inc.
|
201.2 million |
0.00% |
-
|
- |
- |
-
|
|
VYNE VYNE Therapeutics Inc.
|
11.1 million |
0.00% |
-
|
- |
- |
-
|
|
VYNT Vyant Bio, Inc.
|
1.2 million |
- |
0.65
|
- |
- |
-
|
|
WHWK Whitehawk Therapeutics Inc
|
205.2 million |
0.00% |
-
|
- |
- |
-
|
|
WINT Windtree Therapeutics, Inc.
|
539340 |
0.00% |
-
|
- |
- |
-
|
|
WSNAF Wesana Health Holdings Inc.
|
341000 |
0.00% |
-
|
- |
- |
-
|
|
WVE Wave Life Sciences Ltd.
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
|
WXIBF WuXi Biologics (Cayman) Inc.
|
25.6 billion |
- |
46.31
|
- |
- |
-
|
|
WXXWY WuXi Biologics (Cayman) Inc.
|
16.9 billion |
0.00% |
23.76
|
- |
- |
-
|
|
XBIO Xenetic Biosciences, Inc.
|
6.5 million |
0.00% |
-
|
- |
- |
-
|
|
XBIT XBiotech Inc.
|
72.3 million |
0.00% |
-
|
- |
- |
-
|
|
XBRANE.ST Xbrane Biopharma AB (publ)
|
7.3 million |
0.00% |
-194.73
|
- |
- |
-
|
|
XCUR Exicure, Inc.
|
20.1 million |
0.00% |
-
|
- |
- |
-
|
|
XENE Xenon Pharmaceuticals Inc.
|
4.2 billion |
0.00% |
-
|
- |
- |
-
|
|
XENO Xeno Transplants Corporation
|
4036 |
0.00% |
-
|
- |
- |
-
|
|
XERS Xeris Biopharma Holdings, Inc.
|
1.1 billion |
0.00% |
91.86
|
- |
- |
-
|
|
XFOR X4 Pharmaceuticals, Inc.
|
361.2 million |
0.00% |
-
|
- |
- |
-
|
|
XINT.ST Xintela AB (publ)
|
18.8 million |
0.00% |
-3.71
|
- |
- |
-
|
|
XLO Xilio Therapeutics, Inc.
|
46.1 million |
0.00% |
-
|
- |
- |
-
|
|
XLRN Acceleron Pharma Inc.
|
10.9 billion |
- |
-41.22
|
- |
- |
-
|
|
XNCR Xencor, Inc.
|
885.9 million |
0.00% |
-
|
- |
- |
-
|
|
XOMA XOMA Royalty Corp.
|
522.8 million |
5.18% |
26.53
|
- |
- |
-
|
|
XOMAO XOMA Corporation
|
305.8 million |
8.26% |
25.29
|
4 |
6 |
-
|
|
XOMAP XOMA Corporation
|
307.1 million |
8.47% |
25.27
|
4 |
6 |
-
|
|
XRTX XORTX Therapeutics Inc.
|
626600 |
0.00% |
-1.01
|
- |
- |
-
|
|
XRTX.V XORTX Therapeutics Inc.
|
1.3 million |
0.00% |
-0.88
|
- |
- |
-
|
|
XSNX NovAccess Global Inc.
|
6165 |
0.00% |
-
|
- |
- |
-
|
|
XSPRAY.ST Xspray Pharma AB (publ)
|
110.1 million |
0.00% |
-5.74
|
- |
- |
-
|
|
XTLB XTL Biopharmaceuticals Ltd.
|
4.9 million |
0.00% |
-0.90
|
- |
- |
-
|
|
XTLB.TA XTL Biopharmaceuticals Ltd.
|
66309 |
0.00% |
-0.70
|
- |
- |
-
|
|
YDES YD Bio Limited Ordinary Shares
|
226.0 million |
0.00% |
-422.50
|
- |
- |
-
|
|
YDESW YD Bio Limited Warrants
|
1.2 million |
0.00% |
-
|
- |
- |
-
|
|
YECO EV Biologics, Inc.
|
6.1 million |
- |
-0.49
|
- |
- |
-
|
|
YMAB Y-mAbs Therapeutics, Inc.
|
389.4 million |
0.00% |
-17.14
|
- |
- |
-
|
|
YMTX Yumanity Therapeutics, Inc.
|
22.0 million |
- |
-
|
1 |
1 |
-
|
|
ZEAL Zealand Pharma A/S
|
814.1 million |
- |
-13.97
|
- |
- |
-
|
|
ZEAL.CO Zealand Pharma A/S
|
2.5 billion |
0.00% |
2.60
|
- |
- |
-
|
|
ZEOX Zeo ScientifiX, Inc.
|
12.5 million |
0.00% |
-2.37
|
- |
- |
-
|
|
ZGNX Zogenix, Inc.
|
892.0 million |
- |
-3.56
|
- |
- |
-
|
|
ZHCLF Zenith Capital Corp.
|
8.0 million |
0.00% |
-3
|
- |
- |
-
|
|
ZIMCF ZIM Corporation
|
1627 |
0.00% |
-0.02
|
- |
- |
-
|
|
ZIOP ZIOPHARM Oncology, Inc.
|
220.5 million |
- |
-7.57
|
- |
- |
-
|
|
ZIVO ZIVO Bioscience, Inc.
|
11.9 million |
0.00% |
-4.24
|
- |
- |
-
|
|
ZIVOW Zivo Bioscience, Inc.
|
35.3 million |
0.00% |
-
|
- |
- |
-
|
|
ZLAB Zai Lab Limited
|
1.9 billion |
0.00% |
-
|
- |
- |
-
|
|
ZLDAF Zelira Therapeutics Limited
|
4.2 million |
0.00% |
-1.89
|
- |
- |
-
|
|
ZLD.AX Zelira Therapeutics Limited
|
4.1 million |
0.00% |
-1.56
|
- |
- |
-
|
|
ZLDPF Zealand Pharma A/S
|
3.5 billion |
0.00% |
3.85
|
- |
- |
-
|
|
ZLNA.OL Zelluna ASA
|
42.5 million |
0.00% |
-2.25
|
- |
- |
-
|
|
ZNTL Zentalis Pharmaceuticals, Inc.
|
275.5 million |
0.00% |
-
|
- |
- |
-
|
|
ZOTA.NS Zota Health Care Limited
|
387.0 million |
0.08% |
-50.13
|
1 |
9 |
-4%
|
|
ZSAN Zosano Pharma Corporation
|
66.0 million |
- |
-0.33
|
- |
- |
-
|
|
ZURA Zura Bio Limited
|
253.8 million |
0.00% |
-
|
- |
- |
-
|
|
ZVRA Zevra Therapeutics, Inc.
|
647.9 million |
0.00% |
5.37
|
- |
- |
-
|
|
ZVSA ZyVersa Therapeutics, Inc.
|
1.6 million |
0.00% |
-0.07
|
- |
- |
-
|
|
ZYME Zymeworks Inc.
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|